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ABSTRACT 
ALLOSTERIC REGULATION OF PYRUVATE CARBOXYLASE 
 
 
Yumeng Liu 
 
Marquette University, 2018 
 
 
Pyruvate carboxylase (PC; E.C.6.4.1.1) is a multifunctional, biotin-
dependent enzyme that catalyzes the MgATP-dependent carboxylation of 
pyruvate to oxaloacetate. The overall reaction is accomplished by the coupling of 
two half reactions occurring at two spatially distinct catalytic domains by the 
translocation of a carrier domain, resulting in a net transfer of CO2 from 
bicarbonate to pyruvate. PC activity is regulated by multiple allosteric effectors 
with acetyl CoA serving as an activator in most species and L-aspartate serving as 
an inhibitor for microbial PC. The kinetic characterization of PC from different 
species have revealed that PC homologs are subject to divergent degrees of 
allosteric regulation, yet the mechanism controlling the allosteric response still 
remains unknown. 
Rhizobium etli (RePC) is allosterically activated by acetyl CoA, while 
Aspergillus nidulans (AnPC) is unique in not being activated by acetyl CoA. The 
divergent regulatory properties of these two PC homologs were investigated in 
order to uncover the fundamental mechanism underlying the allosteric regulation 
of pyruvate carboxylase. The lack of sensitivity to acetyl CoA activation was 
determined to be an intrinsic property of the BC domain rather than a 
consequence of different acetyl CoA binding sites. Further characterization of 
AnPC compared to RePC revealed that AnPC is a highly stable tetramer that 
remains in a permanently activated state. A more ordered transition state and 
coupled half reactions contribute to its high intrinsic catalytic rate as well as the 
insensitivity to the activation by acetyl CoA. Investigations on the translocation of 
the carrier domain revealed that multiple translocation pathways are adopted by 
the carrier domain in PC during catalysis. Interestingly, an intermolecular 
translocation pathway was promoted upon binding with acetyl CoA in RePC, 
which likely contributes to the enhanced coupling efficiency as well as the 
elevated catalytic rate observed in RePC. Finally, studies on the allosteric 
inhibition of PC by L-aspartate revealed that the antagonistic effects of acetyl 
CoA and L-aspartate to the catalysis of PC result from their competitive binding at 
a partially overlapping binding site. 
Collectively, these studies offer new insights into the mechanism of 
allosteric regulation in pyruvate carboxylase and provide an example of how 
divergent intrinsic properties in homologous enzymes can give rise to their unique 
regulatory properties. 
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I. INTRODUCTION  
Pyruvate carboxylase (PC; E.C.6.4.1.1) is a biotin-dependent enzyme that converts 
pyruvate to oxaloacetate. The reaction catalyzed by PC is the first committed step for 
gluconeogenesis as well as an important anaplerotic reaction to replenish the TCA cycle 
intermediates that are lost to the other competing biosynthetic pathways, including 
carbohydrate, amino acids, and lipid. As functional metabolism is governed by the activity 
of PC, it is not surprising that PC exists in a wide range of species ranging from bacteria to 
mammals. Aberrant PC activity has been identified in several human diseases, such as type-
II diabetes (Kumashiro et al. 2013), obesity, and cancer (Sellers et al. 2015). Studies on the 
catalytic mechanism of PC have lasted for decades since PC was first identified from 
Aspergillus niger, from which an ATP-dependent CO2-fixing system to convert pyruvate 
to oxaloacetate was established (Seubert and Remberger 1961, Woronick and Johnson 
1960). This initial study led to intensive kinetic studies on the catalytic mechanism of PC, 
which revealed that there were two consecutive steps for the complete catalytic turnover 
of converting pyruvate to oxaloacetate (Attwood 1995). The two steps occur at two 
separate subsites, with the co-factor biotin functioning as a carboxyl group carrier to 
transfer the carboxyl group from subsite one to subsite two. The first X-ray structure of PC 
from Rhizobium etli has confirmed that there are two active sites located distantly apart 
from one another in PC. The co-factor biotin is tethered on the carrier domain, translocating 
between the two catalytic domains resulting in the net transfer of the carboxyl group from 
bicarbonate to pyruvate (St Maurice et al. 2007). 
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Allostery is defined as the functional switch that is achieved by the communication 
between the ligand binding site and the functional site of the protein, which is fundamental 
for the protein to perform its function. PC’s activity is finely controlled by allosteric 
effectors in cells ,with acetyl coenzyme A serving as an allosteric activator in most species 
and L-aspartate serving as allosteric inhibitor for the microbial PC (Palacián, de 
Torrontegui, and Losada 1966, Myers, Tolbert, and Utter 1983, Sirithanakorn et al. 2014). 
However, PC from different species are subject to different degrees of regulation by the 
two effectors. For example, PC from Aspergillus nidulans is not activated by acetyl CoA 
and L-aspartate inhibits almost 90% of its activity (Osmani et al. 1981). In comparison, PC 
from Rhizobium etli is very sensitive to activation by acetyl CoA (~10-folds activation) 
while being only moderately inhibited by L-aspartate (50% of its activity) (Sirithanakorn 
et al. 2014). In addition, the two isoforms of PC from yeast, PYC1 and PYC2, are subject 
to the regulation of the two effectors very differently (Jitrapakdee et al. 2007). Kinetic 
studies have revealed that the two molecules competitively bind with PC as well as have 
the antagonistic effects on the catalysis of PC from various species. However, a unified 
mechanism for the competitive binding and the divergent regulatory properties among PC 
homologs still remains elusive.   
The aim of this dissertation is to describe the studies performed on the kinetic and 
structural comparisons between two PC homologs, which have divergent regulatory 
properties for allosteric regulation by acetyl CoA and L-aspartate, in order to further define 
the fundamental mechanism of allostery in PC. By the end of this work, two models will 
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be proposed to illustrate a new insight (crossing guard model) and unified view (free-
energy landscape population shift model) on the mechanism of allosteric regulation of PC. 
1. Fundamental Principles and Mechanisms of Allosteric Regulation  
The phenomenon of allosteric regulation was first observed in the early 1900s by 
Christian Bohr from the sigmoidal curve of oxygen binding to hemoglobin, which was 
interpreted to mean that binding with oxygen at one binding site enhances the binding of 
oxygen at other binding sites. The term “allosteric regulation” was first introduced in 1961 
and was described as the strategy in cells to control metabolic and signal-transduction 
pathways (Monod and Jacob 1961). Cellular metabolism and homeostasis are built on 
networks of interacting proteins. Protein interactions contribute to all of the important 
cellular events, including signal transduction, reaction intermediate handover, modification 
of protein function, etc. Protein function is altered by interactions with other molecules in 
order to optimize cellular function. Such alterations in protein function are typically 
achieved through communication between different sites of the protein, which is the basis 
of allostery. In this section, I will introduce various models that have been developed to 
rationalize allostery in proteins. At the end, I will introduce the allosteric regulation of 
enzymes from both kinetic and thermodynamic points of view. The goal of this section is 
to provide a comprehensive overview of models for allostery that have been developed in 
recent years and how they apply to the regulation of the enzymes.  
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1.1 Evolution of the Allostery Concept 
  The most popular and classic example of allosteric regulation is the binding of 
oxygen in hemoglobin. The sigmoidal curve describing oxygen binding, instead of a 
hyperbola, suggests a positive cooperative binding of oxygen in hemoglobin. After Perutz 
solved the first crystal structure of hemoglobin in 1960 (Perutz et al. 1960) , research began 
to focus on describing protein allostery at the molecular level. The hemoglobin tetramer is 
best described as a homodimer (a2b2) composed of two heterodimers (ab), with one 
oxygen binding sites on each of the subunits, totaling four binding sites over the entire 
tetramer. Binding with oxygen at one subunit alters the conformation of the other subunits 
to a high-affinity state, which facilitates oxygen binding at the other binding sites.   
Two conformations of hemoglobin were named “T” and “R”, representing the 
“tense” and “relaxed” states, respectively. In the T state, hemoglobin has a low affinity for 
oxygen while, in the R state, it has a high affinity. Binding with oxygen will shift the 
conformation from the T state to the R state. The transition from the T to R state gives rise 
to the oxygen-binding cooperativity. Allostery in hemoglobin is classified into two types: 
homotropic and heterotropic allostery. The cooperativity between the four oxygen binding 
sites are considered to be homotropic allostery. 2’3’-Bisphosphoglyceric acid (2’3’-BPG), 
an allosteric inhibitor, binds at the center of the tetramer, stabilizing the T state of 
hemoglobin. This results in an attenuated affinity for oxygen. The inhibition by 2’3’-BPG 
is considered heterotropic allostery. In general, homotropic effectors are the substrates 
themselves, while heterotropic effectors are typically molecules other than the substrates.  
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Two classic models were proposed to describe the allosteric effects in hemoglobin, 
including the “two-state” MWC model by Monod, Wyman and Changeux (Monod, 
Wyman, and Changeux 1965) and the sequential KNF model developed by Koshland, 
Nemethy and Filmer (Koshland, Nemethy, and Filmer 1966) (See Figure I-1). 
 
 
 
  
 
 
6 
 
Figure I-1 Models of allostery of hemoglobin (MWC, KNF) 
R, the relaxed state has high binding affinity with oxygen; T, the tight state that has low binding affinity with 
oxygen.  
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MWC model. In the MWC model, the protein alternates between only two states. 
Either all subunits are in the R (high oxygen affinity) state or they are all in the T (low 
oxygen affinity) state. In the absence of oxygen, the protein is assumed to lie in equilibrium 
between the two states. Binding with oxygen at one site will result in a conformational 
change that will stabilize all subunits in the R state, resulting in enhanced binding affinity 
with oxygen at all other binding sites. Allosteric activators stabilize the R state 
conformation, resulting in a high oxygen binding affinity. In contrast, allosteric inhibitors 
stabilize the T state conformation and shift the population to a low oxygen binding affinity 
state. 
There are three assumptions when using the MWC model to explain protein 
allostery: 1) there are only two states of the protein, active (R) and inactive (T); 2) the state 
of the protein is dictated by the conformation of its quaternary structure; 3) altering the 
state of one subunit induces a quaternary conformational change in the protein, resulting 
in a positive cooperative binding of the ligands.  
KNF model. In the KNF model, in the absence of substrate, all the subunits remain 
in the T state. Each subunit changes individually from the T to the R state upon binding 
with oxygen, so that changes in one subunit promote the conformational change of an 
adjacent subunit to the R state, which in turn has a higher affinity for oxygen.   
There are two assumptions when using the KNF model to explain protein allostery: 
1) there are two states for each subunit, ligand bound (R) and unbound (T); 2) the induced 
conformational change occurs within individual subunits, and in a sequential manner.  
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MWC vs KNF. Both models successfully explain the positive cooperativity 
observed in oxygen binding to hemoglobin. In the MWC model, the cooperativity arises 
from the concerted global conformational change that is promoted at increasing substrate 
concentrations. In the KNF model, the cooperativity arises from the induced 
conformational change mediated through intramolecular interactions between the 
individual subunits. Both models can be applied more generally to the allosteric regulation 
of other proteins that demonstrate sigmoidal ligand binding curves (positive cooperativity). 
However, the KNF model can also be applied to cases where binding with the first ligand 
reduces the binding affinity of the next ligand (negative cooperativity). The MWC model 
does not cover such a scenario, as all the subunits remain in the same state at all times. This 
means binding with a ligand will always promote the transition of the rest of the subunits 
to the same functional state in order to maintain the quaternary symmetry of the protein. 
With ever increasing examples of allosteric regulation being reported in peer-reviewed 
literature, it has been determined that neither of the two models are universal. Rather, 
different proteins are better described using one model over the other, depending on the 
intrinsic properties of the protein. 
Allosteric regulation is classically explained as a functional switch resulting from 
a protein conformational change upon ligand binding. For many years, studies on the 
mechanism of allosteric regulation focused on the conformational change “induced” by the 
ligand. This approach was a result of limited knowledge of allosteric regulation and, more 
importantly, the limited technologies that could be applied to these studies. X-ray 
crystallography represents one of the major technical approaches to examining allosteric 
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mechanisms, with studies focused on describing structural changes in the protein as a result 
of ligand binding. However, X-ray crystallography can only capture static snapshots of the 
protein at certain thermodynamic minima. Increasingly, crystallography has revealed no 
significant conformational changes between the structures in the presence or absence of 
the ligand. This has led to the suggestion that allosteric regulation could take place without 
changing protein conformation.  
The “dynamic allostery” model was proposed in 1984 (Cooper and Dryden 1984). 
This represented a landmark theory to explain allostery in proteins without invoking 
conformational change. With the development of new techniques capable of probing 
protein conformations in solution, specifically advances in nuclear magnetic resonance 
(NMR) technology, new studies began to capture dynamic changes in the protein over 
multiple timescales. Proteins are always in a dynamic state, with movements at the 
nano/pico second timescale (random local motions of individual atoms or groups) or 
micro/milli second (low-frequency domain vibrations and movements) timescale. The 
dynamics of a protein contribute to its free energy state, and can be altered by many factors 
including temperature, pH, allosteric modulations, etc. This dynamic allostery model 
attempted to include entropy-driven effects into allosteric regulation, arguing that allostery 
involves changes of all forms of the dynamic behavior of the protein, from “observable” 
conformational change to “unobservable” entropy-driven effects (Nussinov and Tsai 2014).  
A new model of allostery called “conformation selection and population shift” was 
established by the Nussinov group (Kumar et al. 1999, Tsai et al. 1999), which was based 
on the free-energy landscape theory and significantly advanced the concept of allostery by 
  
 
 
10 
describing the transition between static states to ensembles of multiple states. This model 
proposed that proteins remain in an equilibrium among multiple dynamic states, including 
the “free form” and the “ligand-bound form”. The latter has higher affinity with ligand, 
resulting in a higher likelihood of being selected by ligands and stabilized in this state, 
which will shift the population of the protein from the “free form” to the “ligand-bound 
form”. The biggest contribution of the “conformation selection and population shift” model 
was that it changed people’s perspective regarding allostery: the role of the allosteric 
effectors changed from “inducer” to “stabilizer”. With the development of new 
experimental and computational strategies, the mechanisms of allosteric regulation at the 
atomic level began to be exposed and discussed. The concepts of “allosteric networks” and 
“allosteric pathways” were established. This brough about a growing recognition that the 
communication between two remote sites within a protein involves residues aligned in a 
pathway that can actually be tracked, identified, and even co-evolved (Suel et al. 2003, 
Lockless and Ranganathan 1999). 
A protein can be seen as a matrix that is built on 3-dimensional allosteric pathways. 
Each of the pathways is composed of numerous amino acids that transmit energetic 
connections between different parts of the molecule.  In 2004, the Nussinov group put 
forward the idea that allostery exists in all proteins (Gunasekaran, Ma, and Nussinov 2004). 
In this view, allostery is an intrinsic property derived from the inherent dynamics of a 
protein. A recent molecular dynamics simulation study focused on the entropic 
contributions of individual residues revealed that all of the residues encompassing a protein 
are entropically connected and follow the La Châtelier's principle of chemical equilibrium,  
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which means that increasing the local rigidity of a residue of the protein often leads to an 
increase in the global configurational entropy (Kalescky et al. 2016). This study provided 
a new perspective to characterize protein allostery and further supported the “population-
shift” theory of allostery in proteins.  
For the past several decades, the concept of allostery has been through significant 
development, evolving from a “structure” point of view to the concept of “free-energy 
landscape”, from a “two-state” model to “conformation selection and population shift”. 
Recently, Nussinov established a unified view of “how allostery works” in a simplified 
allostery model called the “Allosteric Two-State Model (ATSM)” (Tsai and Nussinov 
2014), which combines the structural point of view with free energy landscape population 
shift and thermodynamics(See Figure I-2). 
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Figure I-2 Unified view of allostery: Allosteric Two-State (ATSM) Model 
In the ATSM model, the protein was defined as only existing in two states: inactive E, and active E*, which 
are defined based on the state of the active site. S is the substrate binding at the functional site of the protein. 
A is the allosteric effector. L is the equilibrium constant that is represented by the ratio of [E*]/[E]. KA is the 
association constant that represents the binding affinity between effector A and inactive form E. a is a 
coupling constant that represents the allosteric efficacy. From a structural point of view, shown in panel A, 
a represents the communication between the allosteric site and the functional site; from the thermodynamic 
and free-energy landscape population shift point of view, shown in panel A, a represents the modification 
of the equilibrium constant L in the presence of effector A. In other words, it represents the population shift 
to the E* active conformation as a consequence of binding with ligand A. when A is allosteric activator, a is 
bigger than 1. In panel B, the different conformational states are represented as the two low-energy wells. 
The distributions between the E and E* states are governed by the equilibrium constants (L and aL) that are 
determined by the free energy difference between the two states: DG1 and DG2.  
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In the ATSM model, the protein exists in an equilibrium between the two 
conformational states, E and E*. Each state is represented as a stabilized free energy 
minimum. Binding with the allosteric ligand will shift the distribution of the population 
toward the E* state by lowering the free energy of E* (DG1-2 (E*)) and increasing the free 
energy of E (DG1-2,(E)). The parameter a represents the linkage between the allosteric site 
and the functional site. The population shift between E and E*, upon the binding of 
allosteric effector A, can be represented as the free energy change of DG1-2 (E*) and DG1-2 
(E). The difference between DG1-2 (E*) and DG1-2 (E) is surprisingly equal to (-RTlna), 
suggesting that the allosteric efficacy, a, is not determined by the binding affinity of the 
allosteric effectors but, rather, that it derives from the intrinsic thermodynamic property of 
the protein, which gives rise to a shifting of the free energy landscape upon effector binding.   
Understanding the fundamental mechanism of allostery will decode “the second 
secret of life”, advancing our knowledge on how proteins function the way they do. 
1.2 Allostery in Enzymes  
An enzyme’s physiological role is to enhance the rate of an otherwise slow 
chemical reaction by stabilizing the transition state of the reaction. The active sites of an 
enzyme bind with the substrate(s) and orient the substrate(s) to an optimal position for 
catalysis.  The active site residues are not only responsible for immobilizing the substrates 
but, most importantly, function as catalysts to promote and stabilize the formation of the 
transition state. Three primary events constitute an enzyme catalyzed reaction: substrate(s) 
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binding, chemical catalysis, and product(s) release. In general, allosteric effectors regulate 
enzymes by changing any of the above three factors. Kd is the dissociation constant 
representing the binding affinity with the substrates; Km is the Michaelis constant, which is 
a collection of all the microscopic rate constants that contribute to the formation and 
breakdown of the enzyme-substrate complex; kcat represents the maximum turnover rate, 
which can be calculated by dividing the maximum velocity by the total enzyme 
concentration. There are two types of allosteric effectors in enzymes: V type and K type. 
V type allosteric effectors only influence the turnover rate (kcat), while K type effectors only 
change the value of Kd or Km. However, in most cases, binding with allosteric effectors will 
end up changing multiple aspects of the enzyme catalysis. The effector type can be 
determined by titrating the substrate for the reaction in the presence and absence of the 
allosteric effector (See Figure I-3). 
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Figure I-3 Illustration of how heterotropic allosteric effectors alter steady-state enzyme kinetics 
Vmax is the maximum rate of product release. vi is the initial rate of product release. Kd is the dissociation 
constant of the substrate with the enzyme. Km is Michaelis constant that equals to the substrate concentration 
when the initial rate of product release become half of the Vmax.  
For any reaction, the change in Gibbs free energy of activation (DG‡) represents the 
thermodynamic energy that must be overcome to transition from the enzyme-substrate 
complex (ES), in the ground state, to the transition state (E*S) (See Figure I-4). For multi-
function enzymes, there will be more than one transition state as the rate of the enzyme is 
determined by the activation energy for the transition state at the rate-limiting step. The 
S + E ES E*S EP E P+
kcatKd
KmS + E
EP
V’max/ [E]t
Vmax/ 2*[E]t
Km < K’m
Vmax/ [E]t K type 
V type 
Substrate concn.
vi / [E]t
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activation free energy is composed of two factors: activation enthalpy (DH‡) and activation 
entropy (DS‡). DH‡ represents the energy required to stabilize the transition state and DS‡ 
represents the change of entropy (disorder) in going from the ground state to the transition 
state. The turnover rate of catalysis can be accelerated through reducing the activation 
energy. Both of the parameters can be determined experimentally by fitting the data 
(temperature vs turnover rate) using the Eyring equation.  
In the previous section, I reviewed the developed view of allostery on changing the 
free-energy landscape of the protein. The two state R (inactivated state) and R* (activated 
state) of an enzyme can be defined as the protein form performing catalysis with higher 
and lower activation energy (DG‡), respectively (See Figure I-4).  
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Figure I-4 Illustration of thermodynamic parameters of a reaction 
ES, enzyme-substrate complex; EP, enzyme-product complex; E*S transition state of enzyme-substrate 
complex; DG‡ is activation free energy of the inactivated enzyme form E, representing the free energy 
required to transfer the ES to the transition state. DH‡ is activation enthalpy and DS‡ is activation entropy. 
Yellow line represents the activated form (E*) of the enzyme with reduced activation energy D*G‡. DDG‡ is 
the reduction of activation energy between the activated form E* and inactivated form E. 
Hence, allosteric regulation of the enzymes can be also represented as the changing 
of the thermodynamic parameters, which can reveal fundamental information about an 
enzymatic reaction regarding the energy landscape at the transition state. 
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2. PYRUVATE CARBOXYLASE 
Pyruvate carboxylase (PC) is a biotin-dependent enzyme that converts pyruvate to 
oxaloacetate. The full reaction is accomplished by coupling two half-reactions. The first-
half reaction occurs at the biotin carboxylase (BC) domain where the carboxyl group from 
bicarbonate is transferred to the co-factor biotin at the biotin carboxyl carrier protein 
(BCCP) domain by utilizing the energy from cleaving one molecule of ATP. The second 
half-reaction occurs at the carboxyltransferase (CT) domain where the carboxyl group is 
transferred from carboxyl biotin to pyruvate, thus producing oxaloacetate.  
The two half-reactions are coupled by the translocation of the BCCP domain 
between the two individual catalytic domains to transport the carboxyl group from 
bicarbonate to pyruvate (See Figure I-5).  
 
 
 
 
Figure I-5 Catalytic reaction in PC  
The PC monomer structure of Rhizobium etli PC (PDB ID: 2QF7). Blue is biotin carboxylase domain, yellow 
is carboxyltransferase domain, green is allosteric domain, red is biotin carboxyl carrier protein domain. The 
co-factor biotin is not present in this structure.   
BCCP-biotin	+HOCO2- +		ATP
BCCP–biotin	– CO2- +	Pi	+	ADP
BCCP	– biotin	– CO2- +	pyruvate
BCCP	– biotin	+	oxaloacetateBC	domain CT	domain
BCCP	domain-Biotin
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Both the substrate (pyruvate) and product (oxaloacetate) are important metabolites 
in cells and located at the cross road between multiple metabolic pathways, including 
glycolysis, the TCA cycle, fatty acid synthesis and amino acid synthesis etc. The regulation 
of PC is divergent depending on what organisms, tissues, and subcellular locations that the 
enzyme is from, in order to fulfill the specific cellular functions.  The aim of this section is 
to describe the divergent regulation of PC in different types of cells as well as the domain 
contributions to the catalysis and regulation of PC. 
2.1 Metabolic Role of Pyruvate Carboxylase 
PC exists in most species, from bacteria to mammalian cells. It converts pyruvate 
to oxaloacetate to support other biosynthetic pathways, including the TCA cycle, malate-
aspartate shuttle (transferring reducing agents generated from cytosol to mitochondria for 
the production of ATP by the electron transport chain), gluconeogenesis, amino acid and 
lipid biosynthesis and so on. PC’s activity controls the distribution of the carbon flux to 
catabolism, anabolism and energy supply in the cell. The activity of PC is essential to fulfill 
specific cellular functions as well as in response to various environmental stimuli. Here I 
will describe the divergent metabolic roles of PC and the regulation of PC activity under 
different metabolic conditions. 
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2.1.1 PC in Microorganisms and Plants 
Microbes live in very diverse environments, resulting in diverse metabolic systems 
inherited by cells to adopt to their living conditions. PC exists in most of the microbes due 
to its essential role on replenishing oxaloacetate to support the other biosynthetic pathways. 
However, for some microbes, PC’s function is replaced by the enzyme called 
phosphoenolpyruvate carboxylase (PEPC) that converts phosphoenolpyruvate (PEP) to 
oxaloacetate directly, such as in E. coli (Gokarn, Eiteman, and Altman 2000).  Plants also 
have PEPC to convert PEP to oxaloacetate, which additionally serves as an essential step 
to increase local CO2 concentration in the form of oxaloacetate before CO2 is fixed by 
RuBisCO (Ribulose-1,5-bisphosphate carboxylase/oxygenase) in C4 plant.  
The TCA cycle is the major pathway contributing to the production of the fuel 
molecule ATP as well as intermediates that can be utilized by other biosynthetic pathways.  
Pyruvate, the end product of glycolysis, is transported into mitochondria where it is 
converted to acetyl CoA by pyruvate dehydrogenase. Acetyl CoA will react with the 
oxaloacetate produced by PC in order to form citrate. The activation of mitochondrial PC, 
by acetyl CoA, is in response to accelerated level of acetyl CoA so as to enhance the 
running of the TCA cycle as well as other biosynthetic pathways. Mitochondria PCs from 
vertebrates are more effectively activated by acetyl CoA and inhibited by L-glutamate but 
are not significantly inhibited by L-aspartate (Scrutton and White 1974); while cytosolic 
PCs are more effectively activated by long-chain acyl CoA analogues in the presence of 
competitive inhibitors (L-aspartate and α-ketoglutarate) and are inhibited by L-aspartate 
(but not L-glutamate) (Osmani et al. 1981). 
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In yeast, there are two cytosolic PC isoforms that have divergent regulatory 
properties. PCY1’s activity is very dependent on the presence of the allosteric activator 
acetyl CoA, which is similar to mitochondrial PC from chicken liver (Branson et al. 2002). 
While PCY2’s activity stays constant with less response to allosteric effectors (Jitrapakdee 
et al. 2007), the expression of the two genes is regulated depending on the growth phase 
and what kind of carbon source is used to culture the yeast (Huet et al. 2000, Brewster et 
al. 1994). Yeast can utilize small molecule carbon sources through glyoxylate cycle, 
including acetate, wherein the activity of PC is repressed when cells are grown on acetate 
media (de Jong-Gubbels et al. 1998). Similar to yeast PCs, PC from Aspergillus nidulans 
are located in the cytosol and become completely insensitive to acetyl CoA activation. So 
far, cytosolic PCs has only been observed in some fungi species and have different 
regulatory properties compared to mitochondria PCs due to the divergent metabolic roles 
of PC (See Figure I-6).  
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Figure I-6 Summarize of the metabolic roles of PC in diverse organisms  
Oxaloacetate- glutamate transaminase: OGT, Glutamate Dehydrogenase: GDH, Mitochondria: Mt, Cytosolic: 
Ct, Malate Dehydrogenase: MDH, Malate-alpha-ketoglutarate antiporter: Antiporter1, Aspartate-glutamate 
Antiporter 2, orange pathway represents the malate-aspartate shuttle, red pathway represents the pyruvate-
malate shuttle. 
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The cytosolic PC in Aspergillus nidulans might play a role in utilizing ammonia as 
nitrogen source for its cell growth. The glutamate dehydrogenase (GDH) was found to 
localize in cytosol along with pyruvate carboxylase (Osmani and Scrutton 1983).  GDH is 
the major enzyme that was found to fix 50% ammonia in Aspergillus nidulans by 
converting α-ketoglutarate to glutamate (Kusnan, Klug, and Fock 1989). Glutamate is 
converted to L-aspartate by oxaloacetate-aspartate transaminase, using oxaloacetate as the 
amino group receptor. L-aspartate can further be utilized to synthesize other amino acids, 
such as asparagine, threonine etc. Efficient fixation of ammonia requires high levels of 
oxaloacetate in the cytosol, along with GDH, to produce glutamate as well as other 
essential amino acids.  (See Figure I-6).  
In lactic acid bacteria, high production of L-aspartate for milk acidification is 
primarily generated from oxaloacetate to L-aspartate. Consequently, PC from Lactococcus 
lactis has a very high catalytic activity in order to maintain the a functioning TCA cycle 
during high rates of L-aspartate production (Choi et al. 2017). In Bacillus licheniformis, 
increasing PC’s activity shifts the metabolism from glycolysis to gluconeogenesis during 
the sporulation (Renner and Bernlohr 1972).    
2.1.2 PC in Mammalian Cells 
PC’s activity is related to glucose-induced insulin secretion. Insulin is a small 
peptide hormone secreted by pancreas beta cells. High glucose levels in the blood stream 
cause secretion of insulin and trigger cells to take in glucose from the environment and 
store it in the form of glycogen (liver and muscle) or fatty acids (adipose tissue).  Beta 
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pancreas cell PC have high activity, which generates increased levels of oxaloacetate that 
can increase influx to TCA cycle and produce more ATP. Alternatively, the increased PC 
activity can lead to increased malate-pyruvate shuttle, resulting in increasing NADPH level 
in cytosol where the NADPH is generated by conversion from malate to pyruvate via malic 
enzyme (See Figure I-5).   A high ATP/ADP and NADPH/NADP ratio is required for the 
exocytosis of insulin.  
PC’s activity is enhanced in mammalian cancer cells. The most significant feature 
of cancer cells is their rapid replication. Cancer cells are able to reprogram their metabolic 
system to support rapid proliferation and biomass formation. The phenomena of enhanced 
metabolism in cancer cells is called the Warburg effect, wherein cancerous cells primarily 
utilize glycolysis to produce ATP even under aerobic conditions (Kim and Dang 2006). 
The reducing equivalents generated through glycolysis will be transferred into 
mitochondria for further oxidization through the malate-aspartate shuttle, in which 
oxaloacetate is an important transferring intermediate. Cancer cells have developed a 
metabolism that can balance the generation of ATP, and precursor molecules, through 
robust anaplerotic reactions. Glutamine-dependent anaplerosis and pyruvate-dependent 
anaplerosis, two major pathways identified in cancer cells, were found to be 
complementary to each other. Pyruvate-dependent anaplerosis converts pyruvate, a 
glucose-derived product, to oxaloacetate using PC (Cheng et al. 2011). Consequently, the 
activity of PC is enhanced in cancer cells and has recently been considered to be a treatment 
target for cancer therapies (Cheng et al. 2011, Sellers et al. 2015).  
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2.2 Pyruvate Carboxylase Structure 
PC is a multi-domain enzyme with three functional domains and an allosteric 
/tetramerization domain. To date, several complete PC structures have been solved by X-
ray crystallography, revealing the diverse structural properties of the enzyme (See Table I-
1).  
Table I-1 Structures of full-length PC  
Species Type Mutations  PDBa ID Ligands References 
Rhizobium  
etli  
a4 WT 2QF7 CoA, ATP-g-s (St Maurice et al. 2007) 
a4 T882A 3TW6 
phosphonoaceti
c acid, CoA, 
ADP 
(Lietzan et al. 2011) 
a4 T882A 3TW7 - (Lietzan et al. 2011) 
Staphylococ
cus aureus   
a4 WT 3BG5 ATP, pyruvate (Xiang and Tong 2008) 
a4 WT 3HO8 - (Yu et al. 2009) 
a4 A610T 3HB9 ADP (Yu et al. 2009) 
a4 T908A 3HBL ADP (Yu et al. 2009) 
a4 F403A 3HNT ATP, ADP (Yu et al. 2013) 
a4 K442E 3HNU ADP (Yu et al. 2013) 
a4 R54E 4HNV  ATP, ADP (Yu et al. 2013) 
Listeria  
monocytosis  
a4 WT 4QSL - (Sureka et al. 2014) 
a4 WT 4QSH cyclic-di-AMP (Sureka et al. 2014) 
a4 WT 4QSK cyclic-di-AMP (Sureka et al. 2014) 
Lactococcus  
lactis 
a4 WT 5VYW - (Choi et al. 2017) 
a4 WT 5VYZ ADP,  cyclic-di-AMP (Choi et al. 2017) 
a4 G746A 5VZ0 ADP,  cyclic-di-AMP (Choi et al. 2017) 
Methylobacil
lus 
flagellatus 
a2b4 WT 5KS8 pyruvate (Choi et al. 2016) 
All the residues are numbered based on the primary sequence of the individual species.  WT represents wild 
type protein with no mutations introduced. a, PDB is the abbreviation for Protein Data Bank. 
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The overall structure of each individual domains is highly conserved, while the 
spatial arrangement within and between the peptide chains has shown high diversity among 
PC structures derived from different species. In this section, I will discuss the diverse 
domain architectures and conserved active site conformations that contribute to PC 
catalysis.  
2.2.1 Domain Architecture of Pyruvate Carboxylase  
There are two forms of PC in nature, a4 and a4b4, depending on the organism. 
The a4 form prevalent in most bacterial and eukaryotic cells is a single-chain PC, in which 
all the domains are encoded on a single polypeptide chain. In some bacteria and archaea, 
a4b4 is a two-subunit PC, in which the BC domain and CT-BCCP domain are encoded on 
two separate polypeptide chains. 
Prior to the first a4 PC structure was published, from Rhizobium etli (RePC) (St 
Maurice et al. 2007), it had been established that there are three functional domains in PC, 
including two catalytic domains and one carrier domain, which are sufficient to perform 
the overall pyruvate carboxylation reaction. The structure of RePC revealed a new domain 
that was identified and named the “allosteric” domain as the allosteric activator, acetyl 
CoA, was bound at this domain in the structure. The allosteric domain is positioned 
between the BC and CT domains. The carrier BCCP domain is also attached to the 
allosteric domain.  
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A similar domain appears in the structure of another a4 PC from Staphylococcus 
aureus (Yu et al. 2009), in which acetyl CoA binds at the same site. It was named the 
“tetramerization” domain because of the role it played in stabilizing the tetramer of SaPC. 
The overall arrangement of the three catalytic domains and the allosteric/tetramerization 
domain on one polypeptide chain is very similar between RePC and SaPC. However, the 
tetrameric arrangement of the two PC homologues appears to be very different. The first 
RePC structure (PDB 2QF7, with ethyl CoA bound) revealed a so-called “asymmetric” 
tetramer. The asymmetric tetramer has two subunits with a closer distance between the two 
subunits on one face of the tetramer, resulting in the interaction between the two 
allosteric/tetramerization domains on the same face (St Maurice et al. 2007). Conversely, 
in the first SaPC structure (PDB 3HO8, no acetyl CoA bound) the distance between the 
two monomers on each face was similar. With the two allosteric/tetramerization domains 
of SaPC, the different domain faces interact with each other, which results in a stabilized 
tetramer (Xiang and Tong 2008). Initially, the asymmetric nature of RePC was considered 
to be the result of the binding with acetyl CoA, until subsequent structures revealed that 
both RePC and SaPC maintain the same symmetry both in the presence and absence of 
acetyl CoA. Later, both symmetric and asymmetric structures were observed by cryo EM 
in SaPC, leading to the proposal that the symmetry/asymmetry of the tetramer corresponds 
to two functional conformations representing two catalytic states of PC (Lasso et al. 2014).   
The two subunit PC has been called a4b4 based on the domain stoichiometry 
observed in the a4 PC enzymes. It was assumed, therefore, that the two subunit PC 
enzymes should have a similar domain stoichiometry, with one BC domain (a subunit) 
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forming a heterodimer with one CT-BCCP domain (b subunit), and four heterodimers 
forming a homotetramer (Jitrapakdee et al. 2008). Interestingly, a recently published 
structure of the first a4b4 PC from the bacterium Methylobacillus flagellatus shows a a2b4 
stoichiometry, with two hetero trimers a1b2 forming a homodimer through dimerization 
between the a subunits (Choi et al. 2016). Unlike the a4 PCs, in which the tetramerization 
occurring mostly between the dimerization of the same catalytic domains, the structure of 
a2b4 exhibits a “U” shape with the two  b2 dimers hanging on the two sides of the a2 
dimer.  The formation of a1b2 is through a BT-like domain that forms between one a and 
two b subunits. The “BT” domain name is derived from other biotin carboxylase enzymes, 
such as acetyl CoA carboxylase, where it functions to connect the BC and CT domain (Wei 
and Tong 2015). However, this unexpected stoichiometry of catalytic domains may only 
apply to a4b4 PC in bacteria as some essential residues required to form the BT-like 
domain are not conserved in the a4b4 PC in archaea. The most significant difference 
between a4 and a4b4 PC is the allosteric domain, which gives rise to different regulatory 
properties as acetyl CoA can activate a4 PC but not a4b4 PC.  
2.2.2 Domain Catalysis in Pyruvate Carboxylase 
PC is a multi-domain enzyme with two half reactions that are catalyzed at two 
spatially distinct active sites: these active sites are coupled by the translocation of the 
carrier domain. Here I will discuss the catalytic mechanism at each domain and their 
contributions to the overall reaction.  
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Biotin Carboxylase (BC) domain. The first half-reaction catalyzed by PC is the 
transfer of a carboxyl group from bicarbonate to the biotin cofactor, which occurs at the 
BC domain active site. The BC domain from PC belongs to the ATP-grasp superfamily 
(Fawaz, Topper, and Firestine 2011), which are conserved among biotin-dependent 
carboxylases including propionyl-CoA carboxylase (PCC), acetyl CoA carboxylase (ACC), 
urea carboxylase (UC), and Pyruvate carboxylase (PC). This type of structure is typical for 
enzymes that catalyze ATP-dependent ligation of a carboxyl group carbon of one substrate 
using an amino or imino group nitrogen of the second substrate, thereby forming 
acylphosphate intermediates (Ogita and Knowles 1988). The two primary components that 
make up the ATP-grasp active site actually bind with (grasp) one molecule of ATP.  
The BC domain in PC is composed of three subdomains: N-terminal subdomain, 
C-terminal subdomain, and B-subdomain. The N- and C-terminal subdomains contribute 
the bulk of the BC domain, with the B-subdomain connected by two pieces of random coil 
structure to form a lid over the active site. The function of the B-subdomain is to provide 
the phosphate binding residues to form a P-loop. Hence, the orientation of the B-subdomain 
(open vs. closed) is determined by binding with the nucleotide ATP/ADP. In the presence 
of the nucleotide, the B-subdomain closes over the BC domain active site, resulting in the 
closure of the active site and enhanced binding with the BCCP carrier domain (See Figure 
I-7) (Lietzan et al. 2011, Thoden et al. 2000).  
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Figure I-7 Structure of the biotin carboxylase in biotin-dependent carboxylase.  
A, BC domain structures with open B-subdomain lid (1BNC, E. coli biotin carboxylase). B and C, overlay 
of the closed B-subdomain lid (3TW6, Rhizobium etli pyruvate carboxylase) and E. coli biotin carboxylase 
(3G8C). ATP is from the SaPC structure 3BG5. 
There are no specific interactions formed between the residues from the BC and 
BCCP domains (Lietzan et al. 2011). The catalytic mechanism in the BC domain has been 
well studied in a variety of biotin-dependent carboxylases. The mechanism of BC domain 
catalysis was initially proposed from studies on the structure and mechanism of E. coli 
biotin carboxylase (a subunit of E. coli acetyl CoA carboxylase), which revealed the 
binding sites for all compatible substrates, i.e. biotin, bicarbonate and MgADP (Chou, Yu, 
and Tong 2009). Those active site residues are conserved among all the biotin-dependent 
carboxylases, including pyruvate carboxylase. Mutagenesis experiments further confirmed 
the catalytic functions for the active site residues (Zeczycki, Menefee, Adina-Zada, et al. 
2011) (See Figure I-8). 
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Figure I-8 Active site of BC domain 
A, Active site residues at the BC domain in an overlay of E. coli biotin carboxylase (3G8C; pink carbon 
residues) and RePC (3TW6; blue carbon residues). ATP is from the SaPC structure 3BG5 and the two Mg2+ 
ions are from RePC structure 2QF7. All the structures were centered at the biotin carboxylase domain. All 
residues are numbered according to the RePC sequence. B, Proposed catalytic mechanism of the HCO3-
dependent MgATP cleavage and biotin carboxylation. Red colored molecules represent substrates of the 
catalysis; dashed lines represent hydrogen bonds or ionic force. 
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In RePC, MgATP and free Mg2+ bind at the BC domain in a rapid equilibrium 
(Attwood and Graneri 1992, Zeczycki, Menefee, Jitrapakdee, et al. 2011). Lys245 positions 
the 𝛾-phosphate	of ATP at the active site by stabilizing the negative charge of the phosphate 
group from MgATP (Zeczycki, Menefee, Adina-Zada, et al. 2011). The carboxyl group 
from the side chain of Glu218 forms a hydrogen bond with the amino group from Lys245 
assisting in positioning Lys245 (Zeczycki, Menefee, Adina-Zada, et al. 2011).  Glu218 also 
forms a hydrogen bond with Glu305 to promote the deprotonation of bicarbonate as a 
general base (Zeczycki, Menefee, Adina-Zada, et al. 2011). The deprotonated bicarbonate 
initiates a nucleophilic attack on the 𝛾-phosphate	of ATP, which is proposed to form a 
carboxyphosphate intermediate with ADP, thus serving as the leaving group (Ogita and 
Knowles 1988).  Glu218 participates in two essential steps of the BC domain catalysis: it 
positions MgATP for nucleophilic attack and assists Glu305 in serving as a general base 
catalyst to deprotonate bicarbonate. The essential nature of Glu218 was suggested when 
the mutant E218A in RePC completely abolished catalysis (Zeczycki, Menefee, Adina-
Zada, et al. 2011). The carboxyphosphate intermediate is proposed to break down to CO2 
and a trianionic phosphate in the active site, releasing inorganic phosphate for further 
deprotonating the N1’ position of biotin (Menefee and Zeczycki 2013). 
Arg301 works like a general base catalyst to assist the proton transfer from the 
biotin N1’ position to phosphate by bridging PO43- in close proximity to the N1’ of biotin, 
resulting in biotin enolization and releasing the protonated phosphate (Zeczycki, Menefee, 
Adina-Zada, et al. 2011). The biotin enolate is stabilized by Arg353, from which the N1’ 
initiates a nucleophilic attack at the electrophilic carbon of CO2, resulting in formation of 
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caroxybiotin (See Figure I-8B).  It was observed that the route by which biotin enters into 
an active form, and thus participates in catalysis, was altered when it was tethered to the 
carrier BCCP domain (BCCP-biotin, See Figure I-8A). In RePC, Glu248 can interact with 
Arg353 to prevent the BCCP-biotin from accessing the active site (See Figure I-8A). It has 
been proposed that the role of Glu248 and Arg353 is to prevent carboxbiotin from 
reentering the BC domain active site, where it would be easily decarboxylated (Lietzan et 
al. 2011, Zeczycki, Menefee, Adina-Zada, et al. 2011). These two residues have been called 
“gate-keeper residues”, whose roles were confirmed by increased rates of the reverse ADP 
phosphorylation and decreased coupling efficiency when these residues were mutated 
(Lietzan and St Maurice 2013b). 
Carboxyltransferase (CT) domain.  After the biotin cofactor is carboxylated at the 
BC domain, carboxybiotin will transfer its carboxyl group to pyruvate at the CT domain to 
produce oxaloacetate. Unlike the highly conserved BC domain among all biotin-dependent 
carboxylases, the CT domain sequence and structure is much less conserved among this 
group of enzymes and varies depending on the carboxylated substrate. The CT domain in 
PC is composed of an N-terminal TIM-barrel subdomain and a C-terminal funnel 
subdomain (See Figure I-9A).  
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Figure I-9 Structure of the CT domain of PC.  
A, the composition of CT domain from Staphylococcus aureus PC (PDB ID: 3BG5), orange represents the 
TIM-barrel subdomain, green represents the funnel subdomain, yellow represents the BCCP-biotin, magenta 
represents the metal ion Mn2+, grey represents the connection between different subdomains. B, pyruvate-
induced biotin binding pocket at the CT domain active site. The CT domain active site with pyruvate bound 
is from RePC (4JX5, pink carbon residues), without pyruvate bound is from RePC (4JX4, blue carbon 
residues) and with biotin is from SaPC (3BG5). All the residues are numbered based on the RePC sequence. 
C, Proposed catalytic mechanism of the pyruvate carboxylation. Red molecules represent substrates; dashed 
lines represent hydrogen bond or ionic force. 
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The CT domain active site is located at the mouth of the TIM-barrel as well as at 
the interface between the two subdomains. The active site is centered on a structurally 
conserved Lewis acid metal, either Zn2+ or Mn2+, which serves as an electron donor to 
facilitate the binding of pyruvate and stabilizes the enolpyruvate intermediate at the active 
site.  The N-terminal TIM-barrel subdomain is composed of 8 repeated, alternating a-helix 
and b-sheet structures (a8b8), which contribute the bulk of the CT domain structure and 
all of the residues involved in pyruvate binding/enolization. 
The C-terminal funnel structure sits atop the TIM-barrel and guides BCCP-biotin 
to the CT domain active site. The funnel contributes all the residues responsible for BCCP-
biotin binding/enolization. Several essential residues at the active site were identified and 
contribute to the catalytic mechanism in the CT domain, in part through a substrate-induced 
conformational change in the active site upon pyruvate binding. For example, in RePC, 
pyruvate binds at the active site and stabilizes the substrate in a positively charged binding 
pocket by interacting with Arg621, Arg548, and Gln552, in addition to stabilizing the metal 
ions through salt bridges.  
The interaction between pyruvate and Arg621 introduces a rearrangement in the 
active site, which results in a movement of the loop Arg621-Asn630 toward to the pyruvate 
binding site as well as a rotation of the Tyr628 residue that forms a platform upon which 
biotin binds in the active site (Lietzan and St Maurice 2013a). This promotes carboxybiotin 
binding in the active site in the presence of pyruvate, where biotin decarboxylation is 
promoted through stabilization of the biotin enolate by several conserved residues 
(Glutamine 884 and Serine 885) at the active site (Zeczycki et al. 2009). Mutation of the 
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Arg621 results in a complete loss of catalytic activity, highlighting the essential role played 
by Arg621 in binding the substrate (pyruvate) and promoting active site rearrangements 
(Xiang and Tong 2008, Lietzan and St Maurice 2013a). In the absence of pyruvate, the 
position of Arg621 is disordered in the structure of RePC (Lietzan and St Maurice 2013a) 
(See Figure I-9B).   
After carboxybiotin decarboxylation, Thr882 acts as a proton shuttle to transfer a 
proton from the methyl group of pyruvate to the N1’ of the biotin enolate, resulting in a 
protonated biotin and enolpyruvate intermediate that will be stabilized at the active site by 
the same residues contributing to the binding of pyruvate. The nucleophilic pyruvate–
enolate will attack the carbon of CO2, completing the pyruvate carboxylation reaction to 
form oxaloacetate (See Figure I-9C). The proton-shuttle step was demonstrated to be 
indispensable: mutation of the threonine proton shuttle completely abolishes CT domain 
activity in PC from multiple source organisms (Zeczycki et al. 2009)  
The substrate-induced biotin binding pocket explains why a-keto analogues of 
pyruvate can invoke decarboxylation of the carboxybiotin, even when they are not 
substrates for the enzyme. Pyruvate analogues that lack either the carboxyl or a-keto group 
do not promote carboxybiotin decarboxylation (Attwood and Wallace 1986).  
Biotin carboxyl carrier protein (BCCP) domain. The carrier domain is a common 
structure among multi-domain enzymes that channel intermediates between sequential 
reactions at multiple active sites, as in polyketide synthases (PKS) and non-ribosomal 
polypeptide synthases (NRPS). Carrier domains are essential in order to transport the 
reaction intermediates between individual catalytic domains in these enzyme complexes to 
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facilitate the overall reaction. For example, in PKS, the movement of the carrier domain 
was determined to be controlled by the specific interaction between the carrier domain and 
the individual catalytic domain, so as to facilitate the sequential intermediate handover 
(Klaus et al. 2016).  
No such specific interactions have been identified in PC, instead the carboxyl group 
is transferred from bicarbonate to pyruvate through a carboxybiotin intermediate that is 
attached to the BCCP carrier domain. The structure of the BCCP domain is very simple: it 
has a sphere like C-terminal structure that is attached to the allosteric domain by a relatively 
long, N-terminal random coil. The cofactor biotin forms an amide linkage (a pseudo-
peptide bond) with a lysine side-chain that is encoded on a specific peptide sequence, 
MKME. This biotinylation reaction is catalyzed by biotin protein ligase in cells. The non-
biotinylated PC is unable to catalyze the overall pyruvate carboxylation reaction, but it is 
capable of catalyzing the individual domain reactions at a slow rate (Adina-Zada et al. 
2008). In order to translocate between different domains, the position of the BCCP appears 
to be very flexible. The coupling efficiency between the two half-reactions in PC is directly 
linked to the translocation of the BCCP domain.  
Allosteric domain. Given its low sequence conservation, the allosteric domain of 
PC was not identified from the primary sequence until the first structure in Rhizobium etli 
was reported (St Maurice et al. 2007). For a4 PC homologues, the allosteric domain 
structure is composed of one a-helix emanating from the C-terminal end of the BC domain 
and four anti-parallel b-sheets at the C-terminal end of the CT domain. For a4b4 PC 
homologues, the BC (a) and CT-BCCP (b) domain are encoded on two separated 
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polypeptide chains, with one a-helix sequence encoded on the a-subunit and the anti-
parallel b-sheet encoded on the b-subunit (See Figure I-10).  
 
 
 
 
Figure I-10 Structure of the allosteric domain from PC 
A, allosteric domain from a4 PC (PDB ID: 2QF7). B, BT-like domain from a4b4 PC (PDB ID: 5KS8). 
Secondary structures are colored differently; a1 represents the a-helix from the Subunit 1; b1 and b2 
represents the b-sheet from Subunit 1 and 2 respectively.  
The structure of a a4b4 PC from Methylobacillus flagellates is an a2b4 
stoichiometry (Choi et al. 2016). Two b subunits associate with one a subunit through a 
unique structure has never been observed in PC, which is composed of two sets of the anti-
parallel b-sheet (from the b subunits) wrapping around one a-helix structure (from the a 
subunit). Both the structure and the sequence of this domain are similar to the BT domain 
found in the structures from some other biotin-dependent carboxylases, such as propionyl-
CoA carboxylase (PCC) (Huang et al. 2010), and acetyl CoA carboxylase (ACC) (Wei and 
Tong 2015). Since the allosteric domain is a non-catalytic domain, the way it contributes 
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to the catalysis of PC still remains elusive. However, the allosteric domain is conserved 
among all a4 PC homologues that have been solved so far and hosts the binding site for 
the allosteric activator, acetyl CoA. In PC from Staphylococcus aureus, the allosteric 
domain was named tetramerization domain and stabilizes the SaPC tetramer (Xiang and 
Tong 2008). 
Some multi-domain proteins have evolved non-catalytic structures, such as the 
allosteric domain in PC, which function as domains connecting catalytic domains together. 
Several multi-domain enzymes have very diverse structures including biotin-carboxylase, 
fatty acid synthase, and polyketide synthase, despite their conserved catalytic domains 
among homologs. It is the non-catalytic domain positioned between catalytic domains that 
give rise the diverse configurations of these proteins.  The roles played by those non-
catalytical domains have been not well defied, but a couple of examples have shown that 
they were all involved into the regulation of the enzyme. A study has shown that 
phosphorylation of a key residue at the non-catalytical central domain (CD) in fungal acetyl 
CoA carboxylase results in inactivating the enzyme by locking to it into an open structure 
(Hunkeler et al. 2016). 
3. ALLOSTERIC REGULATION OF PYRUVATE CARBOXYLASE 
Before the first structure of PC was published, extensive kinetic studies were 
performed to elucidate the mechanism of PC regulation by different allosteric effectors. 
Acetyl CoA is the most well studied allosteric activator as many studies investigated the 
effects of acetyl CoA activation on PC and its competitive relationship with other allosteric 
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inhibitors, particularly dicarboxylic acids. After the first structure of PC was reported with 
acetyl CoA bound, multiple site-directed mutagenesis studies were performed to 
investigate the mechanism of activation of PC by acetyl CoA. The allosteric regulation of 
PC differs due to the overall reaction and the two individual half-reactions. In this section, 
I will introduce what is known regarding the mechanism of allosteric activation by acetyl 
CoA and its relationship with other allosteric effectors. This will provide a framework to 
describe the communication between the allosteric and active sites in PC.  
3.1 Activation of Pyruvate Carboxylase 
Acetyl CoA is a well characterized allosteric activator of PC from species ranging 
from bacteria to mammals.  Acetyl CoA binds at the interface between the BC and allosteric 
domain in a4 PCs like RePC and SaPC (St Maurice et al. 2007, Yu et al. 2009). 
Additionally, in several cytosolic PCs in fungi and bacteria, acetyl CoA appears to bind 
with but not stimulate the catalytic activity of PC (Osmani et al. 1981, Choi et al. 2017). 
Additionally, a4b4 PCs are insensitive to acetyl CoA activation, likely due to the lack of 
an acetyl CoA binding site (Jitrapakdee et al. 2008). In this section, a discussion of PC 
activation will be limited to the single-chain a4 PCs that are sensitive to acetyl CoA 
activation. Several other PC activators, such as Mg2+, TNP-ATP, and acyl CoA analogues 
will also be discussed relative to acetyl CoA.  
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3.1.1 Acetyl CoA and Acyl CoA analogues 
Acetyl CoA is the final product of fatty acid oxidation and is utilized in several 
other biosynthetic pathways. For example, Acetyl Coa is a substrate for the first reaction 
of the TCA cycle: the condensation of oxaloacetate with acetyl CoA forms citrate and is 
catalyzed by citrate synthase. Kinetic studies determined the locus of action of acetyl CoA 
to be the BC domain. These kinetic studies demonstrated that acetyl CoA activates PC, 
isolated from chicken liver, by accelerating the rate of MgATP cleavage and the formation 
of carboxybiotin at the BC domain (Legge, Branson, and Attwood 1996). Acetyl-CoA was 
also found to enhance the rate of the BC domain half reaction by decreasing the Km of HCO3- 
in thermophilic Bacillus (Libor, Sundaram, and Scrutton 1978).  
Studies employing chimeric enzymes generated from fusions of the two PC 
isoforms from yeast (PYC1 and PYC2) revealed that the locus of action for  the activation 
by acetyl CoA activation is at the BC domain (Jitrapakdee et al. 2007). Conversely, for the 
half reaction catalyzed in the CT domain, no significant effect of acetyl CoA activation has 
been observed (Zeczycki, Menefee, Jitrapakdee, et al. 2011). These studies on allosteric 
activation in PC exclusively focus on the effect of acetyl CoA binding on the catalytic 
turnover in the BC domain. The first structure of PC from Rhizobium etli revealed that 
acetyl CoA is bound at the interface between the BC domain and the allosteric domain, 
which is stabilized by hydrogen bonds with two conserved arginine residues in RePC. One 
of these arginine residues (RePC R427) is located in the BC domain and the other (RePC 
R472) is located at the allosteric domain. Mutations of these two conserved arginine 
residues in RePC resulted in an increased Km for MgATP. Most interestingly, a mutation of 
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RePC R472 at the allosteric domain resulted in a greater attenuation of the activation by 
acetyl CoA compared to the mutant RePC R427 from the BC domain (Adina-Zada et al. 
2012).  
It has become increasingly clear that there are contributions beyond just those in 
the BC domain that contribute to the degree of activation by acetyl CoA. For example, the 
coupling efficiency is enhanced by acetyl CoA in RePC, suggesting that acetyl CoA might 
regulate the movement of the carrier BCCP domain (Zeczycki, Menefee, Jitrapakdee, et al. 
2011). In SaPC, acetyl CoA was found to stabilize the tetramerization mediated by the 
allosteric domain/tetramerization domain (Yu et al. 2009). In RePC, an asymmetric 
tetramer was proposed to be induced by binding with acetyl CoA, in which the reduced 
distance between two subunits will result in an accelerated rate of the translocation of the 
carrier BCCP domain between the two active sites (St Maurice et al. 2007). But this theory 
was called into doubt later when the same asymmetric structure was observed in RePC 
without acetyl CoA bound. A symmetric structure was observed in the X-ray structure of 
SaPC both in the presence and absence of acetyl CoA (Xiang and Tong 2008, Yu et al. 
2009), which further disapproved the idea of asymmetric tetramer induced by acetyl CoA. 
Later, the asymmetric and symmetric tetramer of SaPC were assigned to two catalytic 
states of PC using cryo EM, corresponding to the BC domain and CT domain half reactions 
respectively (Lasso et al. 2014). It was proposed that the two catalytic states oscillate 
between the two faces, resulting in a half-face active catalytic turnover mechanism (Lasso 
et al. 2014). 
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Although the symmetry was proven to not be directly stabilized or induced by 
binding with acetyl CoA, there are some interesting correlations between the number of 
acetyl CoA bound and the symmetry revealed from the X-ray structures of PC. In principle, 
there are four available acetyl CoA binding sites in the PC tetramer, one per subunit. In the 
asymmetric structure of RePC with acetyl CoA bound, there are only two acetyl CoA 
molecules bound to the tetramer while the binding sites are disrupted, both on the same 
face of the tetramer (St Maurice et al. 2007, Lietzan et al. 2011). The symmetrical structure 
of SaPC suggests four acetyl CoA binding sites were occupied. It was proposed that 
binding with acetyl CoA might regulate the oscillation between the catalytic states between 
the two faces (Lasso et al. 2014).  
Acyl CoA analogues had largely been characterized as inhibitors of PC (Scrutton 
and Utter 1967, Libor, Sundaram, and Scrutton 1978). However, these conclusions were 
derived mostly from studies in which the characterizations of the activation were 
performed in the presence of acetyl CoA. Consequently, the observed inhibition from acyl 
CoA analogues were mostly from the competitive binding with acetyl CoA. This was 
confirmed by the structures of PC bound with acyl CoA analogues: RePC with ethyl CoA 
bound and SaPC with CoA bound at the same binding site. The two phosphate groups of 
3’5’-diphosphate adenine were essential for anchoring acetyl CoA. In SaPC, it has been 
shown that 3’5’-diphosphate adenine can almost activate SaPC to the same degree as does 
acetyl CoA, while 3’-dephosphate CoA has no effect on the kcat. This suggests that the two 
phosphate groups from 3’5’-diphosphate adenine  are both necessary and sufficient to 
activate SaPC (Yu et al. 2009). However, PC from different species have divergent 
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regulatory properties as in Bacillus thermodenitrificans PC, where acyl CoA analogues 
with short acyl-chain lengths (£ 5 carbon) can activate the enzyme to the same degree as 
does acetyl CoA. PC from Aspergillus nidulans is not activated by either acetyl CoA nor 
acyl CoA analogues (Osmani et al. 1981).  
3.1.2 Mg2+ 
Mg2+ is an activator of PC, binding at the active site of the biotin carboxylase domain. 
In the structure of the biotin carboxylase domain from E. coli acetyl CoA carboxylase and 
PC from Rhizobium etli, two Mg2+  ions are bound at the active site (St Maurice et al. 2007). 
One Mg2+ ion is bound with ATP as MgATP, the other ion is bound with PC as a free metal 
cation. The activation of PC by free Mg2+ions will be discussed. Studies on sheep liver PC 
led to the realization that Mg2+ might have effects on the catalysis of PC as an independent 
factor. Mg2+ accelerates the rate of oxaloacetate formation under saturating concentration of 
MgATP (Keech and Barritt 1967). Mg2+ was also found to promote the binding of MgATP 
(Attwood, Coates, and Wallace 1984, Geeves, Branson, and Attwood 1995). Mg2+ has been 
studied as an allosteric activator of PC and shows binding cooperativity, just as with acetyl 
CoA. In pig liver PC, binding with acetyl CoA promotes binding with Mg2+ and vice versa 
(Warren and Tipton 1974), suggesting both acetyl CoA and Mg2+ might bind with an active 
conformation of the enzyme, while binding with either of them will stabilize the 
conformation that promotes the binding of the other. However, studies in pigeon kidney 
PC suggest that acetyl CoA has no observed effects on activation by Mg2+(Dugal 1973). In 
sheep liver PC, it was found that Mg2+ promotes the lingering of the BCCP domain at the 
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BC domain active site even in the absence of MgATP. Most interestingly, acetyl CoA shifts 
the BCCP domain over to the CT domain by increasing the dissociation constant of Mg2+. 
In short, PC from different organism exhibit divergent regulatory properties, which might 
be determined by the intrinsic properties of the enzyme. 
3.1.3 TNP-ATP 
2’,3’-O-(2,4,6-Trinitrophenyl) adenosine 5’-triphosphate (TNP-ATP) is a 
fluorescent analogue of ATP, which is often used as an indicator to study the binding 
kinetics of ATP. However, in PC, TNP-ATP does not bind at the ATP binding site; instead, 
it activates PC in a manner similar to acetyl CoA(Adina-Zada et al. 2011). The binding of 
acetyl CoA and TNP-ATP in PC is competitive (Adina-Zada et al. 2011), but not mutually 
exclusive. Binding with acetyl CoA cannot completely replace the binding of TNP-ATP. 
Additionally, mutations in the acetyl CoA binding site only significantly affect the Ka of 
acetyl CoA but do not significantly alter the Ka of TNP-ATP. An examination of the 
chemical structure of TNP-ATP reveals that it does not have the crucial 3’phosphate group 
on adenine, which forms a hydrogen bond with ArgXXX in PC; it is also lacks the 
pantothenic acid arm and acetyl group of acetyl CoA. These two components make the 
major contribution to acetyl CoA binding in PC. Consequently, one would expect the Ka 
for TNP-ATP to be significantly higher than that of acetyl CoA, if they bind with PC with 
similar binding modes. The Ka of TNP-ATP in RePC was determined to be ~20 µM, only 
~4 fold higher than that of acetyl CoA  (Adina-Zada et al. 2011). In comparison, the Ka of 
3’5’-diphosphate adenine is ~1000 fold higher and CoA is ~100 fold higher than the Ka of 
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acetyl CoA (Yu et al. 2009). To summarize, TNP-ATP and acetyl CoA both activate PC, 
but at what appear to be two different binding sites. Communication between these two 
binding sites results in a competitive relationship between the two allosteric activators. 
3.2 Allosteric Inhibition of Pyruvate Carboxylase 
Several PC allosteric inhibitors have been identified over the past fifty years, since 
PC was first discovered by Utter & Keech in chicken liver (Utter and Keech 1960). These 
inhibitors range from simple dicarboxylates to bulky macrolide-type antibiotics. One 
common feature among most of the allosteric inhibitors is their competitive relationship 
with the allosteric activator, acetyl CoA. Some allosteric inhibitors are believed to bind at 
the same binding site with acetyl CoA, such as chlorothricin (Schindler and Zähner 1973). 
Other inhibitors have been demonstrated to be competitive with acetyl CoA, but do not 
share the same binding site, such as L-aspartate and a-ketoglutarate. There are also 
inhibitors where the locus of action is at the CT domain, which display a non-competitive 
relationship with respect to acetyl CoA. I will first introduce some dicarboxylate-based 
inhibitors of PC, and their relationship with acetyl CoA activation, before introducing a 
recently discovered CT domain-bound inhibitor of bacterial PC, cyclic-di-AMP. 
3.2.1 Dicarboxylate-based Allosteric Inhibitors 
Three dicarboxylate-based allosteric inhibitors of PC have been identified so far: 
L-aspartate, a-ketoglutarate and glutamate. In all three cases, their physiological function 
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is to serve as feedback inhibitors of PC in response to excessive production of TCA cycle 
intermediates. L-aspartate acts mostly on microbial PC, glutamate acts on PC from 
vertebrate organisms, and inhibition by a-ketoglutarate is broadly distributed.  
L-aspartate. Most research has focused to describing the inhibition of PC by L-
aspartate and focused on the antagonistic effects compared to the activation by acetyl CoA. 
The mutually exclusive binding of L-aspartate and acetyl CoA has been reported in PC 
from Saccharomyces cerevisiae (Cazzulo and Stoppani 1968), Aspergillus nidulans 
(Osmani et al. 1981), and Rhizobium etli (Sirithanakorn et al. 2014). However, the 
inhibition by L-aspartate is not confined to the binding of acetyl CoA, since, L-aspartate 
also inhibits the acetyl CoA-independent activity of PC. Mutation of the acetyl CoA 
binding site does not impact the inhibition by L-aspartate in RePC, suggesting that they 
occupy independent binding sites (Adina-Zada et al. 2012). So far, no structures have been 
determined with L-aspartate bound to PC, likely due to its high Ki value (~5mM). Similar 
to acetyl CoA activation, L-aspartate does not inhibit the subunit-type (a4b4) PCs, 
indicating that the binding site for L-aspartate may be located at the small allosteric domain 
of PC, just as acetyl CoA (Zeczycki, St. Maurice, and Attwood 2010). The fact that L-
aspartate inhibits the rate of MgATP cleavage, acting as a non-competitive inhibitor with 
respect to MgATP in Aspergillus nidulans PC (Osmani et al. 1981) further suggests L-
aspartate inhibits the catalysis by binding outside of the BC domain active site.  
There are multiple binding sites for L-aspartate in PC. Similar to the binding of 
acetyl CoA, the binding of L-aspartate has been found to have positive cooperativity. L-
aspartate and acetyl CoA competitively bind with PC, and the cooperativity of L-aspartate 
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was enhanced in the presence of acetyl CoA, and vice versa (Cazzulo and Stoppani 1968, 
Jitrapakdee et al. 2007, Sirithanakorn et al. 2014). It has been proposed that PC stays in an 
equilibrium of the active and inactive form. Binding with Acetyl CoA shifts the population 
toward to the active form that has higher affinity with acetyl CoA, resulting to an observed 
positive cooperativity. Binding with L-aspartate stabilizes the inactive form of the enzyme 
that has lower affinity with acetyl CoA, which results to an observed enhanced positive 
cooperativity of acetyl CoA(Jitrapakdee et al. 2007).  
Much like the activation by acetyl CoA, the inhibition of Rhizobium etli PC by L-
aspartate primarily impacts the catalysis in the BC domain, while the half-reaction 
catalyzed in the CT domain is not subject to inhibition by L-aspartate (Sirithanakorn et al. 
2014). Unlike acetyl CoA, L-aspartate does not have effects on the coupling efficiency 
between the two half reactions of Rhizobium etli PC, while acetyl CoA enhances the 
coupling efficiency (Sirithanakorn et al. 2014). 
 a-ketoglutarate. The inhibition of PC by a-ketoglutarate is widely distributed and 
has been characterized from a number of sources, ranging from bacteria (Libor, Sundaram, 
and Scrutton 1978, Modak and Kelly 1995), fungi (Osmani et al. 1981) to avian liver 
(Scrutton and White 1974).  Like L-aspartate, a-ketoglutarate competes with acetyl CoA 
binding in PC from Aspergillus nidulans and was found to occupy a different binding site 
than either acetyl CoA or L-aspartate (Osmani et al. 1981). In chicken liver PC, in the 
presence of acetyl CoA, the hill coefficient of a-ketoglutarate shifts from 1.5 in the absence 
of acetyl CoA to ~3 at a saturating concentration of acetyl CoA. Unlike L-aspartate, a-
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ketoglutarate does not have effects on the hill coefficient of acetyl CoA in avian liver PC. 
(Scrutton and White 1974). 
Glutamate. Glutamate is a non-competitive inhibitor with respect to acetyl CoA, 
while the other two dicarboxylate-based inhibitors are competitive inhibitors. Glutamate 
inhibits PC as a competitive inhibitor with respect to pyruvate but it is non-competitive 
with respect to ATP in chicken, rat and human liver (Scrutton and White 1974, Jitrapakdee, 
Walker, and Wallace 1999), suggesting that its locus of action may be at the CT domain. 
Physiologically, glutamate is replacing L-aspartate and inhibits PC from vertebrates that 
are not sensitive to inhibition by L-aspartate, such as chicken liver PC (Scrutton and White 
1974), serving as a feedback inhibitor of PC for excessive TCA cycle intermediates.  
3.2.2 Cyclic-di-AMP 
Cyclic di-adenosine monophosphate (c-di-AMP) is a broadly conserved second 
messenger required for bacterial growth and infection. A direct interaction between c-di-
AMP and PC was discovered in Listeria monocytogenes (Sureka et al. 2014). c-di-AMP 
was characterized as an allosteric inhibitor of LmPC. The Ki value for c-di-AMP is ~3 µM, 
which represents a relatively high binding affinity. The binding site of c-di-AMP was 
identified by X-ray crystallography to reside at the CT domain of LmPC, 25Å away from 
the CT domain active site (Sureka et al. 2014). But c-di-AMP does not inhibit PC through 
lowering Km value of pyruvate in LmPC and its inhibition can be overcome by a saturating 
concentration of acetyl CoA. Compared to the structure of apo-LmPC, the c-di-AMP 
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bound-LmPC has significant conformational change at the overall quaternary structure, 
evidenced by reduced variation of the orientation among the monomers (Sureka et al. 2014). 
Recently, another structure of PC, from Lactococcus lactis (LlPC), was reported 
with c-di-AMP bound (Choi et al. 2017). The sequence at the c-di-AMP binding site is not 
conserved, but c-di-AMP binds at the same pocket in both LmPC and LlPC through 
divergent interactions with the residues at the binding site. The big difference between the 
two PC homologues with respect to acetyl CoA activation is that LmPC is activated by 
acetyl CoA, while LlPC is insensitive to acetyl CoA activation. Additionally, high 
concentrations of acetyl CoA can overcome the inhibition of LmPC by c-di-AMP, while 
the inhibition of LlPC by c-di-AMP cannot be overcome by the addition of acetyl CoA. In 
contrast to LmPC, there was no significant variation of domain orientations among 
monomers in either free LlPC or c-di-AMP bound LlPC, indicating a more constrained 
structure might be adopted by the acetyl CoA insensitive PC homologue, LlPC. 
4. OVERVIEW 
PC is an important metabolic enzyme, with acetyl CoA acting as its most potent 
allosteric activator. There have been many studies on the mechanisms of allosteric 
regulation by acetyl CoA and other allosteric effectors. Studies on PCs that are sensitive to 
acetyl CoA activation were able to describe the allosteric effects on catalysis but could not 
provide great insights into the fundamental mechanism of allosteric activation. In this 
section, I will review the key questions related to allosteric regulation of PC and outline 
the major contributions this dissertation will make to understanding allostery in PC. 
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Comparing the structures of PC in the presence and absence of acetyl CoA, there 
are no significant conformational changes that correspond to acetyl CoA binding, 
suggesting that the effects of acetyl CoA on catalysis are likely to be entropy-driven 
(Nussinov and Tsai 2014). There has been some evidence showing that acetyl CoA reduces 
the activation entropy in PC in both RePC and SaPC (Sirithanakorn, Jitrapakdee, and 
Attwood 2016, Westerhold et al. 2017). But, so far, the mechanism remains elusive. The 
enhanced coupling efficiency of PC was also observed in the presence of acetyl CoA 
(Zeczycki, Menefee, Jitrapakdee, et al. 2011). Thus far, kinetic analyses have only 
demonstrated that acetyl CoA accelerates the catalytic rate at the BC domain (Attwood and 
Graneri 1992), which does not explain how acetyl CoA enhances the coupling efficiency 
between the two half reactions occurring at two remote active sites. 
The antagonistic regulation of PC between acetyl CoA and L-aspartate has been 
observed and illustrated in PC homologs from various species (Cazzulo and Stoppani 1968, 
Osmani et al. 1981, Sirithanakorn et al. 2014). This is a conserved allosteric property of 
PC that serves to respond to increased energy input from elevated levels of acetyl CoA and 
excessive TCA intermediates from high levels of L-aspartate.  
The aim of the current research is to investigate the mechanism of allosteric 
regulation of pyruvate carboxylase. This is focused, in particular, on the mechanism of 
acetyl CoA activation and L-aspartate inhibition of pyruvate carboxylase, as well as the 
molecular basis for their antagonistic regulatory properties. Many prior studies have sought 
to uncover the fundamental mechanism of allostery in PC. The structure of Rhizobium etli 
PC first demonstrated that acetyl CoA binds at the interface between the allosteric domain 
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and BC domain on the same subunit. Until now, however, there is no structural evidence 
to suggest the precise location of the L-aspartate binding site. However, kinetics studies 
have clearly demonstrated that L-aspartate and acetyl CoA bind with PC competitively 
without sharing the same binding site. This suggests that there is an allosteric 
pathway/network between the two binding sites which negatively regulates the other’s 
binding, but the nature of the pathway and mechanism remains elusive. The fact that acetyl 
CoA binding is not accompanied by any significant structural changes in either the active 
sites or the overall domain architecture suggests that allostery in PC is mediated through 
the dynamics of the enzyme. How is it that acetyl coenzyme A binds so far away from both 
active sites, and yet activates the enzyme without altering the conformation of the enzyme? 
The same question may be asked regarding the inhibition by L-aspartate. This dissertation 
will outline research that is focused on discovering the answers to these questions. 
Two PC homologues are used in this study: PC from the bacterium Rhizobium etli 
(RePC) and the fungus Aspergillus nidulans (AnPC). These two PC homologs have 
opposing regulatory properties regarding the allosteric regulation by acetyl CoA and L-
aspartate. They are an ideal pair for a comparative study on the fundamental mechanism 
contributing to the sensitivity of allosteric regulation in PC. The described studies indicate 
that the divergent response from these two PC homologs are not likely a result of different 
binding modes for the effectors, instead, it is mainly determined by elements in the BC 
domain.  
It has been proposed that AnPC stays in a permanently active state with a more 
stable tetramer and inherently ordered translocation of the BCCP domain during catalysis. 
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In contrast, for the acetyl CoA sensitive PC, RePC stays as an inactive form in the absence 
of acetyl CoA. Binding with acetyl CoA reduces the activation energy by lowering the 
unfavorable activation entropy. The reduced activation entropy is proposed to be resulting 
from the promoted single translocation pathway adopted by the BCCP domain during 
catalysis, which is likely achieved by the previously reported dynamic oscillation between 
the symmetric and asymmetric conformations of the tetramer (Lasso et al. 2014). The 
carrier domain movement is regulated by acetyl CoA in RePC, which could give rise to an 
efficient transfer of the carboxyl group intermediate between the two active sites. Moreover, 
the competitive binding between acetyl CoA and L-aspartate results from their partially 
overlapped binding sites, most likely at the BC domain dimer interface. These combined 
studies led to a unified free-energy landscape population shift model to illustrate the 
allosteric regulation of PC and provides an example of divergent intrinsic properties in 
homologous enzymes can give rise to unique regulatory properties. 
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II. STRUCTURAL AND KINETIC CHARACTERIZATION OF A UNIQUE 
EUKARYOTIC PYRUVATE CARBOXYLASE FROM ASPERGILLUS NIDULANS.  
1. Introduction 
Acetyl CoA is a well-known allosteric activator of pyruvate carboxylase. The first 
structure of PC from Rhizobium etli revealed that acetyl CoA binds at the interface between 
the BC domain and the allosteric domain (St Maurice et al. 2007). Later on, more PC 
structures from different species were determined, including PC from Staphylococcus 
aureus (SaPC) (Xiang and Tong 2008, Yu et al. 2009) and Listeria monocytogenes (LmPC) 
(Sureka et al. 2014). In comparing PC structures with and without acetyl CoA bound, there 
are no significant conformational changes at the active sites nor is the overall arrangement 
of the domain architecture altered upon acetyl CoA binding. This has made it difficult to 
precisely describe the mechanism of allosteric activation in PC. 
Investigations into the mechanism of allosteric activation by acetyl CoA have 
focused on PC enzymes that are sensitive to acetyl CoA. There are two forms of PC in 
nature that differ in their subunit composition and sensitivity to acetyl CoA activation. The 
so-called a4 PCs are composed of 4 identical subunits, with all the catalytic domains 
encoded on a single polypeptide chain. This form is commonly found in eukaryotic cells 
and most bacteria and, in most cases, is sensitive to acetyl CoA activation. In some bacteria, 
PC is composed of two separate subunits: the BC domain comprises the a subunit and the 
CT-BCCP domains comprise the b subunit. These are encoded on two separate polypeptide 
chains and have recently been found to be functioning in an a2b4 stoichiometry in 
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Methylobacillus flagellatus (Choi et al. 2016). The two-subunit PC is not activated by 
acetyl CoA, unsurprisingly due to the absence of an allosteric site and acetyl CoA binding 
site.  Interestingly, among the a4 PCs, PC from Aspergillus nidulans (AnPC) is an outlier 
in which the pyruvate carboxylation reaction is not activated by acetyl CoA. The 
insensitivity of AnPC to acetyl CoA is intriguing because several lines of evidence suggest 
that acetyl CoA binds to the enzyme.  For example, cryo-EM studies revealed that AnPC 
adopts a more compact structure in the presence of acetyl CoA (Osmani et al. 1984). Prior 
studies also described competitive binding between acetyl CoA and L-aspartate in AnPC, 
indicating that acetyl CoA binds to AnPC but does not activate the pyruvate carboxylation 
reaction (Osmani et al. 1981, Osmani et al. 1984). A former lab member, Dr. Adam Lietzan, 
determined the X-ray crystal structure of AnPC, revealing that the overall structure of AnPC 
is very much like the other a4 PC enzymes in its overall quaternary structure. Since AnPC 
binds but does not respond to acetyl CoA, it offers an opportunity to investigate the 
mechanism of allostery in PC through a detailed comparative analysis with acetyl CoA 
sensitive PC enzymes. This chapter describes a comprehensive structural and kinetic 
characterization of the acetyl CoA insensitive PC homolog AnPC, using the acetyl CoA 
sensitive PC homolog RePC as a comparison, to elucidate the fundamental features that 
distinguish AnPC from other PC enzymes in terms of the activation by acetyl CoA. 
2. Materials and Methods 
Protein expression and purification of full-length RePC and AnPC. All full-length 
PC genes were expressed and purified in the same manner. In order to ensure complete 
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biotinylation, all PC clones were co-transformed and co-expressed with Escherichia coli 
biotin protein ligase A (BirA) on vector pCY216 (Chapman-Smith et al. 1994). 
Transformed E. coli BL21(DE3) cells were cultured in M9 minimal media at 37 °C to an 
optical density (600 nm) of 0.8 - 0.9, whereupon cells were induced by adding isopropyl 
1-thio-β-D-galacto-pyranoside (IPTG) and L-arabinose to a final concentration of 1 mM 
and 25 mM, respectively.  In addition, the culture was supplemented with D-(+)-biotin and 
MnCl2 to a final concentration of 3 mg/L and 0.1 mM, respectively. Induced cells were 
incubated with shaking at 16 °C for 20 hours before harvesting by centrifugation.  
All PC full-length enzymes were purified using sequential Ni2+-affinity and anion 
exchange chromatography. The cell paste from 12 L of cell culture was re-suspended in 
200 mL Ni-lysis buffer (20 mM Tris-HCl pH 7.8; 200 mM NaCl; 0.5 mM EGTA; 5 mM 
imidazole; 6 mM β-mercaptoethanol; 1 mM PMSF; 1 μM pepstatin A; and 5 μM E-64). 
Cells were disrupted by sonication at a temperature not exceeding 10 °C and pelleted by 
centrifugation. The supernatant was loaded on a 10 mL Ni2+-nitrilotriacetic acid profinity 
resin column (Bio-Rad, Hercules, CA). The column was washed with 20× column volume 
of wash buffer buffer (20 mM Tris-HCl pH 7.8; 200 mM NaCl; 0.5 mM EGTA; 20 mM 
imidazole; 6 mM β-mercaptoethanol) and the protein was eluted with a gradient from 20 
mM to 250 mM imidazole using wash buffer and elution buffer (20 mM Tris-HCl pH 7.8; 
200 mM NaCl; 0.5 mM EGTA; 250 mM imidazole; 6 mM β-mercaptoethanol). Purified 
protein was pooled and dialyzed against a buffer compatible for anion exchange 
chromatography (20 mM triethanolamine, pH 8.0; 50 mM NaCl; 1 mM EGTA; and 2 mM 
dithiothreotol (DTT)) at 4 °C overnight. The dialyzed protein was loaded on a 10 mL Q-
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Sepharose Fast Flow resin column (GE Healthcare) and was eluted from the column in 
buffer (20 mM triethanolamine, pH 8.0; 50 mM NaCl; 1 mM EGTA; and 2 mM DTT) with 
a gradient from 50 mM to 1 M NaCl. The elution peak of PC full-length protein was 
typically between 400 - 800 mM NaCl. The purified protein was pooled and dialyzed 
against storage buffer (10 mM Tris-HCl pH 7.8; 50 mM NaCl; 10 mM MgCl2, 5% (v/v) 
glycerol, and 2 mM DTT) for > 4 h with at least two successive changes. The protein was 
concentrated to a final concentration of 6 - 10 mg/mL and was drop frozen in liquid 
nitrogen prior to storage at -80 °C. All protein concentrations were determined by 
converting from the measured absorbance at 280 nm using the predicted extinction 
coefficient (ExPASY ProtParam) (Gasteiger et al. 2005).  
Mutagenesis of the AnPC R460S, AnPCR505A, AnPC V452M, AnPCK1171Q and 
RePC M419V, RePC×CT (T882A plus R621A). The RePC and AnPC wild type genes in 
pET17b-(His)9 vectors were site-specifically mutated by whole plasmid mutagenesis using 
the Quikchange method. The correct gene sequence for each set of mutations was 
confirmed by whole gene sequencing by Functional Biosciences (Madison, WI).  
Clones of two chimeric enzymes ReBC-AnPC and AnBC-RePC were generously 
provided by Dr. Sarawut Jitrapakdee, Mahidol University, Thailand.  
Protein expression and induction of PBP(A197C). The plasmid pSN8152/7 
(tetracycline resistance) containing the E. coli phoS gene encoding phosphate binding 
protein, PBP(A197C), and the E. coli strain ANCC75 (for PBP expression, with the wild-
type PBP gene knocked out) were provided by our colleague Dr. Antony (Biological 
Sciences Department, Marquette University) and used for overproduction of PBP(A197C). 
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The materials can be referred in previous literature (Brune et al. 1994) . Basically, PBP 
was cloned from E. coli phoS gene with the residue A197 mutated to cysteine using site-
directed mutagenesis (wild-type PBP does not contain any cysteines), so as to be labeled 
by the fluorophore 7-Diethylamino-3-( ( ( ( 2-Maleimidyl ) ethyl ) amino ) carbonyl ) 
coumarin ( MDCC, Thermo Fisher Scientific) through thiol-maleimide chemical reaction. 
The whole protocol was inherited from Dr. Antony’s lab.  
The E. coli strain ANCC75 with transformed plasmid pSN8152/7 was cultured in 
the high phosphate 1´ TG minimal media (5´ TG stock containing 600 mM Tris-HCL pH 
7.2, 400 mM NaCl, 100 mM KCl, 100 mM NH4Cl, 15mM Na2SO4) containing 0.64 mM Pi, 
with adding of 100´ Supplement (200 g/L glucose, 1 mM FeSO4, 20 mM MgSO4, 20 mM 
CaCl2, 2g/L L-Tryptophan, 1g/L Thiamine), 100´ PLUS (10 g/L L-Arginine HCl, 5 g/L L-
Leucine, 4 g/L L-Histidine HCl, 2 g/L L-Methionine, 1g/L L-Tryptophan, 2g/L Adenosine) 
and 12.5 mg/ml tetracycline antibiotic to the final concentration of 1´ Supplement, 1´ 
PLUS and 12.5 mg/L tetracycline respectively. Cells were cultured at 37 °C with shacking 
till OD600 reached 2.0. After the completion of cell growth, the cells were washed with 1´ 
TG minimal media to remove any remaining Pi and transferred into low Pi concentration 
media containing 0.064 mM Pi, 1´ Supplement, 1´ PLUS and 12.5 mg/L tetracycline 
antibiotic. The step of PBP protein induction was performed at 37 °C for ~16 h with 
shacking until harvesting. All the media was made in double distilled water. 
Protein purification of PBP(A197C). All the buffers for protein purification were 
made with reagent-grade chemicals with minimal phosphate contaminants Milli-Q water 
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(Milli-Q system; Millipore Corp). Additionally, the buffer was stored in plastic containers, 
in order to minimize the free Pi contaminants.  
The cell paste harvested from 6 L cell culture was resuspend in 650 mL Cell wash 
buffer (10 mM Tris-HCl, pH 7.6, 30 mM NaCl) at 25°C and span down in 1 L centrifuge 
bottle at 5000 rpm for 45 min. The cell pellet was resuspended another time with 350mL 
Cell wash buffer and span down at 10000 rmp for 10 mins. After discarding the supernatant. 
the cell pallet was resuspended in 100mL Cell resuspending buffer I (33 mM Tris-HCl, pH 
7.6) by stirring at 25 °C, followed by adding 100mL Cell resuspending buffer II (40% 
(weight/volume) sucrose, 0.1 mM EDTA) quickly. After continuing stirring the solution 
for 10min, the cells were span down at 10000 rmp for 20 mins at 4 °C. In order to burst the 
cell outer membrane and release PBP into solution, the cell pellet was rapidly resuspended 
in 200mL ice-cold Periplasmic lysis buffer (0.5 mM MgCl2) by stirring rapidly for 15 min 
at 4 °C. After the step of cell lysis, the cell lysis solution was centrifuged at 10000 rpm for 
20 min at 4 °C. The supernatant containing the PBP protein was kept for the next step of 
protein purification. The PBP was purified by using cation-exchange chromatography with 
the Q-Sepharose Fast Flow resins (100 mL, GE Healthcare). The protocol can be referred 
to the previous study (Brune et al. 1998). The molecular weight of PBP is ~35 kD. The 
protein molar concentration was determined using spectrometer by applying the Beer’s law 
with the molar extinction coefficient of PBP (6.16´104 M-1cm-1 ) in 1´ Q-Sepharose buffer 
(1 mM Tris-HCl, pH 7.7, 1 mM MgCl2). 
Site-specific labelling of PBP(A197C) with the fluorescent dye MDCC and 
isolating PBP-MDCC from free MDCC dye was performed by using size exclusion 
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chromatography. The labelling and isolating process were done at 25 °C. Buffers and 
reagents for labeling PBP(A197C) with fluorescent dye MDCC were made in Milli-Q 
water. All the containers used in this procedure were plastic. 
10mL PBP(A197C) protein solution was dialyzed against 20 mM Tris-HCl, pH 8.0 
at 4 °C overnight. The protein concentration was determined post dialysis. The Bio-Gel P-
4 size exclusion resins (BioRad) were equilibrated with 10 mM Tris-HCl, pH 8.0 at 25 °C. 
The contaminating Pi from the PBP protein solution was removed by adding the purine 
nucleoside phosphorylase (PNPase, Sigma) and its substrate 7-methyl guanosine (7-MEG, 
Sigma) to a final concentration of 0.2 U/ml and 300 µM respectively to the PBP protein 
solution. After the PBP solution was incubated at 25 °C for 1 h with gentle rocking, the 
MDCC stock solution (~40 mM, dissolved in 100% Dimethylformamid) was added into 
the PBP solution, until the molar ratio of MDCC : PBP reaching to 1.5:1. The mixture of 
PBP and MDCC was incubated at 25 °C in a plastic 50 mL conical tube wrapped with 
aluminum foil for another 1h with gentle rocking. The PBP-MDCC mix in a 50 mL conical 
tube was centrifuged at 4000 rmp for 20 min at 4 °C. Gently transfer the supernatant of 
PBP-MDCC sample from the conical tube to the P-4 column. The column was wrapped in 
aluminum foil to protect the MDCC dye from light. There were three separated yellow 
bands appeared on the column, the yellow color comes from the dye MDCC. Collect the 
first (fastest) band using a plastic conical tube. The labelling efficiency of the sample was 
determined by measuring the concentration of the PBP and MDCC individually. The 
concentration of the PBP protein and MDCC was determined by measuring the absorbance 
of the sample over a range of spectrum from 200-500 nm in a 1mL quartz cuvette (light 
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path length is 1 cm). The PBP concentration was calculated by applying the absorbance at 
A280 and its extinction coefficient to the Beer’s law A = elc, in which A is absorbance, c is 
the concentration of the molecule of interest, e is the extinction coefficient and l is light 
pathlength. Accordingly, the concentration of MDCC was calculated using the absorbance 
at A419 and its extinction coefficient (See Equation II-1). 
Equation II-1 calculation for the labeling efficiency of the MDCC labeled PBP (A197C) Labeling	efficiency = 	 /012
e3455	 /678e9:9	;   
A represents absorbance; e represents extinction co-efficient.  
Coupled enzyme MDH assay. Pyruvate carboxylation activity was monitored 
spectrophotometrically at 340 nm by following the conversion of oxaloacetate to malate 
using the coupled enzyme, malate dehydrogenase (MDH). The reaction catalyzed by MDH 
consumes one molecule of NADH. By adding excessive concentration of the coupled 
enzyme MDH, the produced oxaloacetate by PC will be converted to malate immediately 
coupled by consuming one molecule of NADH. Hence, the rate of oxaloacetate production 
can be monitored by the rate of NADH consumption, which is the changing of absorbance 
at 340nm. 
Reactions were performed in the buffer containing 0.1 M Tris-HCl (pH 7.8), 7 mM 
MgCl2, and 0.1 M KCl. All substrates and coupling reagents were prepared in a 10× stock 
solution at the following concentrations: 250 mM NaHCO3, 25 mM MgATP, 120 mM 
pyruvate, 2.4 mM NADH, and 100 units/mL malate dehydrogenase. For titration of acetyl 
CoA, the final concentration of acetyl CoA ranged from 0 - 5 mM. All reactions were 
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performed in 96-well plate format at 25°C in a total working volume of 200 μL. The final 
PC concentration in the assay ranged between 5 – 50 μg/mL (0.04 µM-0.4 µM) per reaction. 
Reactions were initiated by addition of 20 µL of the 10× substrate stock solution. The 
conversion from the changing of absorbance to the changing of NADH concentration is 
based on Beer’s law: A = elc, in which A is absorbance, e is NADH extinction coefficient 
and l is light pathlength. The absorbance of a known concentration of NADH was measured 
using the 96-well and l was calculated using Beer’s law. The light pathlength for 96-well 
place was determined to be 0.43 cm. 
Coupled enzyme LDH assay. The PC-catalyzed rate of oxaloacetate 
decarboxylation was determined by measuring the reduction of pyruvate to lactate using 
lactate dehydrogenase (LDH).  The reaction catalyzed by LDH consumes one molecule of 
NADH. Similar to the MDH assay, the rate of pyruvate formation can be determined by 
monitoring the rate of NADH consumption. Unless otherwise noted, the steady-state rate 
was measured in reactions that were performed in buffer containing 0.1 M Tris-HCl (pH 
7.8), 0.24 mM NADH, lactate dehydrogenase (10 U, Roche Diagnostics), 0.2 mM 
oxaloacetate (Sigma), 0.5 mM oxamate (Sigma), and 0.25 mM acetyl-CoA (Crystal Chem 
Inc.). 
The titration of oxaloacetate under different concentrations of oxamate (0, 0.25, 0.5, 
1, 2, 5 mM) was performed in two ways. At low concentrations of oxaloacetate, from 2-32 
μM, the reactions were performed in 1 mL quartz cuvettes with a final total volume of 1 
mL and light pathlength of 1 cm at 25 °C.  At high concentration of oxaloacetate, 64-2000 
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μM, the reactions were performed in 96-well plate format at 25 °C in a total working 
volume of 200 μL.	 
All reactions were initiated by the addition of oxaloacetate. The oxaloacetate stock 
solution needed to be kept on ice, due to its spontaneous decarboxylation. The final PC 
concentration ranged from 50 - 200 μg/mL (0.4 µM – 1.6 µM). All kcat values were 
calculated by dividing the experimentally determined Vmax values by the total protein 
concentration [E]t, defined as the subunit molar concentration (i.e. using a molecular weight 
of 126 kDa for RePC and 130 kDa for AnPC).  Protein concentrations were determined 
spectrophotometrically by measuring the absorbance at 280 nm. The extinction coefficients 
for the fully reduced enzyme were calculated from the primary sequence (ExPASY 
ProtParam).  
The titration of acetyl CoA analogues for AnPC using the oxamate-induced 
oxaloacetate decarboxylation assay were done in the 96-well format. The mean rate and 
standard deviation for each reaction were calculated from four repeats. All the analogues 
were ordered from Sigma-Aldrich, except for acetyl CoA (Crystal Chem Inc.) 
Pi release assay. The rate of Pi release from the ATP cleavage at the BC domain 
was measured by monitoring the change of fluorescence intensity at 455nm using the 
fluorophore (MDCC) labeled Phosphate binding protein (PBP-MDCC). The fluorophore 
7-Diethylamino-3-((((2-Maleimidyl) ethyl) amino) carbonyl) coumarin (MDCC, Thermo 
Fisher Scientific) MDCC was excited at 430 nm and emits fluorescence with wave length 
of 455 nm.  Binding with Pi changes the intensity of the fluorescence emitted from PBP-
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MDCC at 455 nm, which we used as the read-out to determine the free Pi concentration in 
solution. All the solutions are made in Milli Q water (Millipore Corp.).  
The “mopping” step before performing the Pi release assay. In order to minimize 
the contaminating Pi in the assay buffer, the 4× assay buffer (0.4 M Tris-HCl (pH 7.8), 28 
mM MgCl2, and 0.4 M KCl) was mopped with 0.01 U/ml purine polynucleotide 
phosphorylase (PNPase, Sigma) and 300 µM 7-methyl-guanosine (7-MEG, Sigma) at 4 °C 
overnight. All the stock solutions were made with the mopped 1× assay buffer (mopped 4× 
assay buffer was diluted with Milli Q water) and further mopped with 0.1 U/ml PNPase 
and 300 µM 7-methyl-guanosine (7MEG) at room temperature for 2h before starting the 
assay. 
The reactions were performed in the 1× assay buffer containing 0.1 M Tris-HCl 
(pH 7.8), 7 mM MgCl2, and 0.1 M KCl. All substrates were mixed in a 10× stock solution 
that containing components at the following concentrations: 250 mM NaHCO3, 25 mM 
MgATP, 120 mM pyruvate. The 10× stock solution of acetyl CoA and MDCC-PBP were 
prepared separately with concentration of 2.5 mM and 80 µM respectively. The final 
working concentration of PC was 0.0004 µM for AnPC and 0.004 µM for RePC in the 
presence of acetyl CoA, 0.0004 µM for AnPC and 0.02 µM for RePC in the absence of 
acetyl CoA (the PC concentration is represented as the molar concentration of the subunits). 
The 10× stock solution of the substrates and PBP-MDCC were mixed before adding to the 
well, in order to equilibrate the contaminating Pi left from the “mopping” step in the 
substrates solutions. All the reactions were performed in the 96-well (no-lid opaque plate) 
format at 25 °C in a total working volume of 200 µL and initiated with adding of PC. In 
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order to reduce the errors introduced by hands, the enzyme and assay buffer (the amount 
needed to fill up the total volume to 200 µL) were pre-mixed before initiating the reaction. 
The assay was initiated by adding of the enzyme and followed by reading the plate 
immediately. The mean rate and standard deviation for each reaction were calculated from 
four repeats. 
Standard curve for the Pi release assay. The intensity of fluorescence signal was 
converted to the Pi concentration in solution by generating a standard curve of fluorescence 
vs Pi concentration. The fluorescence intensity of PBP-MDCC was determined at a series 
of known Pi concentration in 1× assay buffer. The 10× Pi stock solution 5 µM, 10 µM, 15 
µM, 20 µM, 25 µM, 30 µM and 40 µM were prepared in Milli Q water. Each well was 200 
µL total volume and composed of: 50 µL mopped 4× assay buffer + 20 µL 10× Pi stock 
solution + 20 µL 10× PBP-MDCC stock solution (80 µM) + 110 µL Milli Q water. Two 
repeats per each Pi concentration were performed.  
Determination of Ka for acetyl CoA and acyl CoA analogues. The activity of 
oxaloacetate decarboxylation was measured over a range of acyl CoA analogue 
concentrations, in order to determine the Ka for acetyl CoA and the acyl CoA analogue. The 
Ka value was determined from the plot of the initial velocity vi/[E]t (kcat) against analogue 
concentration. After fitting the data to the equation II-2 using least-squares nonlinear 
regression, where [A] is the acyl CoA analogue concentration. All least-square fits were 
performed using Prism7 program. vi/[E]t (or kcat) is the initial velocity normalized for the 
enzyme concentration; kcat0 is the kcat value in the absence of the analogue; kcatAcoA is the kcat value 
  
 
 
66 
at saturating concentrations of the activator, Ka is the activation constant for the activator; 
and h is the Hill coefficient. 
Equation II-2 	 𝒗𝒊[𝑬]𝒕 = B𝒌𝒄𝒂𝒕𝟎 	+ 𝒌𝒄𝒂𝒕𝑨𝒄𝒐𝑨 	×	K[𝑨]𝑲𝒂M𝒉O /B𝟏 + K[𝑨]𝑲𝒂M𝒉O 
 
Determination of the thermodynamic parameters of AnPC and RePC using the 
coupled enzyme MDH assay. The coupled-enzyme assay was performed using 1 mL quartz 
cuvettes with a total volume of 1 mL and light pathlength of 1 cm. The assay was performed 
at a series of different temperature from 15 °C to 55 °C. all the reactions were incubated at 
the corresponding temperature for 15 min before initiated by adding of the enzyme. The 
enzyme concentrations of RePC and AnPC used in the assay were 5 µg/mL and 3 µg/mL, 
respectively.  
Characterization of the oligomerization state of the PC tetramers. Size exclusion 
chromatography was applied using FPLC equipment to characterize the oligomerization 
state of the PC tetramers. The size exclusion column was equilibrated using degassed and 
filtered FPLC buffer (with at least 1 column size buffer) containing 20 mM Tris pH 7.4, 
150 mM NaCl and 2 mM dithiothreitol (DTT) at flow rate of 0.3 ml/min. 1mg/ml protein 
solution was prepared in FPLC buffer and filtered before being injected to the column. 
Elution of the protein was performed by running FPLC buffer through the column at 0.3 
ml/min. Different oligomerization state of PC was eluted at different retention volume. 
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Crystallization of apo-AnPC structure and X-ray diffraction data collection. The 
structure of apo-AnPC was performed by Dr. Adam Lietzan. The construct used for 
producing the protein was the N-terminal (42 amino acids, only conserved in PC from 
Aspergillus niger) truncated AnPC construct DN-AnPC. DN-AnPC protein was reductively 
methylated before crystallization in order to decrease the solvent content in the protein 
crystal so as to improve the final resolution of the structure to ~3 Å. 
3. Results 
3.1 Structure of Aspergillus nidulans Pyruvate Carboxylase 
3.1.1 Symmetry of the Quaternary Structure of Aspergillus nidulans Pyruvate 
Carboxylase 
X-ray crystal structures of PC from multiple species have revealed significant 
variation in the overall symmetry of the PC tetramer. The first reported structure of PC, 
from Rhizobium etli (RePC), revealed a highly asymmetric tetramer, with two acetyl CoA 
molecules bound at one face of the tetramer (St Maurice et al. 2007). The “top” face with 
acetyl CoA bound is more compact, with the two subunits positioned in much closer 
proximity than the other two subunits from the opposite “bottom” face of the tetramer. The 
reduced intermolecular distance between the two subunits on the top face was believed to 
result from an induced-conformational change caused by the binding of acetyl CoA, which 
was proposed to lead to a faster intermolecular rate of translocation for the carrier domain 
during catalysis. This hypothesis was called into question, however, when the structure of 
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RePC without acetyl CoA bound also revealed an asymmetric tetramer (Lietzan et al. 2011). 
Meanwhile, a highly symmetric tetrameric arrangement was observed in the structure of 
Staphylococcus aureus PC, both in the presence and absence of acetyl CoA (Xiang and 
Tong 2008, Yu et al. 2009). Recent Cryo EM studies demonstrated that the symmetry of 
the tetramer correlates with different catalytic states of the enzyme, associated with the 
position of the carrier domain. Translocation of the carrier domain from the first-half 
reaction active site (BC domain) to the second-half reaction active site (CT domain) is 
associated with the transition from an asymmetric to a symmetric tetramer.  
The X-ray crystal structure of AnPC was previously determined in the laboratory 
by Dr. Adam Lietzan, but the analysis of this structure was left largely incomplete. Here, I 
provide a detailed analysis of the unique structural features of AnPC, based on the crystal 
structure determined by Dr. Lietzan. The overall structure of AnPC is very much like the 
structures of other a4 PCs, with two subunits arranged in an antiparallel fashion on one 
face of the tetramer and the other two subunits perpendicularly arranged on the opposite 
face of the tetramer, with homodimerization contacts between domains at each of the four 
corners of the tetramer (See Figure II-1A).  
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Figure II-1 Structural characterization of AnPC 
A, quaternary structure of the apo-AnPC tetramer. The BC domain is colored blue, the CT domain is colored 
yellow, the allosteric domain is colored green, and the BCCP domain is colored red. B, overlay of the four 
subunits from AnPC centered at the CT and allosteric domain.  subunit 1 (dark shade) and 3 (light shade) are 
colored, subunit 2 (dark grey) and 4 (light grey) are grey. C, overlay of RePC (PDB ID, 2QF7) subunit with 
AnPC subunit 2. .RePC is colored grey, AnPC is colored by individual domains The BCCP domain from 
AnPC subunit1 is colored red and overlapped with the BCCP from RePC  
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The symmetry of the structure can be evaluated based on the rotation angle between 
the BC domains from different subunits when they are all structurally aligned at the CT 
and allosteric domain. Large rotation angles between equivalent residues are an indication 
of increased asymmetry in the tetramer. From the structural overlay of the four subunits of 
AnPC, centered on the CT and allosteric domains, the two BC domains from the same face 
have very similar orientations (See Figure II-1B). However, between faces, the orientation 
of the BC domains deviates by a ~25° rotation (See Figure II-1B). Compared to the 
asymmetric tetramer structure of RePC, where the BC domains deviate between faces by a 
40° rotation (St Maurice et al. 2007), and the symmetric tetramer of SaPC, where the four 
subunit orientations largely overlap with only 6° difference among all four BC domains 
(Xiang and Tong 2008, Yu et al. 2009), we can say that the symmetry of AnPC lies halfway 
between the asymmetric RePC and the symmetric SaPC.   
The symmetry of the PC tetramer is proposed to correlate with two different 
catalytic states, contributing to the dogma that a single translocation pathway is adopted by 
the carrier domain during catalysis (Lasso et al. 2014). The asymmetric conformation is 
assigned to the intramolecular interaction between the carrier BCCP domain and the BC 
domain of its own subunit (BC domain reaction) and the symmetric conformation is 
assigned to intermolecular interaction between the carrier domain and the CT domain of 
the opposing subunit (CT domain reaction). The symmetry of AnPC lies in between these 
two states, indicating the possibility of a new catalytic state in AnPC.  Moreover, the 
tetramer of AnPC appears to be in a more open state, with the distance (~80 Å) between 
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the two active sites even greater than what has been observed in the homologues PC 
enzymes (~60-70 Å).  
3.1.2 Position of the BCCP domain 
There is only one well-defined BCCP domain present in electron density maps of 
the apo-AnPC structure. The electron density corresponding to the other three BCCP 
domains was largely disordered and could not be accurately modeled. Very interestingly, 
the position of the BCCP domain from AnPC locates adjacent to the BC domain of the 
opposing subunit, an orientation that had never previously been observed in PC structures 
adopting either the symmetric or asymmetric tetramers. It is noteworthy, however, that all 
prior PC structures were of acetyl CoA sensitive enzymes. Additionally, a recent PC 
structure from lactic acid bacteria, that is also not activated by acetyl CoA, also shows four 
structured carrier BCCP domains positioned at the BC domain of the opposing subunit 
(Choi et al. 2017). Thus, structures from both of the acetyl CoA insensitive PC homologues 
showed an unusual intermolecular interaction between the BCCP and BC domains from 
opposing subunits. It has been believed that the carrier domain translocate between the BC 
and CT domain through a single intermolecular translocation pathway, from the BC 
domain of its own subunit to the CT domain of the opposing subunit. This unique position 
of the BCCP domain in AnPC and LlPC suggests an alternative translocation pathway. This 
pathway is inconsistent with existing models of PC catalysis, where it has been proposed 
that an oscillation between symmetric and asymmetric conformations is driven by a single 
translocation pathway of the carrier domain during catalysis (Lasso et al. 2014).  
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Moreover, the relative position and intermolecular interaction between the BCCP 
domain and the BC domain from the opposing subunit in AnPC is very similar to the 
intramolecular interaction between the BCCP domain and BC domain observed in RePC 
(Figure II-1C), indicating that, despite the unique position occupied by the carrier domain 
in the context of the AnPC tetramer, the relative spatial relationship between the carrier 
domain and BC domain is conserved.  
3.2 Molecular Basis of the Unique Response to the Allosteric Activation by Acetyl 
Coenzyme A in Aspergillus nidulans Pyruvate Carboxylase 
3.2.1 Acetyl Coenzyme A Activates the Oxamate-induced Decarboxylation of 
Oxaloacetate at the Carboxyltransferase Domain 
PC is composed of two separate catalytic domains, where the half-reactions in each 
domain can be individually measured using separate enzyme kinetics assays. The overall 
pyruvate carboxylation reaction, catalyzed by wild-type AnPC, is not activated by acetyl 
CoA (Osmani et al. 1981). However, the sensitivity of the individual half-reactions to 
acetyl CoA activation has never been explored in AnPC.  
The reverse half-reaction, oxaloacetate decarboxylation, is catalyzed by the CT 
domain at a very slow rate. However, it was found that oxamate, a CT domain active site 
inhibitor of PC, can stimulate the oxaloacetate decarboxylation reaction (Lietzan, Lin, and 
St Maurice 2014, Marlier, Cleland, and Zeczycki 2013). Oxaloacetate decarboxylation 
proceeds through a carboxyl group transfer to the biotin co-factor. Oxamate subsequently 
binds at the CT domain active site and accepts the carboxyl group from carboxybiotin, 
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freeing biotin for a subsequent round of oxaloacetate decarboxylation (Marlier, Cleland, 
and Zeczycki 2013). Both oxamate and oxaloacetate display substrate inhibition through 
the formation of dead-end complexes with the inappropriate enzyme form (Lietzan, Lin, 
and St Maurice 2014). 
The rate of oxamate-induced decarboxylation of oxaloacetate by AnPC was 
determined using a coupled enzyme assay with LDH. Comparing to the acetyl CoA 
sensitive PC enzyme RePC, the rate of oxamate-induced decarboxylation of oxaloacetate 
by AnPC was determined to be more sensitive to acetyl CoA activation (See Table II-1).  
 
 
 
Table II-1 Steady-state kinetics parameters of AnPC and RePC 
Catalytic reactions 
RePC, (acetyl CoA sensitive 
PC) 
AnPC (acetyl CoA insensitive 
PC) 
- acetyl CoA, 
kcat0, min-1 
+ acetyl 
CoA, kcatAcoA, 
min-1 
- acetyl CoA, 
kcat0, min-1 
+ acetyl CoA, 
kcatAcoA, min-1 
Pyruvate carboxylation 140 ± 11 1180 ± 60 2400 ± 150 1900 ± 35 
Oxamate-induced oxaloacetate 
decarboxylation 2.98 ± 0.13 6.15 ± 0.29 2.75 ± 0.07 14 ± 2 
kcat0, kcat in the absence of acetyl CoA; kcatAcoA, kcat under saturating concentration of acetyl CoA (0.25 mM) 
In order to further kinetically characterize the role of acetyl CoA in this AnPC-
catalyzed reaction, oxaloacetate was titrated over a series of fixed oxamate concentrations, 
to determine the Km and Ki values of oxaloacetate in the presence and absence of acetyl 
CoA. Global curve fitting of the titration kinetics data was originally performed using the 
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steady state equation describing substrate inhibition for a Ping Pong Bi Bi system (Equation 
II-3) (Lietzan, Lin, and St Maurice 2014).  
Equation II-3 𝑘STUTVV
= [oxamate] × [𝑂𝐴𝐴] 	×	𝑘STU𝐾/^ × [oxamate] × K1 + [𝑜𝑥𝑎𝑚𝑎𝑡𝑒]𝐾f/ M +	𝐾g^ × [𝑂𝐴𝐴] 	×	K1 + [𝑂𝐴𝐴]𝐾fg M + [𝑂𝐴𝐴] × [oxamate] 
kcatapp is measured the initial velocity vi divided by total enzyme concentration [E]t. kcat is maximum initial velocity 
Vmax divided by total enzyme concentration [E]t, which is determined from the curve fitting; [OAA] is 
oxaloacetate concentration; KmA is the Michaelis constant of oxaloacetate; KmO is the Michaelis constant of 
oxamate; KiA is the inhibition constant of oxaloacetate; KiO is the inhibition constant of oxamate. 
However, global curve fitting was unsuccessful, likely due to insufficient 
experimental data points. Instead, a single substrate inhibition equation (Equation II-4) was 
applied to fit the titration data to obtain the apparent KmA app and KiA app values of oxaloacetate 
under different concentrations of oxamate. 
Equation II-4  𝑘STUTVV = [𝑂𝐴𝐴] 	×	𝑘STU𝐾/^	TVV + [𝑂𝐴𝐴] × K1 + [𝑂𝐴𝐴]𝐾f/	TVVM 
kcatapp is measured the initial velocity vi divided by total enzyme concentration [E]t. kcat is maximum initial velocity 
Vmax divided by total enzyme concentration [E]t, which is determined from the curve fitting; [OAA] is 
oxaloacetate concentration; KmA app is the apparent Michaelis constant of oxaloacetate; ; KiA app is the apparent 
inhibition constant of oxaloacetate 
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Using the single substrate inhibition equation, the curve fitting was successful and 
reveals that acetyl CoA promotes the catalytically productive form of the enzyme, as 
evidenced by the decreased KmA app value for oxaloacetate and increased KiA app value for 
substrate inhibition of oxaloacetate (See Figure II-2, Table II-2). 
 
 
 
 
Figure II-2 Curve fitting of the steady-state kinetics of oxamate-induced oxaloacetate 
decarboxylation of wild-type AnPC using single substrate inhibition equation 
A, titration curve in the absence of acetyl CoA; B, titration curve in the presence of 0.25 mM acetyl CoA. 
Blue circle, 250 µM oxamate; red rectangle, 500 µM oxamate; purple circle, 2000 µM oxamate; The insert 
is the zoomed in view of the curve at low concentration of oxaloacetate (0-100 µM). 
 
Table II-2 Kinetic parameters of the oxamate-induced oxaloacetate decarboxylation in AnPC from 
curve fitting of single substrate inhibition equation 
Oxamate, µM 
+ 0 mM AcoA  + 0.25 mM AcoA 
kcat, min-1 KmAapp, µM KiAapp, µM  kcat, min-1 KmAapp, µM KiAapp, µM 
250 9.0 ± 2.0 4.8 ± 2.2 22.6 ± 8.1  12.8 ± 1.2 0.6 ± 0.8 285 ± 100 
500 16.7 ± 8.9 7.4 ± 7.0 22.8 ± 19.0  16.6 ± 1.2 0.4 ± 0.5 385 ± 90 
2000 31.3 ± 7.3 24.3 ± 9.6 97.2 ± 39.5  22.7 ± 2.2 1.6 ± 0.9 306 ± 100 
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The role played by oxamate and biotin in oxaloacetate decarboxylation was well 
studied in RePC (Lietzan, Lin, and St Maurice 2014, Marlier, Cleland, and Zeczycki 2013), 
where it was determined that the steady-state rate of oxaloacetate decarboxylation is 
determined by the rate-limiting decarboxylation of carboxybiotin (Lietzan, Lin, and St 
Maurice 2014). In order to investigate the role of biotin in the activation of AnPC by acetyl 
CoA, steady-state rates of the oxamate-induced oxaloacetate decarboxylation were 
determined in the presence of a biotin-deficient mutant, which has the biotinylated lysine 
residue mutated to glutamine. In the absence of biotin, oxaloacetate decarboxylation is 
biotin-independent and is not activated by acetyl CoA (Table II-3).  
 
Table II-3 The rate of oxaloacetate decarboxylation under different conditions in AnPC and mutants 
AnPC constructs 
a0.5 mM oxaloacetate, kcat, min-1 
nothing + 0.25 mM ACoA + 0.5 mM oxamate + 0.5 mM oxamate,  + 0.25 mM ACoA 
Wild-type AnPC 0.13 ± 0.03 0.44 ± 0.05 2.75 ± 0.07 14 ± 2 
AnPC K1171Q 1.12 ± 0.06 1.19 ± 0.04 1.27 ± 0.01 1.12 ± 0.03 
AnPC  
R662A T923A 1.16 ± 0.10 1.42 ± 0.23 1.29 ± 0.03 1.52 ± 0.10 
a, the oxaloacetate concentration applied in the assay was 0.2 mM  
An additional mutation was generated in the CT domain (AnPC R662A&T923A), 
where the threonine that is responsible for proton shuttling between pyruvate and biotin 
was mutated to alanine and the arginine that is responsible for binding with pyruvate was 
also mutated to alanine. Hence, the reaction catalyzed by the AnPC T923A/R662A was 
biotin-independent oxaloacetate decarboxylation.  The results suggested that acetyl CoA 
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does not activate biotin-independent decarboxylation of oxaloacetate at the CT domain, 
indicating that the catalytically productive form promoted by acetyl CoA involves the 
biotin binding pocket, possibly by enhancing the binding of biotin at the CT domain for 
the decarboxylation of oxaloacetate.   
3.2.2 The Molecular Basis of the Binding of Acetyl Coenzyme A in AnPC 
Having demonstrated that acetyl CoA stimulates the oxamate-induced 
decarboxylation of oxaloacetate at the CT domain of AnPC instead of the overall pyruvate 
carboxylation reaction, I next sought to determine whether acetyl CoA binds at the same 
binding site as it does in acetyl CoA sensitive PC homologues. Two conserved arginine 
residues have been identified to play an essential role in the binding of acetyl CoA in PC 
from Rhizobium etli and Staphylococcus aureus (St Maurice et al. 2007, Yu et al. 2009, 
Adina-Zada et al. 2012) (See Figure II-3).   
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Figure II-3 Molecular structure of acetyl CoA and the conserved acetyl CoA binding site. 
A, Overlay of RePC (PDB ID: 2QF7) and AnPC centered at the acetyl CoA binding site. The biotin 
carboxylase (BC) domain is shown in blue, allosteric domain is shown in green. RePC is colored by domains, 
AnPC is colored in grey. Two conserved arginine residues and 3’5‘- diphosphate adenine is shown in sticks. 
B, the structure of acetyl CoA. two essential phosphate groups that form hydrogen bond with the conserved 
arginine residues in PC are highlighted red. 
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Mutations of those residues in RePC have significantly reduced the binding affinity 
of acetyl CoA and reduced the sensitivity to the activation by acetyl CoA (Adina-Zada et 
al. 2012). To determine whether these same arginine residues contribute to acetyl CoA 
binding in AnPC, the equivalent residues in AnPC, Arg505 and Arg460, were individually 
mutated to R505A and R460S respectively. The impact of these mutations on acetyl CoA 
binding was determined by measuring the activation constant, Ka, of acetyl CoA on the 
steady-state rate of pyruvate carboxylation and oxamate-induced oxaloacetate 
decarboxylation. The Ka values were determined by fitting the titration data to equation II-
2. No significant change on the rate of pyruvate carboxylation, either in the presence or 
absence of acetyl CoA, was observed (See Table II-4), which is consistent with the fact 
that the pyruvate carboxylation catalyzed by AnPC is not affected by acetyl CoA.  
 
Table II-4 The activation by acetyl coenzyme A of the wild-type AnPC and mutants 
 Oxamate-induced oxaloacetate decarboxylation 
 Pyruvate carboxylation 
AnPC constructs kcat0, min-1 kcatAcoA, min-1 Ka, μM  kcat0, min-1 kcatAcoA, min-1 
AnPC wild type 2.67±0.01 11.6±0.5 3.5 ± 0.2  2400 ± 90 2200 ± 90 
AnPC R460S 5.10±0.03 15.5±0.2 170 ± 20  2100 ± 80 1830 ± 40 
AnPC R505A 1.31±0.03 12.3±1.3 901 ± 70  2100 ± 170 2000 ± 210 
 
Mutations on the equivalent residues of the acetyl CoA sensitive RePC have shown 
attenuated activity only in the presence of acetyl CoA, indicating that these residues only 
participate in the activation of RePC catalysis in the presence of acetyl CoA (Adina-Zada 
et al. 2012).  
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For the oxamate induced oxaloacetate decarboxylation, both mutants displayed a 
significantly increased Ka value for acetyl CoA relative to the wild type enzyme, suggesting 
that acetyl CoA binds with the same conserved arginine residues in AnPC as it does in 
RePC. Of the two mutations in RePC, the mutation of the arginine located at the allosteric 
domain (RePC R472) has a greater effect in reducing the binding affinity of acetyl CoA 
(Adina-Zada et al. 2012). Similar to RePC, AnPC R505A mutant has a greater negative 
influence on the Ka value for acetyl CoA than does AnPC R460S, suggesting a very similar 
binding mode and binding site for acetyl CoA in AnPC as in RePC (See Table II-4).  
Determining the Ka value for acetyl CoA in AnPC has not previously been possible, 
given the lack of acetyl CoA activation of the pyruvate carboxylation reaction. Previous 
studies could only measure the apparent Ka value of acetyl CoA in the presence of the 
allosteric inhibitor L-aspartate, based on the competitive binding of acetyl CoA and L-
aspartate to PC. The current study determined that acetyl CoA significantly activates the 
oxaloacetate decarboxylation activity in the presence of oxamate, from which a direct 
measure of the Ka for acetyl CoA could be performed. The experimentally determined Ka 
values for acetyl CoA are very similar between wild-type AnPC and RePC.  
My data strongly suggests that, in AnPC, acetyl CoA activates the oxamate-induced 
decarboxylation of oxaloacetate by binding at the same site as it does in RePC. However, 
given that the full pyruvate carboxylation reaction is not activated by acetyl CoA in AnPC, 
it remains to be determined whether the molecular determinants responsible for acetyl CoA 
activation of the oxamate-induced decarboxylation of oxaloacetate in AnPC are the same 
as they are for the activation of pyruvate carboxylation in the other PC enzymes.   
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Acetyl CoA is composed of a 3’-phosphate ADP connected to a long carbon chain 
pantothenic acid, linked with a b-mecaptoethylamine group through an amide bond. The 
acetyl group forms a thioester with the sulfhydryl group from b-mecaptoethylamine. Based 
on the structure of RePC and SaPC with acetyl CoA bound, the primary binding 
determinants are the hydrogen bond between the 3’- and 5’-phosphate groups and two 
conserved arginine residues at the binding pocket. 3'-Dephospho CoA does not activate the 
pyruvate carboxylation in SaPC (Yu et al. 2009), suggesting that the phosphate group is 
indispensable for anchoring acetyl CoA in PC. Conversely, 3',5'-diphosphate adenine and 
CoA can activate SaPC almost to the same degree as acetyl CoA but with much lower 
affinity (Yu et al. 2009), suggesting that the acetyl group along with the pantothenic acid 
arm makes a major contribution to acetyl CoA binding and that these are dispensable for 
the activation of the enzyme.  
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To further characterize the molecular basis of acetyl CoA binding and activation of 
the oxamate-induced oxaloacetate decarboxylation reaction in AnPC, a series of acetyl 
CoA analogues were assessed as allosteric activators of AnPC. Several acetyl CoA 
analogues were kinetically characterized for their activation of the oxamate-induced 
decarboxylation of oxaloacetate in AnPC (See Table II-5).  
 
Table II-5 Kinetic parameters of the acetyl CoA analogues on the activation of oxamate-induced 
oxaloacetate decarboxylation in AnPC 
Compounds kcat0, mini-1 kcatA, mini-1 Ka, µM h 
Acetyl CoA 4.3 ± 0.6 20.1 ± 0.5 3.5 ± 0.4 1.5 ± 0.2 
Malonyl CoA 4.6 ± 0.2 21.7 ± 0.8 111 ± 8 1.8 ± 0.1 
CoA 5.4 ± 0.6 24.4 ± 0.3 150 ± 1 2.4 ± 0.3 
Hexanoyl CoA 5.3 ± 0.6 20.8 ± 0.5 0.040 ± 0.003 1.5 ± 0.2 
Butyryl CoA 4.5 ± 0.3 19.9 ± 0.1 0.82 ± 0.05 2.2 ± 0.3 
Adenine 3'5' diphosphate 6.0 ± 0.5 26.1 ± 0.3 8100 ± 1300 1.6 ± 0.2 
3'-Dephospho CoA 4.5 ± 0.3 5.4 ± 0.1 N/A N/A 
Palmitoyl CoA 4.5 ± 0.3 1.9 ± 0.2 N/A N/A 
Oleyl CoA 4.5 ± 0.3 2.04 ± 0.1 N/A N/A 
The range of working concentration for each chemical: acetyl CoA: 0 – 2.5 mM; Malonyl CoA: 0 - 2.3 mM; 
CoA: 0 – 2.6 mM; Hexanoyl CoA: 0 - 2.2 mM; Butyryl CoA: 0 – 2.4 mM; Adenine 3’5’ diphosphate: 0 – 
20mM; 3’-Dephosphate CoA: 0 – 2.9 mM; Palmitoyl CoA: 0 – 2 mM; Oleyl CoA: 0 – 2 mM. kcat0 represents 
the kcat in the absence of the effectors; kcatA represents the kcat at saturating concentration of the effectors. Ka is the 
activation constant. h is the hill coefficient.  
The acetyl CoA analogue missing the 3’ phosphate on adenosine (3’-dephospho 
CoA) does not activate AnPC. The analogues with acyl group modifications in place of the 
acetyl moiety all activate AnPC to the same degree as acetyl CoA. However, the affinity of 
these acyl substituted CoAs vary, indicating that the acyl group contributes exclusively to 
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the binding affinity but not to the extent of activation. 3',5'-diphosphate adenine is a highly 
truncated analogue of CoA that lacks both the pantothenic acid chain and the acetyl group. 
However, 3',5'-diphosphate adenine retains the two phosphate groups that anchor the 
molecule in the binding pocket at the allosteric binding site. This activates the oxamate-
induced oxaloacetate decarboxylation to the same degree as acetyl CoA, but with a much 
lower binding affinity. This suggests that the ligand binding at the nucleotide binding 
pocket of the allosteric site is sufficient to maximally stimulate catalysis in the CT domain 
of AnPC, and that the remainder of the acetyl CoA molecule serves only to enhance the 
binding affinity. To summarize, the activation of the CT domain half-reaction of AnPC by 
acetyl CoA behaves the same as does the activation of pyruvate carboxylation in the other 
PC homologues. This indicates that the insensitivity of AnPC to acetyl CoA activation in 
the overall reaction is due to an intrinsic property of the enzyme and is not merely the result 
of an altered binding mode for acetyl CoA in AnPC. 
Long-chain acyl CoA analogues, such as palmitoyl CoA and oleyl CoA, did not 
activate the oxamate-induced oxaloacetate decarboxylation in AnPC. It has been previously 
reported that these long-chain acyl CoA analogues compete with the binding of acetyl CoA 
in AnPC, but these studies did not investigate the ability of these compounds to activate the 
oxamate-induced decarboxylation of oxaloacetate (Osmani et al. 1981). These long chain 
acyl CoAs have a lower apparent Ka value than acetyl CoA in the presence of the inhibitor 
L-aspartate, indicating that the long-chain acyl CoA molecules bind and compete with L-
aspartate in AnPC more efficiently than acetyl CoA.  The present study reveals that, 
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although these long-chain acyl CoA molecules bind with PC and compete with L-aspartate, 
they do not activate the oxamate-induced decarboxylation of oxaloacetate.  
3.2.3 Domain Contributions to the Allosteric Regulation of Pyruvate Carboxylase  
The binding mode of acetyl CoA in AnPC is similar to that in other acetyl CoA 
sensitive PC homologues, suggesting that the unique regulatory property of AnPC could be 
derived from the unique features of AnPC itself.  
It has been demonstrated that the locus of action for acetyl CoA activation of PC is 
at the BC domain (Zeczycki, Menefee, Jitrapakdee, et al. 2011), where acetyl CoA 
activates pyruvate carboxylation through activation of the rate of bicarbonate-dependent 
ATP cleavage (Attwood and Wallace 1986, Legge, Branson, and Attwood 1996). In order 
to determine the sensitivity of the ATP cleavage catalyzed by AnPC to the activation by 
acetyl CoA, the ATP cleavage reaction in the BC domain was measured in the presence 
and absence of acetyl CoA (See Table II-6).    
 
Table II-6 Kinetic characterization of pyruvate carboxylation and ATP cleavage by RePC and AnPC 
Enzyme Catalysis 
RePC, kcat, min-1 AnPC, kcat, min-1 
- AcoA + 0.25 mM AcoA - AcoA 
+ 0.25 mM 
AcoA 
Pyruvate carboxylation 90 ± 1 1100 ± 30 2400 ± 150 1900 ± 35 
HCO3- dependent ATP cleavage  
(BC domain) 230 ± 1 1800 ± 15 3020 ± 70 3010 ± 150 
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Acetyl CoA does not activate the ATP cleavage reaction in AnPC (See table II-6), 
which correlates with the insensitivity of AnPC to acetyl CoA in the overall pyruvate 
carboxylation reaction. Previous studies (St Maurice et al. 2007, Yu et al. 2009) and those 
described in chapter II 3.2.2, have demonstrated that acetyl CoA binds at the interface 
between the BC and allosteric domain in both AnPC and RePC, with the nucleotide moiety 
of acetyl CoA stabilized by interactions with two arginine residues: one  is part of the BC 
domain, and the other is part of the allosteric domain. In order to investigate the relative 
domain contributions to the sensitivity of activation by acetyl CoA in PC, two chimeric 
enzymes were generated by reconstructing full-length PC from a recombination of 
individual domains from RePC (acetyl CoA sensitive PC) and AnPC (acetyl CoA 
insensitive PC). The acetyl CoA binding pocket is at the interface of the BC and allosteric 
domains, facilitating the construction of two chimeric enzymes by swapping the intact BC 
domain from RePC and AnPC at the acetyl CoA binding site. A similar strategy was applied 
to other PC homologues, enabling studies on the domain contributions to PC catalysis 
(Jitrapakdee et al. 2007, Islam, Sueda, and Kondo 2005), though these studies were 
performed without knowledge of the three-dimensional protein structure, limiting their 
precision.  
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The chimeric design splits and recombines the two conserved arginine residues at 
the acetyl CoA binding site as well as the two catalytic domains between two different PC 
homologues. The two chimeric enzymes were named based on their construction: ReBC-
AnPC and AnBC-RePC (Figure II-4).  
 
 
Figure II-4 Construction of the two chimeric enzyme AnBC-RePC and ReBC-AnPC 
The illustration of the primary structure of PC. AnPC is shown in outlined shape and RePC is shown in solid 
shape. Blue represents biotin carboxylase domain (BC domain); green represents allosteric domain; yellow 
represents the carboxyltransferase domain (CT domain); red represents the biotin carboxyl carrier protein 
domain (BCCP domain). the residues were shown in black sticks. The color of the residue indicates which 
domain it is from. 
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The sensitivity of the two chimeras to acetyl CoA activation was kinetically 
characterized (See Table II-7).  
 
Table II-7 Kinetic characterization of the activation by acetyl CoA in chimeric PC enzymes 
 kcat0, min-1 kcatAcoA, min-1 kcatAcoA / kcat0 KaAcoA, µM 
RePC 90 ± 1 1100 ± 30 12.2 ± 0.4 5.1 ± 0.2 
AnPC 2400 ± 150 1900 ± 35 1.3 ± 0.1 3.5 ± 0.4a 
ReBC-AnPC 37 ± 2 500 ± 5 13.5 ± 0.1 1330 ± 70 
AnBC-RePC 68.9 ± 2.5 181 ± 18 2.6 ± 0.1 230 ± 30 
a, the Ka value is determined from the oxamate induced decarboxylation of oxaloacetate using the LDH 
coupled enzyme assay. All other Ka values were determined for pyruvate carboxylation using the coupled 
MDH enzyme assay. 
Firstly, both chimeric enzymes showed increased Ka values for acetyl CoA, likely 
resulting from disrupted binding of acetyl CoA at the reformed acetyl CoA binding site. 
The acetyl CoA binding affinity is much lower for ReBC-AnPC than for AnBC-RePC, in 
spite of its higher sensitivity to acetyl CoA activation. Interestingly, while the pyruvate 
carboxylation reaction in the wild-type AnPC is insensitive to the activation by acetyl CoA, 
grafting the BC domain from RePC results in a 13-fold activation for the ReBC-AnPC 
chimera. However, the AnBC-RePC chimera having the BC domain from the wild-type 
AnPC became significantly less sensitive to acetyl CoA activation (~3-fold activation) 
compared to wild-type RePC (~10-fold activation) (See Table II-7). These results 
demonstrate that the divergent sensitivity to the activation by acetyl CoA between RePC 
and AnPC is primarily determined by the BC domain.   
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3.2.4 Mutation of a Conserved Methionine Residue at the BC Domain Dimer Interface of 
RePC Attenuated the Activation by Acetyl CoA 
The results from sections 3.2.2 and 3.2.3 strongly suggest that the sensitivity to 
activation by acetyl CoA is primarily determined by the BC domain. The fact that the 
sensitivity to acetyl CoA activation in AnPC can be significantly changed, simply by 
replacing its BC domain with the BC domain from RePC, suggests there are fundamentally 
divergent features of the BC domain between these two PC homologous that determine 
their divergent responses to the activation by acetyl CoA. 
It has been reported that PC functions exclusively as a tetramer (Attwood et al. 
1993), with homodimerization interfaces between the same catalytic domains connecting 
the top and bottom faces at the four corners of the tetramer. The orientation of the BC 
domain is highly flexible (St Maurice et al. 2007, Xiang and Tong 2008, Yu et al. 2009, 
Sureka et al. 2014). Structural overlays of PC subunits derived from the same tetramer 
structure reveal that nearly all structural variations within the tetramer arise from the BC 
domain orientation, suggesting that multiple, low-energy conformational states may be 
adopted by the BC domain during catalysis. The BC domain dimer interface contributes 
significantly to the overall tetramerization and catalysis of PC (Yu et al. 2013). Mutations 
at the BC dimer interface disrupt the formation of the tetramer and completely eliminate 
the enzyme activity (Yu et al. 2013). Previous studies have shown that there is a domain 
rearrangement at the BC domain dimer interface in the presence of acetyl CoA (Yu et al. 
2009), which could contribute to the activation by acetyl CoA. 
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Based on these previous studies, I decided to investigate the features of the BC 
domain dimerization interface that might differ between AnPC from RePC, as a possible 
source for the divergent sensitivities to acetyl CoA activation. To probe the contributions 
to the BC domain dimerization in the two PC homologues, the online server ROSIE 
(Rosetta Online Server that Includes Everyone) was employed using the program 
“Peptiderive” to analyze the amino acids that make major contributions to the BC domain 
interaction at the dimer interface. Using the BC domain dimer from AnPC and RePC as the 
input, the program predicted those regions (10 amino acids in length) that contribute to the 
association energy between the two domains. Peptides were identified as making major 
contributions to the dimerization of the BC domain by forming the lowest-energy complex 
with its partners. One specific pair of helices (a1 and a2) at the dimer interface were 
identified that interact strongly through an extended series of hydrogen bonds (see Figure 
II-5A). In PC from Staphylococcus aureus, mutations of conserved residues located at this 
helix pair, R21 (equivalent residue AnPC R61 on a1) and K411 (equivalent residue AnPC 
K451 on a2), disrupted the dimerization between the BC domain and resulted in 
catalytically inactive enzymes or mutants that became completely insensitive to acetyl CoA 
activation (Yu et al. 2013). Those prior studies validated the current approach of using the 
ROSIE server to identify important residues that contribute to the dimerization of the BC 
domain. A sequence alignment of PC homologues revealed that, except for the residue 
V452 in AnPC, all the residues composing the two helices, a1 (AnPC I57-L66) and a2 
(AnPC R449-E458), are highly conserved among all PC homologues. At the equivalent 
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position to V452 (from a2) in AnPC, all the other acetyl CoA sensitive PC homologues 
maintain a conserved methionine (See Figure II-5B). 
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Figure II-5 Analysis of the protein-protein interaction at the AnPC BC dimer interface and the 
sequence alignment of PC from multiple species 
A, BC domain dimer from AnPC. The ATP-g-s structure is from RePC (PDB ID: 2QF7). The two helixes, a1 
and a2 that make major contributions to the dimerization of the BC domains were colored orange. The 
conserved residues that contribute to the dimerization of the BC domain by forming hydrogen bond are shown 
in lines and framed by dashed line. RePC M419 and AnPC V452 are shown in sticks. The methionine residue 
from RePC is shown in cyan and valine from AnPC is shown in orange. B, sequence alignment between PC 
homologs from different species. 
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Intriguingly, helix a2 also houses one of the two the conserved arginine residues 
(AnPC R460 / RePC R427) that form a critical interaction with the 3’phosphate of acetyl 
CoA.  Given that the helix predicted to have the most influence on BC domain dimerization 
also contributes a key residue responsible for anchoring acetyl CoA to PC, the one residue 
changing in AnPC (Met to Val) might contribute to the insensitivity of AnPC to acetyl CoA 
activation. To test this hypothesis, the conserved methionine residue in RePC was mutated 
to a valine, equivalent to the amino acid in AnPC, predicting that the mutant RePC M419V 
would be less sensitive to acetyl CoA activation. Equivalently, V452 in AnPC was mutated 
to methionine, predicting that the mutant AnPC V452M would be activated by acetyl CoA.  
 Steady-state kinetic characterization of both RePC M419V and AnPC V452M 
showed reduced activity relative to the wild-type enzymes (See Table II-8). AnPC V452M 
remained insensitive to activation by acetyl CoA, while RePC M419V showed a reduced 
degree of activation by acetyl CoA (~2-fold) compared to wild type RePC (~10-fold).  Most 
interestingly, RePC M419V exhibits a very similar binding affinity for acetyl CoA, 
indicating that the reduced degree of activation by acetyl CoA is not due to an attenuated 
binding affinity of acetyl CoA (See Table II-8). 
 
Table II-8 Kinetic characterization of the activation by acetyl CoA of RePC and AnPC and their 
mutants  
 kcat0, min-1 kcatAcoA, min-1 kcatAcoA / kcat0 Ka AcoA, µM 
Wild-type RePC 105 ± 10 1070 ± 50 10 ± 1 4.7 ± 0.3 
RePC M419V 27.3 ± 0.7 59.2 ± 3.0 2.2 ± 0.1 8.4 ± 0.5 
Wild-type AnPC 1870 ± 60 1970 ± 10 1.1 ± 0.3 N/A 
AnPC V452M 1470 ± 50 1290 ± 40 0.88 ± 0.04 N/A 
kcat0, kcat of the pyruvate carboxylation in the absence of acetyl CoA; kcatAcoA, kcat of the pyruvate carboxylation at 
saturating concentration of acetyl CoA (0.25mM); KaAcoA, activation constant of acetyl CoA.  
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According to previous studies, mutations of residues at the BC dimer interface 
contributed to a loss of tetramerization (Yu et al. 2013). To determine whether the reduced 
activity relative to the wild-type enzymes resulted from a disruption of the tetramer, the 
oligomerization state of the mutants was examined using size-exclusion chromatography 
(See Figure II-6).  
 
 
 
 
Figure II-6 Size-exclusion chromatography elusion profile  
 
The mutant AnPC V452M mostly remains as a tetramer in solution, suggesting that 
the reduced activity of the mutant is directly tied to reduced catalytic turnover.  RePC 
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M419V exists mostly as dimers, monomers and aggregates in solution, with only a small 
percentage of the RePC M419V protein forming catalytically functional tetramers. This is 
consistent with the significantly reduced activity observed for the mutant, and means that 
the reduced activity of RePC M419V cannot be directly tied to the attenuation of the 
catalytic rate. Size-exclusion chromatography was performed with RePC M419V in the 
presence of 0.1 mM acetyl CoA. Acetyl CoA did not shift the distribution of the population 
toward the tetramer. 
To further probe the basis for the reduced catalytic activity and the degree of 
activation in RePC M419V, ATP and pyruvate were titrated in the presence and absence 
of acetyl CoA for the wild-type enzymes and mutant RePC M419V, in order to compare 
their Km values for pyruvate and ATP in the overall pyruvate carboxylation reaction (See 
Table II-9).  
 
Table II-9 Km values for ATP and pyruvate in the overall pyruvate carboxylation reaction 
PC constructs 
ATP  pyruvate 
Km0, µM Km AcoA, µM  Km0, µM KmAcoA, µM 
Wild-type RePC 430 ± 50 199 ± 11  645 ± 37 310 ± 15 
Wild-type AnPC 270 ± 60 330 ± 40  790 ± 30 490 ± 10 
RePC M419V 430 ± 70 707 ± 56  810 ± 80 340 ± 20 
Km0 is the Michaelis constant in the absence of acetyl CoA; KmAcoA is the Michaelis constant in the presence of 
0.25 mM acetyl CoA 
Since the Km value is independent of protein concentration, the experimentally 
determined Km values for ATP for the mixed population of RePC M419V oligomers is equal 
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to the true Km values of ATP for the mutant RePC M419V in the tetramer, assuming that 
contributions made by the monomer and dimers to ATP binding and catalysis are negligible. 
Acetyl CoA reduced the Km values for both ATP and pyruvate in wild-type RePC. For the 
mutant RePC M419V, the Km values for pyruvate were slightly decreased compared to the 
wild-type enzyme and acetyl CoA further reduced the Km of pyruvate, as in the wild-type 
RePC.  Most interestingly, in the absence of acetyl CoA, the Km value for ATP in RePC 
M419V remains the same as wild type while, in the presence of acetyl CoA, the Km value 
of ATP is significantly higher than in wild-type RePC.  
Since acetyl CoA does not change the percentage of tetramer in the population, 
acetyl CoA activation of the mutant can be assumed to be resulting from the activation of 
the intact tetramers and not from a shift in the population toward a higher percentage of 
tetramers. Thus, the decreased degree of acetyl CoA activation in RePC M419V can be 
directly attributed to dysfunction arising from the mutation of methionine to valine. The 
reduced degree of activation by acetyl CoA stems from a reduced rate of catalysis in the 
presence of acetyl CoA. This correlates with a general disruption of BC dimerization, as 
evidenced by the destabilization of RePC M419V tetramers. Compared to RePC M419V, 
AnPC V452M remains intact as a tetramer and remains insensitive to the activation by 
acetyl CoA.  This leads to two significant conclusions: (1) allosteric sensitivity cannot 
simply be attributed to a single amino acid change of methionine in acetyl CoA sensitive 
PC enzymes to valine in AnPC and (2) the AnPC dimer interface is less sensitive to 
disruption than the RePC dimer interface. Thus, the AnPC appears to have a lower free-
energy minimum for the BC domain dimerization than RePC.  
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To summarize, a conserved methionine residue is located on a helix at the BC 
domain interface in all the acetyl CoA sensitive PC homologues. This residue contributes 
to the dimerization of the BC domain (mutation of this residue in RePC disrupted intact 
tetramers) and to the degree of activation by acetyl CoA (mutation of this residue in RePC 
substantially reduced the degree of activation). The RePC M419V mutant demonstrates a 
reduced rate in the presence of acetyl CoA, which is likely caused by disruption of the BC 
domain interface, accompanied by an increased Km for ATP. Moreover, the BC dimer of 
RePC is more “fragile” than AnPC, which might contribute to its overall sensitivity to 
acetyl CoA activation. A further investigation on the thermodynamic features of these two 
PC enzymes is needed to explore this possibility further.  
3.2.5 Thermodynamic Characterization of Pyruvate Carboxylation by AnPC and RePC 
Associated with the Activation by Acetyl CoA 
From the characterization of BC domain dimer interface mutations in both AnPC 
and RePC, I concluded that the BC dimer interface in RePC is particularly sensitive to 
disruption compared to AnPC, which could contribute to its sensitivity to activation by 
acetyl CoA. Here, thermodynamic analyses were performed in both AnPC and RePC, to 
gain insights into the fundamental differences in thermodynamic properties between AnPC 
and RePC.  
The thermodynamic parameters for the pyruvate carboxylation reaction in PC were 
determined experimentally by measuring the kcat for pyruvate carboxylation over a range of 
temperatures from 25 °C to 55 °C (288.15 K- 328.15 K). Protein denaturation at high 
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temperatures precluded the inclusion of rates measured at temperatures exceeding 45°C. 
The thermodynamic parameters were determined from a rearrangement of the Eyring 
equation (See Equation II-5).  
Equation II-5 𝑙𝑛 𝑘STU𝑇 = 	−Δ𝐻‡𝑅 ∗	 1𝑇	 + ln 𝑘qℎ +	Δ𝑆‡𝑅  
kB is Boltzmann's constant equaling to 1.38064852(79) × 10−23J/K; h is Planck constant equaling to 
6.626069934(89)×10−34J⋅s; R is gas constant equaling to 8.3144598(48) J⋅mol−1⋅K−1. 
When I tried to do curve fitting with the measurement from 15 °C to 45 °C, the R2 
that represents the goodness of fit is ~ 0.5, which is not optimal. Chicken liver PC was 
reported to have severely cold inactivation (77%) at 0 °C, and observed slight inactivation 
at 23 °C (Irias, Olmsted, and Utter 1969). In order to obtain the best curve fitting result 
(high R2 value), considering the cold inactivation of PC, only the measures at temperature 
from 20 °C to 45 °C were used for the non-linear regression curve fitting with a R2 of 0.98 
as shown in Figure II-7.  
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Figure II-7 Eyring plot of AnPC and RePC associated with pyruvate carboxylation 
The kcat value for the pyruvate carboxylation was determined over a range of temperatures: 288.15 K (15 °C), 
293.15 K (20 °C), 298.15 K (25 °C), 303.15 K (30 °C), 308.15 K (35 °C), 313.15 K (40 °C), 318.15 K (45 °C), 
323.15 K (50 °C), 328.15 K (55 °C). At high temperature >45 °C or low temperature <25 °C, the data deviates 
from linearity, contributing to a poor R2  ~ 0.5. Fitting only the data collected between 298.15 K (25 °C) and 
318.15 K (45 °C), results in a straight line with R2 ~ 0.98. blue is RePC in the absence of effectors; red is 
RePC in the presence of 0.25 mM acetyl CoA; green is AnPC in the absence of effectors; purple is AnPC in 
the presence of 0.25 mM acetyl CoA. 
Again, our thermodynamic analysis demonstrates that RePC is a more “fragile” 
structure than AnPC. The meaning of the word “fragile” can be interpreted by applying the 
thermodynamic features of the two PC homologues. Firstly, “fragile” can be interpreted as 
“unstable” based on the fact that RePC denatures at lower temperatures than AnPC. 
Secondly, “fragile” can be interpreted to mean “more dynamic”. The low negative 
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activation entropy DS‡ in RePC suggests a more “disordered” transition state compared to 
AnPC (See Table II-10).  
 
Table II-10 Thermodynamic parameters of AnPC and RePC associated with pyruvate carboxylation. 
 DG‡, kJ (298.15K) DS
‡, J*mol-1*K-1 DH‡, kJ 
RePC 71.1 ± 1.7 -123.8 ± 3.8 34.2 ± 1.2 
RePC + 0.25mM AcoA 65.6 ± 2.4 -106.0 ± 5.6 34.0 ± 1.7 
AnPC 64.7 ± 2.2 -131.7 ± 5.1 25.4 ± 1.6 
AnPC + 0.25mM AcoA 64.4 ± 3.2 -137.8 ± 7.4 23.3 ± 2.3 
DS‡ and DH‡ were obtained from curve fitting to Eyring equation. DG‡ was calculated through function DG‡ = 
DH‡ -TDS‡ 
The dynamics of the transition state are not equivalent to the dynamics of the 
enzyme in the ground state, but a more disordered system in the transition state system is 
consistent with a more naturally dynamic protein. Correspondingly, the decreased 
activation entropy DS‡ induced by acetyl CoA was observed in both RePC and SaPC. This 
is highly suggestive that binding with acetyl CoA results in a more disordered/dynamic 
transition state in acetyl CoA sensitive PC homologues. In AnPC, the enzyme has a more 
“ordered” (entropically unfavorable) transition state both in the presence and absence of 
acetyl CoA as evidenced by its high DS‡. In short, I propose that RePC has a more dynamic 
structure than AnPC and that acetyl CoA activates RePC by increasing the dynamics of the 
transition state.  
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3.2.6 The Coupling Efficiency between the Two Half Reactions in AnPC is Not 
Enhanced by Acetyl Coenzyme A 
The thermodynamic parameters of the transition state are altered by acetyl CoA in 
RePC.  However, it is difficult to establish the rate-limiting step (or steps) responsible for 
impacting the thermodynamics of the transition state in PC, due to the complexity of this 
multi-step reaction. Catalysis in PC can be most simply broken down into a two-step 
process. Previous studies have suggested that the rate limiting step for the pyruvate 
carboxylation reaction is the transfer of the carboxyl group from the BC domain to the CT 
domain, coupled by the translocation of the carrier domain between the remote active sites 
(Attwood and Wallace 1986), which requires a large conformational change in PC.  If the 
rate limiting step is, indeed, carboxyl transfer between active sites, the activation entropies 
and enthalpies measured using the Eyring plot inform on the thermodynamics of carrier 
domain translocation. An accessible kinetic probe for carrier domain translocation is the 
measurement of the efficiency of coupling between the two half-reactions in PC. In this 
section, I will measure the coupling efficiency in AnPC and RePC, in order to gain more 
insights into whether carrier domain translocation is altered by acetyl CoA.  
Acetyl CoA enhances the coupling efficiency between the BC domain and CT 
domain catalyzed half-reactions in RePC (Zeczycki, Menefee, Jitrapakdee, et al. 2011). In 
the absence of acetyl CoA, abortive ATP cleavage occurs at the BC domain active site, 
without carboxylation of pyruvate at the CT domain active site (Legge, Branson, and 
Attwood 1996, Zeczycki, Menefee, Jitrapakdee, et al. 2011).  
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In the current study, the concentration of Pi in solution was measured using a 
fluorophore (7-Diethylamino-3-((((2-Maleimidyl)ethyl)amino)carbonyl) coumarin, 
MDCC)-labeled phosphate binding protein (PBP) from E. coli (Brune et al. 1994). The 
PBP binds with inorganic Pi on a rapid timescale, making it a very sensitive Pi sensor. Upon 
Pi binding to PBP-MDCC, the intensity of fluorescence increases, which can be used to 
determine the concentration of Pi released from ATP via cleavage at the BC domain. Using 
this fluorescence assay, the rate of Pi release under a variety of conditions was measured. 
Comparing these rates with the rate of oxaloacetate formation at the CT domain using the 
MDH-coupled enzyme assay enabled the coupling efficiency to be determined between the 
two-half reactions in PC (Table II-11).  
 
Table II-11 Coupling efficiency between the two half-reactions in AnPC and RePC 
 + 0 mM AcoA  + 0.25 mM AcoA 
 Pi release, kcat min-1 
OAA 
production, kcat 
min-1 
Pi/OAA  Pi release, kcat min-1 
OAA 
production, kcat 
min-1 
Pi/OAA 
AnPC 3020 ± 70 2400 ± 150 1.23 ± 0.08  3010 ± 150 1900 ± 35 1.58 ± 0.08 
RePC 230 ± 1 90 ± 1 2.56 ± 0.03  1800 ± 15 1100 ± 30 1.64 ± 0.05 
 Pi release, kcat min-1 (no pyruvate)  Pi release, kcat min-1 (no pyruvate) 
AnPC 5.96 ± 0.01  9.30 ± 0.05 
RePC 5.82 ± 0.07  12.3 ± 0.3 
 
In RePC, the coupling efficiency was enhanced by acetyl CoA. This means that, in 
the absence of acetyl CoA, there is a higher rate of abortive ATP cleavage at the BC domain 
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active of RePC. Assuming that biotin is efficiently carboxylated upon ATP cleavage, two 
scenarios can lead to abortive ATP cleavage: either carboxylated biotin returns to the BC 
domain where it undergoes decarboxylation, or carboxybiotin undergoes decarboxylation 
at the CT domain in the absence of bound pyruvate. The rate of Pi release in the absence 
of pyruvate is very slow, indicating there is little spontaneous decarboxylation of 
carboxybiotin occurring at either BC or CT domain active sites, consistent with previous 
experiments that demonstrated that carboxybiotin is very stable when there were no 
substrates present (Goodall et al. 1981, Attwood and Wallace 1986). In the presence of 
pyruvate, the rate of Pi release is stimulated significantly, including the rate of functional 
(resulting in carboxylation of pyruvate) and abortive ATP cleavage.  Pyruvate stimulates 
the rate of functional ATP cleavage by accepting the carboxyl group from carboxybiotin, 
freeing up biotin for the next round of ATP cleavage. A study employing kinetic isotope 
effects data showing only 50% of the occupancy of pyruvate at the CT domain active site 
is committed to form oxaloacetate (Cheung and Walsh 1976). However, a previous study 
argued that abortive ATP cleavage results from the induced decarboxylation of 
carboxybiotin at the CT domain active site without formation of oxaloacetate, when the 
occupancy of pyruvate is low (Zeczycki, Menefee, Jitrapakdee, et al. 2011). However, this 
interpretation was called into question in a recent description of the biotin binding pocket 
at the CT domain active site, which was observed only when pyruvate was present (Lietzan 
and St Maurice 2013a). The above study suggests that the unproductive decarboxylation 
of carboxybiotin is unlikely to take place at the CT domain in the absence of pyruvate.  
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In support of this suggestion, the coupling efficiency of RePC is close to 1 at low 
concentration of pyruvate in the current study (See Figure II-8), which supports the 
hypothesis that carboxybiotin can only decarboxylate in the presence of pyruvate, through 
the formation of an induced biotin binding pocket. 
 
 
 
 
Figure II-8 Coupling efficiency between Pi release and oxaloacetate (OAA) formation in RePC and 
AnPC over a range of pyruvate concentrations 
The Acetyl CoA concentration is at 0.25 mM. Black dots and line represent the theoretical plot for 100% 
coupling between the two half reactions. 
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Counter to prior interpretations of abortive ATP cleavage, I argue that abortive ATP 
cleavage is a consequence of ATP cleavage at the BC domain without formation of 
carboxybiotin. This subsequently results in a biotin-independent ATP cleavage that has 
been well documented in multiple studies on PC enzymes from a variety of sources (Islam, 
Sueda, and Kondo 2005, Sueda, Islam, and Kondo 2004). 
Compared to RePC, AnPC in the absence of acetyl CoA has a substantially higher 
coupling efficiency than RePC at high concentration of pyruvate. Interestingly, AnPC has 
a more “ordered” transition state evidenced by the higher activation entropy (See section 
3.2.5). There may be a different mechanism for controlling carrier domain translocation in 
AnPC. In the presence of acetyl CoA, it was surprising to observe a decreased coupling 
efficiency in AnPC. The decreased coupling efficiency could result from the oxaloacetate 
decarboxylation reaction at the CT domain, which was demonstrated to be promoted by 
acetyl CoA in previous section chapter II 3.2.1. 
4. Discussion  
This chapter provides a comprehensive structural and kinetic analysis of the acetyl 
CoA insensitive PC from Aspergillus nidulans (AnPC). These studies centered on 
investigating the underlying mechanism of the insensitivity to acetyl CoA activation for 
the pyruvate carboxylation in AnPC. Using PC from Rhizobium etli for comparison, as the 
acetyl CoA sensitive PC, as a comparison, I aimed to uncover the fundamental mechanism 
of the activation of PC by acetyl CoA.  
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The most significant structural difference between AnPC and other acetyl CoA 
sensitive PC homologues is the unique position of the carrier BCCP domain, which 
interacts with the BC domain across the face on the opposing subunit. This unique BCCP 
domain position has never been seen in the other acetyl CoA sensitive PC homologues, and 
does not conform to the proposed dogma of a single translocation pathway for the carrier 
domain in PC. This unique position of the BCCP domain was recently observed in another 
acetyl CoA insensitive PC enzyme from Lactococcus lactis (LlPC) (Choi et al. 2017), 
suggesting a possibly common structural feature among acetyl CoA insensitive PC 
homologues. It is tempting to speculate that, in the acetyl CoA insensitive AnPC and LlPC, 
a different translocation pathway is adopted by the BCCP carrier domain, mostly likely 
between the BC domain from the opposing subunit to the CT domain of its own subunit.  
Chapter III describes detailed efforts to further test this hypothesis. 
Obviously, the most significant catalytic feature of AnPC is that the pyruvate 
carboxylation reaction is not activated by acetyl CoA, which could result from a different 
binding mode of acetyl CoA. A detailed investigation of the binding mode of acetyl CoA 
in AnPC was performed, revealing that, even though acetyl CoA activates the CT domain 
reaction instead of the overall pyruvate carboxylation reaction in AnPC, it likely binds with 
AnPC in the same manner as it does in other acetyl CoA sensitive PCs. The acetyl CoA 
activation of the CT domain reaction in AnPC primarily originates from the nucleic acid 
component (3’5’- diphosphate adenine), while the pantothenic acid arm and acetyl group 
serve only to enhance the binding affinity and have no impact on the degree of activation. 
Similar effects were observed in acetyl CoA activation of the overall pyruvate 
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carboxylation reaction in the acetyl CoA sensitive PC enzyme, SaPC (Yu et al. 2009). 
These data indicate that there are unique, intrinsic properties of AnPC that make it respond 
differently to acetyl CoA, rather than inherent differences in the binding of acetyl CoA.  
The locus of action for acetyl CoA activation is the ATP cleavage at the BC domain 
in acetyl CoA sensitive PC homologues (Legge, Branson, and Attwood 1996).  The fact 
that the ATP cleavage catalyzed by AnPC is not activated by acetyl CoA suggests that the 
acetyl CoA sensitivity might track with the BC domain. This idea was tested using two 
chimeric enzymes by swapping the BC domains from two PC homologues that have 
opposite sensitivities to activation by acetyl CoA. When the BC domain of RePC is grafted 
on AnPC, wild type AnPC is converted to one that is stimulated by acetyl CoA. Thus, 
simply replacing the AnPC BC domain with the BC domain from the acetyl CoA sensitive 
RePC creates an enzyme that is sensitive to acetyl CoA activation, which highly suggests 
that the sensitivity to acetyl CoA activation in PC is determined by the BC domain. Similar 
studies have been done in chimeric enzymes generated using the two PC isoforms of yeast, 
PYC1 and PYC2, that are activated by acetyl CoA 16-fold and 3.7-fold, respectively 
(Jitrapakdee et al. 2007). It was determined in these studies that the locus of action of acetyl 
CoA activation is at the BC domain and that PYC2 remains in the activated R form, as 
evidenced as its higher activity in the absence of acetyl CoA, which decreases its sensitivity 
to acetyl CoA activation.  
It should be mentioned that AnPC is a naturally faster catalyst for the pyruvate 
carboxylation reaction than RePC. Recent studies on PC from Lactococcus lactis (LlPC) 
indicate it insensitive to acetyl CoA activation and has a high intrinsic catalytic activity 
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like AnPC (Choi et al. 2017). This study suggests that wherever 3’5’- diphosphate adenine 
binds there are enhanced interactions between the allosteric domain from one subunit and 
the BC domain of the subunit on the opposite face of the tetramer. These enhanced 
interactions may serve to permanently stimulate the catalytic activity of LlPC (Choi et al. 
2017).  However, the residues unique to LlPC that were identified as making the major 
contributions to the BC-allosteric domain interaction are not conserved in AnPC. In 
contrast, these equivalent residues in AnPC are conserved with all acetyl CoA sensitive PC 
homologues, suggesting that either the hypothesis proposed for LlPC is insufficient or that 
AnPC might remain permanently activated through a different mechanism.  
The thermodynamic analysis indicates that acetyl CoA activates RePC by reducing 
the activation energy. There is no change in the activation enthalpy DH‡ in the presence of 
acetyl CoA for RePC. However, the activation entropy DS‡ is negative (unfavorable) in 
both RePC and AnPC, consistent with a more “ordered” system in the transition state. The 
unfavorable DS‡ was significantly reduced for RePC in the presence of acetyl CoA, in 
agreement with what was recently reported for SaPC (Westerhold et al. 2017). Conversely, 
acetyl CoA does not alter the thermodynamic parameters for the AnPC catalyzed pyruvate 
carboxylation reaction. Notably, the values of DH‡ and DS‡ are dramatically different 
between AnPC and RePC.  AnPC has much lower DH‡ and higher DS‡, indicating that, at 
the transition state, AnPC is in a more ordered state relative to the ground state. This 
unfavorable entropy is offset by a smaller DH‡, which leads to a lower overall DG‡. This 
experiment also reveals that AnPC is more stable than RePC at high temperature. When the 
temperature is higher than 45 °C (318.15 K), the activity of both RePC and AnPC is 
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attenuated, deviating from the linear relationship with increasing temperature, likely due 
to protein denaturation. For RePC, the degree of inactivation was much higher than AnPC, 
hinting that the thermal denaturation of RePC occurs at a lower temperature compared with 
AnPC, adding further evidence to support that RePC is less stable than AnPC (See Figure 
II-6) 
In the presence of acetyl CoA, a more dynamic transition state is adopted by RePC, 
giving rise to an elevated catalytic rate as well as enhanced coupling efficiency. The more 
dynamic transition state can be explained from previous Cryo EM studies, through which 
it was shown the two faces of the tetramer stay in different catalytic state with the carrier 
domain locating at the two catalytic domains during catalysis. Hence, in order to perform 
the overall pyruvate carboxylation reaction, the oscillation between the two catalytic states 
on one face is completed by a structural transition from symmetry to asymmetry (Lasso et 
al. 2014). One possible mechanism for activation is that acetyl CoA promotes the 
oscillation between the two catalytic states. This would be consistent with a more dynamic 
transition state in RePC in the presence of acetyl CoA.  
Most interestingly, the rate of ATP cleavage was found to be enhanced in a PC 
mutant without the carrier domain (Islam, Sueda, and Kondo 2005) suggesting low 
occupancy of the carrier domain BCCP at the BC domain will promote the biotin-
independent ATP cleavage. In the present study, coupling efficiencies were reduced at 
increasing concentrations of pyruvate (See Figure II-3). High pyruvate concentrations are 
likely to promote BCCP interactions at the biotin binding pocket in the CT domain active 
site, resulting in an elevated rate of abortive biotin-independent ATP cleavage at the BC 
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domain active site.  Based on this proposal, acetyl CoA is likely to change the free-energy 
landscape profile of the enzyme, resulting to a reduced occupancy of the BCCP domain at 
the CT domain active site. Actually, according to the results from the thermodynamic 
studies in section 3.2.5, in the presence of acetyl CoA, a more dynamic transition state, 
possibly represented as the dynamic translocation of the carrier domain, is likely present 
due to the observed decreased activation entropy. Consequently, I argue that the dynamic 
translocation of the carrier domain generated by binding with acetyl CoA is able to free the 
carrier domain from the bound state at the CT domain active site, resulting in a 
redistribution of the equilibrium regarding to the position of the BCCP domain between 
the two active sites so as to enhance the coupling efficiency. 
Compared to other acetyl CoA sensitive PC homologous, AnPC has unique 
catalytic properties. Most notably, the CT domain reaction, which requires the presence of 
BCCP-biotin, is particularly sensitive to activation by acetyl CoA. The intrinsically high 
activity of AnPC is not from a more dynamic transition state, since AnPC has a relatively 
high activation entropy (more ordered) at the transition state. In addition, the BCCP domain 
is positioned across the face of the tetramer in the structure of AnPC, adjacent to the BC 
domain from the opposing monomer. This conformation has never been observed in the 
oscillating PC tetramers of the acetyl CoA sensitive PC homologues (Lasso et al. 2014). 
The unique features of AnPC reveal that, most likely, a different mechanism is adopted by 
AnPC for the translocation of the carrier domain. Consequently, in the following chapter 
III, I will further test the translocation pathway of the carrier domain in AnPC and RePC, 
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to gain insight into the unique features about AnPC compared to the other acetyl CoA 
sensitive PC enzymes.   
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III. ALLOSTERIC ACTIVATION BY ACETYL COENZYME A ALTERS CARRIER 
DOMAIN TRANSLOCATION IN PYRUVATE CARBOXYLASE 
1. Introduction  
In chapter II, I have demonstrated that the divergent sensitivities to acetyl CoA 
activation between AnPC and RePC are likely from the different intrinsic properties of their 
BC domains. The catalysis at the BC domain is not stimulated by acetyl CoA in AnPC, 
while in RePC, acetyl CoA activates the rate of catalysis the same degree as it does to the 
pyruvate carboxylation catalyzed by the full-length PC, suggesting the rate limiting step in 
PC occurs at the BC domain. Steady-state and pre-steady state kinetics in PC suggest that 
acetyl CoA activates the overall reaction by accelerating the rate-limiting HCO3- - 
dependent MgATP cleavage in the BC domain in other acetyl CoA sensitive PC from 
chicken liver (Legge, Branson, and Attwood 1996, Attwood and Graneri 1992). 
Interestingly, in the absence of acetyl CoA, the PC-catalyzed rate of ATP cleavage is 
significantly reduced while, at the same time, the efficiency of coupling between the 
reactions in the BC and CT domains is decreased due to high levels of abortive ATP 
cleavage (Zeczycki, Menefee, Jitrapakdee, et al. 2011). The effect of acetyl CoA on the 
reaction coupling efficiency suggests that it alters more than just the rate of ATP cleavage 
in the BC domain. Acetyl CoA may also regulate intermediate transfer between active sites, 
possibly by altering the physical translocation of the BCCP domain (Westerhold et al. 
2017). It has been determined that the BCCP domain can translocate within one layer of 
the tetramer, between the BC domain of its own subunit and the CT domain of the opposing, 
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antiparallel subunit (St Maurice et al. 2007, Lasso et al. 2014, Westerhold et al. 2016) 
(Figure III-1, movement a). The BCCP domain is connected to, but offset from, the rest of 
the subunit by a flexible linker comprised entirely of random coil. This permits the BCCP 
domain to access a wide range of positions within the tetramer, consistent with the low 
occupancy of this domain in several X-ray structures of PC (St Maurice et al. 2007, Xiang 
and Tong 2008, Lietzan et al. 2011, Yu et al. 2009).  
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Despite the broad positional flexibility inherent to the BCCP domain, no studies 
have systematically assessed whether it is capable of additional catalytically productive 
translocations (Figure III-1, movements b, c, and d). 
 
 
 
 
Figure III-1 The BCCP domain is theoretically capable of four catalytically productive translocation 
pathways between the individual active sites of PC.  
Subunits 1 and 2 from the upper layer are colored according to their individual domains, while the lower 
layer is colored in grey for clarity. The four translocation pathways (a, b, c and d) are shown for the BCCP 
domain (colored in red) from subunit 1. For clarity, the BCCP domain from subunit 2 is displayed as partially 
transparent, but it is also capable of adopting these same four translocation pathways. 
X-ray crystallographic studies of PC cloned from multiple source organisms have 
provided structural snapshots of the enzyme both in the presence and absence of acetyl 
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CoA. PC structures reveal either a symmetric (Staphylococcus aureus PC (Xiang and Tong 
2008, Yu et al. 2009)) or an asymmetric tetramer (Rhizobium etli PC (St Maurice et al. 
2007, Lietzan et al. 2011)), irrespective of whether acetyl CoA is present. Cryo-EM studies 
in SaPC more recently revealed that PC oscillates between a symmetrical and asymmetrical 
state during the catalytic cycle (Lasso et al. 2014). In SaPC, acetyl CoA was found to 
stabilize and promote BC domain dimerization through a subtle reorganization of the BC 
and allosteric (PT) domain dimers (Yu et al. 2009). However, despite multiple structures, 
there is as yet no evidence to support a significant remodeling of the domain organization 
or active site architecture in PC in response to acetyl CoA binding. Consequently, acetyl 
CoA is more likely to stimulate catalysis by altering dynamic processes, such as BCCP 
domain translocation. 
This chapter describes a series of mutated, hybrid PC enzymes that were used to 
perform a detailed analysis of multiple translocation pathways for the BCCP domain during 
catalytic turnover in PC. I demonstrate that, surprisingly, the BCCP domain is capable of 
a much broader range of catalytically productive movements than previously recognized. 
This chapter also describes the effect of allosteric effectors on BCCP domain translocation 
during catalysis by both Aspergillus nidulans PC (AnPC) and Rhizobium etli PC (RePC), 
two enzymes that respond very differently to acetyl-CoA activation. I report that carrier 
domain translocation is regulated by acetyl CoA in R. etli PC, an acetyl CoA sensitive PC 
enzyme. These findings significantly alter the classical description of catalysis in PC and 
suggest that carrier domain motions in swinging domain enzymes may be far more complex 
than previously imagined. 
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2. Materials and Methods 
Generation of the RePC and AnPC domain inactivated mutants. The RePC and 
AnPC wild type genes in a pET17b-(His)9 vectors were site-specifically mutated by whole 
plasmid mutagenesis using the Quikchange method. The specific mutations used to 
inactivate individual domains of both RePC and AnPC are provided in Table III-1.  The 
correct gene sequence for each set of mutations was confirmed by whole gene sequencing 
by Functional Biosciences (Madison, WI). 
 
Table III-1 Design of mutations used to generate hybrid tetramers of AnPC and RePC 
PC individual domains 
Residues 
Proposed Function 
Mutations 
RePC AnPC RePC AnPC 
Biotin carboxylase domain 
E218 E256 MgATP binding and cleavage E218A E256A 
E305 E342 General base to deprotonate HCO
3
- E305Q E342Q 
Carboxyltransferase domain 
T882 T923 proton shuttle between carboxybiotin and pyruvate T882A T923A 
R621 R662 Pyruvate binding  R621A R662A 
Biotin carboxyl carrier protein 
domain K1119 K1171 Biotin attachment site K1119Q K1171Q 
  
Cloning of RePC and AnPC into compatible co-expression vectors. RePC hybrid 
tetramers were generated by co-expressing two individual domain mutants on a pETDuet-
1 vector. Pairs of genes encoding poly(His)9-tagged RePC domain inactive mutants were 
inserted into the pETDuet-1 vector in tandem by PCR-based amplification from pET-17b 
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followed by ligation-based cloning into the pETDuet-1 vector. In all cases, one of the 
domain inactivated RePC genes was inserted into the first multiple cloning site (MCS) 
using the XbaI/NotI restriction endonuclease sites; the second gene was inserted into the 
second MCS using the NdeI/PacI restriction endonuclease sites. In all cases, both domain 
inactivated mutant genes encode a recombinant poly (His)9-tag at the protein N-terminus. 
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The co-expression of pairs of AnPC mutants for the generation of hybrid tetramers 
was performed by the co-transformation of two compatible plasmids, pSFDuet-1 and pET-
17b, with one member of the pair encoded on pSFDuet-1 while the other member of the 
pair was encoded on pET-17b (Table III-2). Three domain inactivated mutants were 
maintained in pET-17b while three complementary domain inactivated mutants were 
cloned into the pRSFDuet-1 MCS site using the NcoI/PacI restriction endonuclease sites 
(Table III-2).   
 
Table III-2 Design of the co-expression constructs for generating hybrid tetramers of AnPC and 
RePC 
Co-expression constructs Domain inactive mutants Vector insertion site 
N-terminal 
tag 
RePC ×BC/×CT×BCCP 
RePC ×BC 
pETDuet-1 
XbaI/NotI His9 
RePC ×CT×BCCP NdeI/PacI His9 
RePC ×CT/×BC×BCCP 
RePC ×CT 
pETDuet-1 
XbaI/NotI His9 
RePC ×BC×BCCP NdeI/PacI His9 
RePC ×BCCP/×BC×CT 
RePC ×BCCP 
pETDuet-1 
XbaI/NotI His9 
RePC ×BC×CT NdeI/PacI His9 
RePC wild type 
/×BC×CT×BCCP 
RePC wild type 
pETDuet-1 
XbaI/NotI - 
RePC ×BC×CT×BCCP NdeI/PacI His9 
AnPC ×BC/×CT×BCCP 
AnPC ×BC pRSFDuet-1 NcoI/PacI - 
AnPC ×CT×BCCP pET-17b N/A His9 
AnPC ×CT/×BC×BCCP 
AnPC ×CT pRSFDuet-1 NcoI/PacI - 
AnPC ×BC×BCCP pET-17b N/A His9 
AnPC ×BCCP/×BC×CT 
AnPC ×BC×CT pRSFDuet-1 NcoI/PacI - 
AnPC ×BCCP pET-17b N/A His9 
AnPC wild type 
/×BC×CT×BCCP 
AnPC wild type 
pETDuet-1 
XbaI/NotI - 
AnPC ×BCCP NdeI/PacI His9 
×BC represents inactive BC domain with the active site residues mutated; ×CT represents inactive CT domain 
with the active site residues mutated; × BCCP represents the dysfunctional carrier domain with the biotin 
binding site mutated. 
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In this system, the domain inactivated mutant genes encoded on pET17b included 
a recombinant poly (His)9-tag at the protein N-terminus, while those genes encoded on 
pRSFDuet-1 did not include an affinity tag. 
Refer to chapter II materials and methods for protein induction and purification of 
the full-length and hybrid PC tetramers. 
Avidin gel shift assays. Avidin gel shift assays were performed to measure the 
degree of PC biotinylation. Avidin is a homotetramer of molecular weight ~60 kDa with 
four very high affinity biotin binding sites per avidin tetramer. Chicken egg white avidin 
(Sigma, 1.2 mg/mL) and denatured PC protein (1 mg/mL) were prepared in buffer (50 mM 
HEPES, pH 7.5, 200 mM NaCl) and mixed in equal volumes to a final molar ratio of 10:1, 
avidin:PC. The mixture was incubated at room temperature (25 °C) for 40 minutes. 
Biotinylated PC binds with avidin irreversibly, retarding its migration on SDS-PAGE. In 
contrast, unbiotinylated PC does not bind with the avidin and migrates on SDS-PAGE at a 
molecular weight of a single subunit, ~126 kDa.  
Determination of Ka for acetyl CoA. The activity of pyruvate carboxylation was 
measured over a range of L-aspartate/acetyl CoA concentrations, in order to determine the 
Ki for L-aspartate and the Ka for acetyl CoA. The Ka value for acetyl CoA was determined 
from a plot of the initial velocity (normalized for enzyme concentration) against acetyl 
CoA concentration and by fitting the data to equation III-1 using least-squares nonlinear 
regression, where [AcoA] is the acetyl CoA concentration. All least-square fits were 
performed using KaleidaGraph programs. vi/[E]t is the initial velocity normalized for the 
enzyme concentration; kcat0 is the kcat value in the absence of acetyl CoA; kcatAcoA is the kcat value 
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at saturating concentrations of acetyl CoA; Ka is the activation constant for acetyl CoA; and 
h is the Hill coefficient with respect to acetyl CoA. 
Equation III-1  uv[w]x = y𝑘STUz 	+ 𝑘STU/S{/ 	× 	|[/S{/]}~  / y1 + |[/S{/]}~ 				  
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3. Results 
3.1 Generation of Hybrid Tetramers to Probe BCCP Domain Translocation Pathways 
To individually assess the translocation pathways adopted by the BCCP domain 
during catalysis by both AnPC and RePC (Figure III-1), a series of hybrid PC tetramers 
were designed. These hybrids were comprised of two different mutated PCs (mutant 1 and 
2) that had been inactivated in a combination of the catalytic and/or carrier domains (Figure 
III-2).  
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Figure III-2 A schematic of the three hybrid tetramers (A, B, and C) designed to probe the three 
intermolecular BCCP domain translocation pathways (a, b, and c) in PC. 
Blue is biotin carboxylase (BC) domain, yellow is carboxyltransferase (CT) domain, red is biotin carboxyl 
carrier protein (BCCP) domain, green is allosteric domain. The inactivated domain is labeled black. 
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The nomenclature ×BC, ×CT and/or ×BCCP was used to indicate the inactivation 
of these domains in various constructs. Both the BC and CT domain were inactivated by 
mutations in the individual active sites, while the BCCP domain was rendered 
nonfunctional by mutating the specific biotinylated lysine in the conserved MKME motif. 
The individual subunits expressed by these mutants can be represented as M1 and M2, 
respectively. In this approach, when M1 and M2 are co-expressed together, a 
heterogeneous population of homo-tetramers and hybrid-tetramers will form (Figure III-3).  
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Figure III-3 The heterogeneous population of tetramers formed through co-expression of two PC 
full-length genes.  
M1, mutant 1; M2, mutant 2. Assuming the activity is from the catalysis catalyzed by individual domains on 
the same layer of the tetramer, combinations M1M1 and M2M2 are inactive. M1M2 is able to recover activity 
only if the carrier protein domain is able to adopt certain translocation pathways. 
Assuming that catalysis takes place only between subunits located on the same 
layer of the tetramer, all M1M1 or M2M2 combinations will remain inactive. When M1 
and M2 combine on the same layer, however, activity will be recovered only if the 
functional BCCP domain is capable of a catalytically productive translocation between the 
two-remaining functional active sites. When expressed and purified individually, the 
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catalytic activity of each mutated PC enzyme was ~0, even in the presence of the allosteric 
activator, acetyl CoA (Table III-3). Thus, any catalytic activity recovered from a mixture 
of these mutated PC enzymes can only be the result of forming catalytically functional 
hybrid tetramers. Hybrids A, B and C represent the catalytically productive enzymes 
corresponding to the translocation pathways a, b and c (Figure III-2). These hybrid 
tetramers can be used to unambiguously test three pathways (a, b and c in Figure III-1) of 
BCCP translocation during catalytic turnover. 
 
Table III-3 Pyruvate carboxylation activity recovered from hybrid tetramers generated by re-mixing 
and co-expression  
PC  
homotetramers 
RePC + 0.25 mM acetyl coenzyme A  AnPC + 0.25 mM acetyl coenzyme A 
kcat 
(min-1) 
kcatmixing 
(min-1)1  
kcatcoexp 
(min-1) 2  
 kcat 
(min-1) 
kcatmixing 
(min-1)1  
kcatcoexp 
(min-1) 2  
xCT 0.05 ± 0.01 43 ± 2   320 ± 4    0.39 ± 0.07 4.1 ± 0.5 102 ± 6 
xBCxBCCP 0.8 ± 0.3  3.1 ± 0.4 
xBC 0.17 ± 0.05 0.8 ± 0.3 12 ± 1  0.16 ± 0.08 0.6 ± 0.1 32 ± 1 
xCTxBCCP 1.7 ± 0.4  0.33 ± 0.04 
xBCCP 0.16 ± 0.25  10 ± 1  1.8 ± 0.7 2.6 ± 0.3 9.9 ± 0.4 
xBCxCT 0.21 ± 0.12  0.99 ± 0.26 
1 kcat of the PC hybrid tetramers composed of two PC mutants individually purified and mixed together at a 1:1 
ratio 
 2 kcat of the PC hybrid tetramers purified from the co-expression of two PC mutants in E. coli 
Initially, hybrid tetramers were generated by mixing together two individually 
purified enzymes, as performed in several prior studies (St Maurice et al. 2007, Westerhold 
et al. 2016). While this approach resulted in some recovered catalytic activity, the data 
suggested a low degree of hybridization between the two populations. In comparison, co-
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expression of two PC genes resulted in a significantly higher recovery of activity, 
consistent with a much higher degree of hybridization (Table III-3). 
To unambiguously confirm the co-expression of two PC genes successfully 
generated a set of recombined hybrid tetramers, untagged wild-type RePC and fully 
inactivated N-terminally (His)9-tagged RePC (RePC ×BC×CT×BCCP) were co-expressed 
using a pETDuet-1 vector in E. coli BL21(DE3). In this system, wild-type RePC can only 
be co-purified if it recombines with (His)9-tagged RePC ×BC×CT×BCCP to form hybrid 
tetramers. The degree of recombination into hybrid tetramers was assessed using an avidin 
gel shift assay. Successful recombination was expected to result in a purified population 
containing both untagged wild-type RePC (biotinylated) and (His)9-tagged 
×BC×CT×BCCP (un-biotinylated). A mobility shift in the presence of avidin confirmed 
the co-purification of wild type, untagged, biotinylated RePC, and demonstrated that hybrid 
tetramers were successfully generated by co-expression (Figure III-4).  
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Figure III-4 Avidin gel shift assay of the control experiment.  
1) wild-type RePC; 2) RePC ×BC×CT×BCCP; 3) RePCxBCxCTxBCCP / untagged-RePC wild type; 4) wild-
type AnPC ;5) AnPC ×BC×CT×BCCP; 6) AnPCxBCxCTxBCCP / untagged-AnPC wild type 
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Using this same approach, the degree of biotinylation was assessed for all three co-
expression products of RePC, confirming that ~50% of the protein population was 
biotinylated, as would be expected for a well-combined population of hybrid tetramers 
(Figure III-5). 
 
Figure III-5 Avidin gel shift assays showing the successful production of all three co-expression 
products of RePC and AnPC.  
(1) ×BC; (2) ×CT×BCCP; (3) ×BC / ×CT×BCCP; (4) ×CT; (5) ×BC×BCCP; (6) ×CT / ×BC×BCCP; (7) 
×BC×CT; (8) ×BCCP; (9) ×BCCP / ×BC× CT 
kDa
300
250
180
130
100
70
50
40
250
150
100
75
50
37
Avidin - + - + - +
(1) (2) (3)
- + - + - +
(4) (5) (6)
- + - + - +
(7) (8) (9)
RePC + avidin
RePC 
AnPC + avidin
AnPC 
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A similar assessment was performed on AnPC, demonstrating the successful 
production of hybrid tetramers by co-expressing untagged wild type AnPC with (His)9-
tagged AnPC ×BC×CT×BCCP. For reasons that are not clear, co-expression of mutated 
AnPC genes in the pETDuet-1 vector, in some cases, resulted in very poor expression levels 
for one of the two genes. This issue was resolved by converting to a co-expression method 
that involved co-transforming with two compatible plasmids, with each plasmid carrying 
an individually mutated PC gene (Table III-2). This approach successfully generated well-
combined hybrid tetramers of AnPC.  
3.2 The PC Tetramer Adopts Multiple Carrier Domain Translocation Pathways 
The steady state catalytic activity of hybrid tetramers was measured with saturating 
concentration of substrates, in order to determine which translocation pathways are 
functional during catalysis. The system is designed such that, while all translocation 
pathways are available to any particular hybrid enzyme, only one pathway is catalytically 
productive.  For example, the carrier domain of hybrid A may proceed through all four 
translocation pathways represented in Figure III-2, but only motion a will be catalytically 
productive. Thus, while a hybrid system may adopt multiple carrier domain motions, it will 
only report on a single translocation pathway.   
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For both RePC and AnPC, the activities recovered in the hybrid tetramers were 
much higher than the activities of the individual PC mutants (Table III-4 and III-5).  
 
Table III-4 Activation by acetyl coenzyme A of wild type and mutated RePC and hybrid tetramers 
RePC mutants kcatAcoA (min-1) 
RePC 
hybrid tetramers 
*kcatAcoA 
( min-1) 
kcat0 
( min-1) 
kcatAcoA 
/kcat0 
Ka 
(μM) h 
RePC wild type - - 1450 ± 30 130 ± 10 11 ± 1 3.2 ± 0.1 4.5 ± 0.2 
×CT 0.05 ± 0.01 
×CT/×BC×BCCP 320 ± 4 12 ± 4 27 ± 9 5.7 ± 0.1 5.6 ± 0.7 
×BC×BCCP 0.8 ± 0.3 
×BC 0.17 ± 0.05 
×BC/×CT×BCCP 12 ± 1 13 ± 1 1.0 ± 0.1 ND ND 
×CT×BCCP 1.7 ± 0.4 
×BCCP 0.16 ± 0.25 
×BCCP/×BC×CT 10 ± 1 9 ± 1 1.1 ± 0.2 ND ND 
×BC×CT 0.21 ± 0.12 
*kcat values were determined using the subunit molecular weight of RePC (126 kDa). Each subunit contributes 
a single BC-CT active site pair.  
Table III-5 Activation by acetyl coenzyme A of wild type and mutated AnPC and hybrid tetramers 
AnPC mutants kcatAcoA (min-1) 
AnPC 
hybrid tetramers 
*kcatAcoA 
(min-1) 
kcat0 
 (min-1) 
kcatAcoA 
/kcat0 
Ka 
 (μM) h 
AnPC wild type - - 1910 ± 100 2030 ± 110 0.9 ± 0.1 ND ND 
×CT 0.39±0.07 
×CT/×BC×BCCP 90 ± 10 102 ± 6 0.9 ± 0.1 ND ND 
×BC×BCCP 3.1±0.4 
×BC 0.16±0.08 
×BC/×CT×BCCP 30 ± 1 32 ± 1 0.9 ± 0.1 ND ND 
×CT×BCCP 0.33±0.04 
×BCCP 1.8±0.7 
×BCCP/×BC×CT 11 ± 1 10 ± 1 1.1 ± 0.1 ND ND 
×BC×CT 0.99±0.26 
*kcat values were determined using the subunit molecular weight of AnPC (130 kDa). Each subunit contributes 
a single BC-CT active site pair.  
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This surprising result demonstrated that all three intermolecular translocation 
pathways are catalytically functional in PC. In comparing the catalytic activities between 
different hybrid tetramers, it is tempting to draw conclusions about the relative contribution 
of one translocation pathway over another. For example, the activities measured from the 
hybrid tetramers in AnPC vary, potentially indicating that translocation pathway a 
contributes more to the catalytic turnover than b and c in AnPC. Theoretically, if each 
mixed population resulted in an equal degree of recombination between the two mutants 
M1 and M2, the activities could serve as a useful measure of the relative catalytic turnover 
derived from each translocation pathway. However, it must be noted that the total degree 
of recombination during co-expression could not be fully controlled or determined. Thus, 
while these results clearly establish that each pathway does contribute to catalysis, the 
current approach cannot determine the relative contribution that each pathway makes to 
catalytic turnover in the wild-type enzyme. 
3.3 Activation by Acetyl CoA is Dependent on the Promotion of a Single Translocation 
Pathway of the Biotin Carboxyl Carrier Protein Domain in PC.  
Acetyl CoA significantly enhances the coupling efficiency between the biotin 
carboxylation reaction in the BC domain and the carboxyl transfer reaction in the CT 
domain of PC (Zeczycki, Menefee, Jitrapakdee, et al. 2011).  This enhanced coupling 
efficiency may result from acetyl CoA regulating the BCCP translocation pathway in PC, 
though this has never been systematically investigated. 
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In order to determine whether the enhanced coupling efficiency of RePC in the 
presence of acetyl CoA occurs through the regulation of BCCP domain translocation, the 
three populations of RePC hybrid tetramers were kinetically characterized in the presence 
of acetyl CoA (Table III-4). The Ka value determined for acetyl CoA in hybrid A was very 
similar to that determined for wild-type RePC, indicating that acetyl CoA binding is not 
disrupted in this hybrid tetramer. The overall degree of acetyl CoA activation is 
significantly higher in hybrid A than it is in the wild type enzyme (Table III-4; ~30-fold vs 
~10-fold). Most notably, only RePC hybrid A was significantly activated by acetyl CoA 
while the two other hybrid tetramers were not. Thus, acetyl CoA specifically activates 
pathway a in RePC, while it has no effect on pathways b and c.  
While RePC and AnPC both enable multiple carrier domain translocation pathways, 
AnPC is insensitive to acetyl CoA activation. To determine whether the activation of 
translocation pathway a by acetyl CoA correlates with acetyl CoA sensitivity, similar 
experiments were performed in AnPC. Acetyl CoA did not activate any BCCP domain 
translocation pathway in AnPC (Table III-5). Thus, the activation of translocation pathway 
a is dependent on the sensitivity of the enzyme to allosteric activation by acetyl CoA. 
4. Discussion 
This study sought to unambiguously assess the productivity of three intermolecular 
BCCP translocation pathways in catalytically distinct PC enzymes from two different 
species. Contrary to the accepted dogma, which states that the BCCP domain transits 
exclusively between a single combination of BC and CT domains, the present study 
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suggests a much more fluid and flexible carrier domain that travels in catalytically 
productive pathways between multiple combinations of active site pairs. Considering that 
RePC and AnPC are evolutionarily and functionally divergent, and that the kinetic and 
thermodynamic features of the vast majority of PC enzymes are highly conserved, we 
believe that these findings are broadly applicable to all PC enzymes. 
The three hybrid tetramers assessed in this study were designed to examine three 
possible intermolecular translocation pathways (Figure III-1, pathways a, b, and c) by 
measuring recovered catalytic activity from the products of co-expressed PC domain-
inactivated mutations. The fourth translocation (Figure III-1, pathway d) involves an 
intramolecular pathway and, therefore, cannot be easily assessed.  In principle, 
intramolecular pathway d can be isolated and evaluated using hybrid tetramers generated 
between a wild type PC and a triply domain-inactivated mutant (×BC×CT×BCCP); this 
combination ensures that, for the hybrid tetramer, pathway d is the only catalytically viable 
pathway. However, co-expression results in a heterogeneous population that includes a 
significant proportion of catalytically active wild-type homotetramer. Since neither mixing 
nor co-expression techniques allow for a predictable, fully heterogeneous population of 
tetramers, the catalytic contribution from wild-type homotetramers and hybrid tetramers 
cannot be disentangled, precluding an accurate assessment of translocation pathway d in 
the tetramer. Nevertheless, the flexibility of the carrier domain observed in the dimeric 
ΔBC RePC (Lietzan, Lin, and St Maurice 2014, Liu et al. 2018) indicates that the BCCP 
domain is fully capable of adopting an intramolecular interaction with the CT domain of 
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the same subunit. Thus, translocation pathway d is also very likely to contribute to catalytic 
turnover in the PC tetramer.  
Intermediate transfer via carrier domain translocation is essential to ensure a high 
coupling efficiency between the individual half-reactions in PC (Zeczycki, Menefee, 
Jitrapakdee, et al. 2011, Westerhold et al. 2017). Several studies have focused on specific 
mechanistic features in both the BC and CT domains that contribute to the enzyme’s high 
coupling efficiency (Westerhold et al. 2016, Lietzan et al. 2011, Zeczycki, Menefee, 
Jitrapakdee, et al. 2011, Lietzan and St Maurice 2013a). These studies point to specific 
gatekeeping features in the individual active sites that reduce the potential for abortive ATP 
cleavage and ensure a high probability of carboxyl-group transfer from carboxyl biotin to 
pyruvate in the CT domain. Interestingly, in the absence of acetyl CoA, the efficiency with 
which MgATP cleavage at the BC domain is coupled with oxaloacetate formation at the 
CT domain is reduced, even at saturating concentrations of all substrates (Zeczycki, 
Menefee, Jitrapakdee, et al. 2011). It is known that acetyl CoA accelerates MgATP 
cleavage in the BC domain (Legge, Branson, and Attwood 1996), but the enhanced 
coupling efficiency in the presence of acetyl CoA indicates that there are additional factors, 
beyond substrate-mediated control of the individual active sites, which contribute to 
efficient intermediate channeling in PC. Since intermediate transfer via carrier domain 
translocation is essential to link the catalytic activities of the individual half-reactions, 
acetyl CoA might enhance the coupling efficiency by mediating BCCP translocation in PC.  
Recent thermodynamic and kinetic studies have shown that acetyl CoA facilitates 
the long-range communication between the individual BC and CT domains in the intact 
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PC tetramer and have suggested that the BCCP carrier domain may play a role in mediating 
this communication (Westerhold et al. 2017, Westerhold et al. 2016). For the acetyl CoA-
sensitive RePC, the results presented here offer direct evidence that acetyl CoA activates a 
single, specific translocation pathway: the translocation of BCCP from the BC domain of 
its own subunit to the CT domain of the neighboring subunit (pathway a, Figure III-1). 
This offers a compelling mechanistic explanation for the enhanced coupling efficiency that 
has been observed in the presence of acetyl CoA (Zeczycki, Menefee, Jitrapakdee, et al. 
2011, Westerhold et al. 2017).  
Studies on chicken liver pyruvate carboxylase (Attwood and Wallace 1986) have 
revealed that acetyl CoA increased the activation entropy, possibly through promoting a 
more ordered transition state. This ordered transition state was originally attributed to more 
compact quaternary structures that were observed in low-resolution cryo EM images in the 
presence of acetyl CoA (Mayer, Wallace, and Keech 1980). However, several more recent 
high-resolution X-ray crystal and cryo-EM structures in the presence and absence of acetyl 
CoA have not provided any corroborating evidence to support a more compact PC 
quaternary structure in the presence of acetyl CoA (St Maurice et al. 2007, Xiang and Tong 
2008, Yu et al. 2009, Lietzan et al. 2011). Furthermore, the acetyl CoA insensitive AnPC 
was also shown in cryo-EM studies to adopt a more compact structure in the presence of 
acetyl CoA (Osmani et al. 1984). This leads us to believe that the compact structure 
observed in the presence of acetyl CoA is more likely to be a general structural feature of 
all PC enzymes and is not related to the proposed ordered transition state.  
  
 
 
135 
Recent studies have reported detailed thermodynamic analyses of PC catalysis, 
where acetyl CoA has been shown to decrease the activation entropy for the reaction 
catalyzed by both Rhizobium etli (Sirithanakorn, Jitrapakdee, and Attwood 2016) and 
Staphylococcus aureus PC (Westerhold et al. 2017), indicating that acetyl CoA facilitates 
a more dynamic transition state during catalytic turnover.  Recent Cryo EM studies have 
revealed oscillations between a symmetric and asymmetric conformations of the tetramer 
during catalytic turnover of PC from Staphylococcus aureus. This oscillation occurs 
through a single translocation of the BCCP domain between the BC domain of its own 
subunit to the CT domain from the opposing subunit, which is also the pathway that was 
identified to be promoted in the presence of acetyl CoA in my studies. Consequently, I 
propose that acetyl CoA promotes the single translocation pathway of the BCCP domain 
by facilitating the oscillation between the symmetric and asymmetric conformations of the 
tetramer, which results in a more dynamic translocation of the BCCP domain with a 
corresponding lower activation entropy. 
The increased sensitivity of RePC Hybrid A to activation by acetyl CoA (Table III-
4; ~30-fold rate enhancement), compared to wild-type RePC (Table III-4; ~10-fold rate 
enhancement), is fully consistent with the above hypothesis. Only one of the four 
translocation pathways are catalytically productive in Hybrid A, resulting in a reduced 
baseline activity compared to wild-type RePC, where all four translocation pathways yield 
productive turnover. However, in the presence of acetyl CoA, the BCCP domain 
predominantly transits through translocation pathway a in both wild-type RePC and Hybrid 
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A. This enhances the effect of acetyl CoA on the catalytic activity of Hybrid A and 
contributes to its increased allosteric sensitivity. 
Carrier proteins and carrier domains are commonly used to shuttle covalently bound 
intermediates between remote active sites in large, multi-enzyme complexes, such as fatty 
acid synthases (FAS) (Maier, Leibundgut, and Ban 2008), polyketide synthases (PKS) 
(Dutta et al. 2014), non-ribosomal peptide synthetases (NRPS) (Reimer et al. 2016), 
pyruvate dehydrogenase (PDH) (Milne et al. 2006), and the broader family of biotin-
dependent enzymes (Tong 2017). In all cases, the transfer of reaction intermediates 
between spatially distinct active sites requires long-range movements of the carrier domain 
during catalytic turnover. In NRPS, for example, the peptidyl carrier protein domain rotates 
~75 ° and translocates ~60 Å as it transports intermediates between active sites (Reimer et 
al. 2016). Such long-range motions between multiple active sites require the carrier domain 
to combine remarkable flexibility with exquisite selectivity in order to appropriately 
present the proper intermediates to the correct active sites.  
For type I modular PKS and NRPS, the carrier domain transfers reaction 
intermediates among multiple modules and mediates specificity through protein-protein 
interactions between the carrier domain and the individual catalytic domains (Klaus et al. 
2016, Sundlov et al. 2012). Iterative enzyme complexes, such as yeast type I FAS, use 
separate reaction chambers to constrain and control intermediate transfer and avoid off-
pathway reactions with improperly positioned intermediates (Lomakin, Xiong, and Steitz 
2007). Consistent with the model established for FAS, it has long been envisioned that PC 
confines the carrier domain to a single reaction chamber between one set of active site pairs. 
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Unlike most assembly-line enzymes, however, PC is not at risk for off-pathway reactions 
when the carrier domain travels between alternate combinations of active site pairs.  Instead, 
PC presents a new example for catalytic control in a swinging domain enzyme, through 
regulated movement of the carrier domain in the presence of the allosteric activator, acetyl 
CoA. Instead of constraining carrier movements as a means to control specificity, altered 
carrier domain movements in PC contribute to enhanced catalytic efficiency. These studies 
reveal a new mechanism for carrier domain movement and allosteric regulation in swinging 
domain enzyme.   
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IV. ALLOSTERIC INHIBTION OF PRUVATE CARBOXYLASE BY L-ASPARTATE  
1. Introduction 
L-aspartate is a well-characterized allosteric inhibitor of PC. In RePC, it was 
determined that L-aspartate inhibits the production of oxaloacetate by reducing the rate of 
the first half reaction of bicarbonate-dependent ATP cleavage catalyzed at the biotin 
carboxylase (BC) domain.  The binding site of L-aspartate is still elusive, likely due to the 
relatively high Ki value (~5 mM). Hence, it has proven difficult to determine the binding 
site of L-aspartate using X-ray crystallography. However, by kinetically characterizing the 
inhibition of L-aspartate in the presence of acetyl CoA, previous studies have suggested 
that binding with the two effectors is mutually exclusive while occupying two distinct 
binding sites (Sirithanakorn et al. 2014, Osmani et al. 1981). Hence, the classical method 
of describing the mutually exclusive relationship between the two binding sites involved 
two conformations of the protein, one favors binding with acetyl CoA and the other favors 
binding with L-aspartate. In the presence of either one of the effectors, it will shift the 
population towards the conformation that disfavors binding with the other, resulting in 
mutually exclusively binding between the two effectors (Sirithanakorn et al. 2014). The 
acetyl CoA binding site has been identified to bind with the allosteric domain in multiple 
PC enzymes (Yu et al. 2009, St Maurice et al. 2007). Binding with acetyl CoA stabilizes 
the tetramer through the allosteric domain, which was suggested by the dissociation of the 
tetramers caused by a mutation at the allosteric domain that was rescued by binding with 
acetyl CoA. Early Cryo EM studies determined that binding with L-aspartate does not 
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change the overall structural property of Aspergillus nidulans PC, but significantly 
attenuates the compact structure caused by binding with acetyl CoA (Osmani et al. 1984). 
Hence, it is very likely that L-aspartate may also be binding somewhere in the small 
allosteric domain, counteracting the effects caused by the allosteric domain when binding 
with acetyl CoA (Zeczycki, St. Maurice, and Attwood 2010). However, the target of 
inhibition by L-aspartate has been identified as the BC domain, since L-aspartate only 
inhibits the catalysis occurring at the BC domain and has no effect on the oxaloacetate 
decarboxylation catalyzed at the carboxyltransferase (CT) domain (Sirithanakorn et al. 
2014).  
 If L-aspartate does bind at the allosteric domain, how does it inhibit the catalysis at 
the BC domain? In this chapter, two chimeric enzymes (ReBC-AnPC and AnBC-RePC) 
from chapter II were used to dissect the domain contributions to the inhibition by L-
aspartate. AnPC and RePC are subject to the divergent degree of inhibition by L-aspartate, 
with 90% and 50% inhibition, respectively. Kinetic characterization of the two chimeric 
enzymes have shown that the locus of action for the inhibition by L-aspartate also primarily 
locates at the BC domain. However, the results from the chimeric enzymes didn’t fully 
support the concept that L-aspartate binds at the allosteric domain. Instead, it was shown 
that L-aspartate most likely shares the binding site with acetyl CoA at the BC domain 
interface.  
In chapter III, binding with acetyl CoA altered the movement of the carrier domain. 
Due to the counteracting effects caused by the two effectors towards the catalysis of PC, it 
is tempting to observe whether or not the translocation of the carrier domain is regulated 
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by L-aspartate. Thus, in this chapter, I will present the results for the regulation of the 
translocation of the carrier domain by L-aspartate.   
 The goal in this chapter is to better define the binding site of L-aspartate so as to 
explain the competitive binding between L-aspartate and acetyl CoA in PC to better 
understand the mechanism of its inhibition towards PC. 
2. Materials and Methods 
Clones of two chimeric enzymes ReBC-AnPC and AnBC-RePC were generously 
provided by Dr. Sarawut Jitrapakdee, Mahidol University, Thailand. 
Protein induction and purification of the chimeric enzymes and PC hybrid tetramers 
were performed using the same general method for purification of the full-length PC 
described in chapter II materials and methods. 
Enzyme assays. The coupled enzyme MDH assay was performed to determine the 
rate of pyruvate formation in 1 ml quartz cuvettes or 96-well format, as previously 
described in chapter II materials and methods.  
Determination of apparent Ka for the allosteric activators and apparent Ki for L-
aspartate. The activity of pyruvate carboxylation was measured using the coupling enzyme 
MDH assay over a range of allosteric effector concentrations, in order to determine the 
apparent Ki for the inhibitor and the Ka for the activator. The equations used for curve fitting 
the initial velocity vs allosteric effector concentration can be referred to in chapter II - 
materials and methods.  
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Global fitting of the data of initial velocity vs acetyl CoA concentration at varied 
L-aspartate concentrations in order to determine the Ki value of L-aspartate. The Ki value 
for L-aspartate was determined from a plot of the initial velocity (normalized for enzyme 
concentration) against acetyl CoA concentration under a series of L-aspartate 
concentrations. Global fitting of the data to equation IV-1 using least-squares nonlinear 
regression, based on the scheme IV-1, was according to the competitive binding between 
acetyl CoA and L-aspartate with PC, where [A] is the acetyl CoA concentration and [Asp] 
is the L-aspartate concentration. All least-square fits were performed using Prism7 
programs. vi/[E]t is the initial velocity normalized for the enzyme concentration; kcat0 is the 
kcat value in the absence of any effectors; kcatA  and kcatasp  are the kcat values at saturating 
concentrations of acetyl CoA and L-aspartate respectively; Ka is the activation constant for 
acetyl CoA; Ki is the inhibition constant for L-aspartate.  
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Scheme IV-1 
 
Equation IV-1 𝑘TVV = ~x8 	~x ∗([/] }~⁄ )1	~x~∗([/V] }v⁄ )6	([/] }~⁄ )1	([/V] }v⁄ )6      
h1 and h2 are the Hill coefficient with respect to acetyl CoA and L-aspartate. 
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3. Results 
3.1 Dissecting the Domain Contributions to the Inhibition by L-aspartate of PC  
The extent of L-aspartate inhibition is very different between AnPC and RePC, with 
additional significant differences in the Ki value for L-aspartate. Wild-type RePC retains 
~50 % residual activity at saturating concentrations of L-aspartate with the Ki of ~5 mM for 
L-aspartate, while AnPC retains only ~5 % activity with a Ki of ~3 mM (See Table IV-1).  
 
Table IV-1 Kinetic parameters of the inhibition of oxaloacetate production of PC by L-aspartate   
PC constructs kcat0, min-1 kcatasp, min-1 Kiasp, mM h Residual activity  KappASPcat/ k0cat, % 
Wild-type RePC  150± 8 81± 2 4.7 ± 0.7 a1.2 ± 0.2 54% 
Wild-type AnPC  2200 ± 90 108 ± 8 2.6 ± 0.1 a 1.7 ± 0.1 5% 
ReBC-AnPC 50 ± 2 53 ± 2 2.8 ± 0.7 b 1.6 ± 0.5 100% 
AnBC-RePC 120 ± 5 9.6 ± 0.1 0.99 ± 0.38 b 1.4 ± 0.3 8% 
a, curve fitting of acetyl CoA-independent L-aspartate inhibition; b, global curve fitting of acetyl CoA-
dependent L-aspartate inhibition 
From the results, we can see that the two chimeric enzymes display much reduced 
activity relative to the wild type enzymes, suggesting the integrity of the enzyme plays an 
important role in catalysis; catalytic activity can’t be restored by simply recombining three 
functional individual domains together. Additionally, in contrast to the significantly 
increased Ka value of acetyl CoA (See chapter II.3.2.5), the undisrupted binding of L-
aspartate in both chimeric enzymes again confirmed that L-aspartate does not bind at the 
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acetyl CoA binding pocket at the interface between the allosteric domain and the BC 
domain (See Table IV-1). 
The two chimeric enzymes (ReBC-AnPC and AnBC-RePC) have the BC domain, 
the target of inhibition, replaced by the BC domain from the other PC homologue that has 
a much different sensitivity to the inhibition by L-aspartate. For AnBC-RePC, which has 
the BC domain from AnPC, there remains a similar degree of L-aspartate inhibition (~8 % 
residual activity) compared to wild type AnPC (~5 % residual activity). In comparison, 
ReBC-AnPC, which has the BC domain from AnPC (~5 % residual activity) replaced with 
the BC domain from RePC (50 % residual activity), became insensitive to the inhibition by 
L-aspartate, suggesting that the inhibition by L-aspartate in PC is primarily determined by 
the BC domain. 
The sensitivity to L-aspartate inhibition is contributed by multiple factors, such as 
the binding site for L-aspartate and the communication between the catalytic domain and 
the effector binding site. The insensitivity to L-aspartate in ReBC-AnPC could be from the 
loss of binding site or communication between the binding site and BC domain. Titration 
of acetyl CoA in the presence of L-aspartate confirmed that ReBC-AnPC binds, but is not 
inhibited by, L-aspartate. After global fitting the initial velocity data, I was able to 
determine the Ki value of L-aspartate for both of the chimeric enzymes (See Figure IV-1).  
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Figure IV-1 Titration of acetyl CoA at different concentration of L-aspartate in chimeric enzymes  
All the traces represent the steady-state rate of oxaloacetate production over a range of acetyl CoA 
concentration at a certain concentration of L-aspartate.  
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Hence, it seems as if the insensitivity to L-aspartate inhibition in ReBC-AnPC is due 
to the loss of response to the binding of the molecule, which could be the result of the 
rearrangement of the BC domain of RePC.   
Using these two chimeras, I was also able to test binding site of L-aspartate in PC. 
However, the determination of the Ki value for L-aspartate was not conclusive. The Ki value 
in RePC-AnPC (the allosteric domain isolated from the wild type AnPC) is close to the wild 
type AnPC, which supports the original hypothesis that L-aspartate binds at the allosteric 
domain of PC. However, the Ki value of L-aspartate in the other chimera AnBC-RePC is 
significantly decreased compared to the both wild type enzymes, which is not consistent 
with the original hypothesis (as L-aspartate binds at the allosteric domain). 
To summarize, in this section, it was demonstrated that, similarly to the activation 
by acetyl CoA, the inhibition by L-aspartate is primarily determined by the BC domain. 
Additionally, based on the Ki value of L-aspartate determined from the chimeric enzymes, 
it is not conclusive that L-aspartate binds at the allosteric domain of PC as suggested in the 
previous literature. 
3.2 Defining the L-aspartate Binding Site 
As studies carried out on the chimeric enzymes failed to locate the L-aspartate 
binding site in PC, further investigation on the binding site of L-aspartate will be performed 
in this section using other approaches. Although previous studies have demonstrated that 
L-aspartate doesn’t bind at the acetyl CoA binding pocket, specifically not binding with the 
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two conserved arginine residues that form hydrogen bond with the nucleotidyl moiety of 
acetyl CoA, the binding site for the rest of the acetyl CoA molecule has been overlooked. 
Interestingly, previous kinetic studies have shown that acetyl CoA analogues with long 
acyl chains, like palmitoyl CoA (C16-CoA) and oleyl CoA(C18-CoA), can compete for 
binding with L-aspartate more effectively in AnPC compared to the shorter chain CoA 
analogues (Osmani et al. 1981). The above suggests that binding site for L-aspartate might 
overlap with the binding site for the acetyl group of acetyl CoA. To test this hypothesis, I 
measured the Ka value of CoA molecule in the presence and absence of L-aspartate. Since 
CoA doesn’t have the acetyl group attached, if the hypothesis is correct, L-aspartate will 
not have any influence on the Ka value of CoA. The results indicate that L-aspartate 
increased the Ka of CoA, most likely due to competitive binding (See Table IV-2).  
 
Table IV-2 Activation constant of acetyl CoA analogues in the presence and absence of L-aspartate 
for the oxamate-induced oxaloacetate decarboxylation reaction 
Acetyl CoA 
analogues 
Ka , µM h0 hasp + 0MM 
L-aspartate, 
+ 5mM 
L-aspartate, 
Acetyl CoA 3.5 ± 0.4 2520 ± 40 1.5 ± 0.2 4.7 ± 0.2 
CoA 150 ± 1 a2130 ± 170 2.4 ± 0.3 a1.4 ± 0.1 
3',5'-diphosphate 
adenine 8100 ± 1300 7600 ± 2000 1.6 ± 0.2 1.0 ± 0.3 
Ka, activation constant representing the concentration of the activator when the initial velocity reaches to half 
of the Vmax; h0 represents the hill co-efficient in the absence of L-aspartate; hasp represents the hill co-efficient in 
the presence of 5 mM L-aspartate. a, the Ka and hasp value of CoA in the presence of L-aspartate was determined 
for the pyruvate carboxylation reaction. 
To further investigate the binding mode for the rest of the acetyl CoA molecule 
beyond the nucleotidyl moiety regarding its relationship with the binding of L-aspartate, 
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the interaction between L-aspartate and 3',5'-diphosphate adenine was investigated. 3',5'-
diphosphate adenine contains only the nucleic acid portion of acetyl CoA and is missing 
the entire pantothenic acid arm. The results from titration of 3',5'-diphosphate adenine in 
the presence and absence of 5 mM L-aspartate showed that the Ka value of 3',5'-diphosphate 
adenine is unaffected by the addition of L-aspartate (See Table IV-2). In comparison, the 
Ka value of acetyl CoA in the presence and absence of L-aspartate was also measuring using 
kinetics assay. The apparent Ka of acetyl CoA is approximately 1000-fold higher in the 
presence of L-aspartate as compared to the absence of L-aspartate (Table IV-2). In addition, 
while high concentrations of acetyl CoA can recover maximum activation in the presence 
of L-aspartate, 3',5'-diphosphate adenine cannot. The maximum degree of the activation by 
3',5'-diphosphate adenine in the presence of L-aspartate is only ~50% of its maximum 
degree of activation, suggesting that the binding with 3',5'-diphosphate adenine is not 
mutually exclusive with the binding of L-aspartate in AnPC. 
The binding of acetyl CoA with PC has shown positive cooperativity (Jitrapakdee 
et al. 2007, Adina-Zada, Zeczycki, and Attwood 2012). It was proposed that there are two 
states of PC,  T and R, in which the R state has higher affinity with acetyl CoA compared 
to the T state (Jitrapakdee et al. 2007).  Since there are four acetyl CoA binding sites 
identified in the PC structure, binding with one acetyl CoA molecule will shift the 
population from the T state to the R state, resulting to an enhanced binding affinity for the 
binding with the following acetyl CoA molecules. In addition, the hill coefficient for the 
binding of acetyl CoA increases in the presence of L-aspartate (Sirithanakorn et al. 2014). 
It was proposed that binding with L-aspartate will stabilize the T state that has lower affinity 
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with acetyl CoA. The mutually exclusive binding between L-aspartate and acetyl CoA 
results in a population shift from T to R upon binding with acetyl CoA in the presence of 
L-aspartate, resulting in an increased hill coefficient for acetyl CoA. In the current study, 
unlike acetyl CoA, the hill co-efficient of 3’5’-diphoaphate adenine, the truncated version 
of acetyl CoA analogue, did not increase in the presence of L-aspartate, suggesting very 
likely that the protein population still stays in the T state due to the incapability of replacing 
L -aspartate by binding with 3’5’-diphoaphate adenine (See Figure IV-2). 
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Figure IV-2 Titration of 3',5'-diphosphate adenine in the presence and absence of 5 mM l-aspartate 
for the oxamate-induced oxaloacetate decarboxylation in AnPC. 
A, illustration of the increased hill co-efficient of acetyl CoA in the presence of L-aspartate; B, illustration of 
the changing of hill co-efficient of 3’5’-diphoaphate adenine in the presence of L-aspartate. Blue line 
represents the titration curve of acetyl CoA in the absence of L-aspartate; Red line represents the titration 
curve of acetyl CoA in the presence of 5 mM L-aspartate; Black line represents the titration curve of 3’5’-
diphosphate adenine in the absence of L-aspartate; Orange line represents the titration curve of 3’5’-
diphosphate adenine in the presence of 5 mM L-aspartate. Cube and letter T represent the T state of PC; circle 
and R represent the R state of PC. The value of hill co-efficient is shown in the color that is equivalent to the 
titration curve under different conditions 
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To summarize, in this section, the kinetic characterize of the activation of AnPC by 
3’5’-diphoaphate adenine for the CT domain catalysis have provided very convincing 
evidence that l-aspartate and acetyl CoA partially share the binding site of the pantothenic 
acid and acetyl group of the acetyl CoA molecule, which results in their competitive 
binding with PC.  
3.3 The Allosteric Inhibition by L-aspartate is Independent of Carrier Domain 
Translocation 
In chapter III, I have introduced the four pathways for the translocation of the 
carrier domain to transport the carboxyl group between BC and CT domain active sites 
(See Figure III-1). After measuring the activity recovered from three hybrid tetramers 
(hybrid A, B, C) in which only a single translocation pathway (pathway a, b, c) is 
catalytically functional (See Figure III-2), it was demonstrated that in PC, the carrier 
domain adopts multiple translocation pathways to perform catalysis. Acetyl CoA promotes 
a single translocation pathway, pathway a, in RePC (See Figure III-1). It was hypothesized 
that the enhanced coupling efficiency observed in the presence of acetyl CoA results from 
this single translocation pattern. However, L-aspartate doesn’t have effects on the coupling 
efficiency between the two half reactions (Sirithanakorn et al. 2014). In order to investigate 
whether L-aspartate inhibition in RePC also results in changes to BCCP domain 
translocation, L-aspartate inhibition was measured for each of the three hybrid tetramers in 
the absence of acetyl CoA. In contrast to what was observed with acetyl CoA activation, 
all three of the hybrid tetramers were inhibited by L-aspartate. In the absence of acetyl CoA, 
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the apparent Ki values determined for L-aspartate with each of the hybrid tetramers were 
very similar to the Ki value determined for the wild type enzyme, indicating that L-aspartate 
binding was not disrupted in the hybrid tetramers. Whereas RePC hybrid tetramer A was 
specifically activated by acetyl CoA, its inhibition by L-aspartate was no greater than 
inhibition in any other RePC hybrid tetramer. When this experiment was repeated in the 
presence of acetyl CoA, wild-type RePC and all of the RePC hybrid tetramers were again 
inhibited by L-aspartate (See Table IV-3). For both wild type RePC and the three hybrid 
tetramers, the apparent Ki values for L-aspartate determined in the presence of acetyl CoA 
were significantly increased as a result of the competition for binding with acetyl CoA.  
 
Table IV-3 Inhibition of wild type RePC and hybrid tetramers by L-aspartate in the presence and 
absence of acetyl coenzyme A 
RePC 
constructs 
+ 0 mM acetyl coenzyme A  + 0.25 mM acetyl coenzyme A 
*kcat0 
(min-1) 
kcatasp 
(min-1) 
kcatasp 
/kcat0 
Kiapp 
(mM) h  
kcat0 
(min-1) 
kcatasp 
(min-1) 
kcatasp 
/kcat0 
Kiapp 
(mM) h 
wild type 150± 8 81± 2 0.54 ± 0.03 4.7 ± 0.7 1.2 ± 0.2  1200 ± 60 180±40 0.15 ± 0.03 138 ± 5 4.8 ± 0.7 
RePC_×CT/ 
×BC×BCCP 11.5 ± 0.8 7.4 ± 0.3 0.64 ± 0.05 6.2 ± 0.5 1.6 ± 0.1  240 ± 7 34 ± 2 0.14 ± 0.01 26 ± 1 1.6 ± 0.1 
RePC_×BC/ 
×CT×BCCP 10 ± 1 2.8 ± 0.4 0.28 ± 0.05 8.2 ± 1.3 1.3 ± 0.2  12.5 ± 0.4 2.9± 0.1 0.23 ± 0.01 61 ± 6 1.2 ± 0.1 
RePC_×BCCP/ 
×BC×CT 7.9 ± 0.2 2.3 ± 0.3 0.29 ± 0.04 9.7 ± 1.5 1.2 ± 0.2  10.5 ± 0.8 3.3 ± 0.3 0.31+ 0.04 53 ± 5 1.2 ± 0.1 
*kcat values were determined using the subunit molecular weight of RePC (126 kDa). Each subunit contributes 
a single BC-CT active site pair.  
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L-aspartate inhibition was measured for each of the three hybrid tetramers of AnPC 
in both the presence and absence of acetyl CoA (See Table IV-4). The inhibition of AnPC 
by L-aspartate revealed that, as with RePC, the apparent Ki values were increased in the 
presence of acetyl CoA, suggesting that acetyl CoA and L-aspartate compete for binding to 
AnPC. Since AnPC is insensitive to acetyl CoA activation, the degree of inhibition from L-
aspartate was not enhanced in the presence of acetyl CoA for any of the AnPC hybrid 
tetramers. 
 
Table IV-4 Inhibition of AnPC wild type and hybrid tetramers by L-aspartate in the presence and 
absence of acetyl coenzyme A 
AnPC  
constructs 
+ 0mM acetyl coenzyme A  + 0.1mM acetyl coenzyme A 
*kcat0 
(min-1) 
kcatasp 
(min-1) 
kcatasp 
/kcat0 
Ki 
(mM) h  
kcat0 
(min-1) 
kcatasp 
(min-1) 
kcatasp 
/kcat0 
Ki 
(mM) h 
wild type 2200 ± 90 108 ± 8 0.049 ± 0.004 2.6 ± 0.1 1.7 ± 0.1  1970 ± 100 123 ± 7 0.062 ± 0.005 3.8 ± 0.3 2.7 ± 0.4 
AnPC_×CT/ 
×BC×BCCP 84 ± 3 3.1 ± 0.5 0.037 ± 0.006 1.8 ± 0.2 1.7 ± 0.4  94 ± 8 4.5 ± 0.2 0.048 ± 0.005 7.5 ± 0.2 3.1 ± 0.3 
AnPC_×BC/ 
×CT×BCCP 31.4 ± 1.3 2.6 ± 0.3 0.08 ± 0.01 2.3 ± 0.1 1.8 ± 0.2  34 ± 3 3.4 ± 0.4 0.10 ± 0.01 13 ± 1 2.0 ± 0.2 
AnPC_×BCCP/ 
×BC×CT 10 ± 1 1.1 ± 0.2 0.11 ± 0.21 1.86 ± 0.02 2.1 ± 0.1  9.4 ± 0.5 1.1 ± 0.1 0.12 ± 0.01 10 ± 1 1.7 ± 0.2 
*kcat values were determined using the subunit molecular weight of AnPC (130 kDa). Each subunit contributes 
a single BC-CT active site pair.  
Thus, all three of the hybrid tetramers in both RePC and AnPC are inhibited by L-
aspartate in the absence of acetyl CoA. In the presence of acetyl CoA, only hybrid tetramer 
A from RePC is subjected to enhanced inhibition by L-aspartate, consistent with the unique 
sensitivity of translocation pathway a to acetyl CoA activation.  
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4. Discussion 
In this chapter, I investigated the binding site and the major domain contribution to 
the inhibition by L-aspartate in PC. Contrary to what has been suggested in the literature 
(Zeczycki, St. Maurice, and Attwood 2010), L-aspartate does not appear to bind at the 
allosteric domain. Rather, the competitive binding between acetyl CoA and L-aspartate 
most likely results from the overlapping binding site at the pantothenic acid arm of acetyl 
CoA. Similar to the activation by acetyl CoA, the sensitivity to L-aspartate inhibition is 
majorly determined by the BC domain of PC as well. Additionally, studies on the 
regulation of the carrier domain by L-aspartate revealed that, unlike its competitor acetyl 
CoA altering the movement of the carrier domain (See chapter III), L-aspartate doesn’t alter 
the translocation pattern of the carrier domain in PC.  
AnPC belongs to cytosolic PC, of which the most significant feature is its 
insensitivity to acetyl CoA and other short chain acyl CoA molecules, while very high 
sensitivity to the long chain acyl CoA molecules (Osmani et al. 1981). However, the 
sensitivity to acyl CoA molecules tested in previous studies in AnPC were represented as 
their ability to replace L-aspartate, due to no observable effects on the catalysis of pyruvate 
carboxylation in AnPC by those “activators”. In chapter II, I have described that the CT 
domain catalysis of AnPC is stimulated by acetyl CoA, with which I was able to directly 
characterize the activation of PC by acyl CoA analogues. In my studies, I also tested the 
activation of CT domain catalysis by the long acyl chain acyl CoA molecule. Palmitoyl 
CoA (C16-CoA) and oleyl CoA (C18-CoA) did not show any activation of the CT domain 
catalysis in spite of their observed ability to replace L-aspartate more efficiently than acetyl 
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CoA from previous studies (Osmani et al. 1981). In other words, the previous activation of 
the pyruvate carboxylation by the long chain acyl CoA analogues, catalyzed by the full-
length AnPC, might solely be due to the replacement of L-aspartate.  
Attempts to determine the binding site of L-aspartate in PC have not been successful, 
due to the low binding affinity between PC and L-aspartate. It has been well established 
that L-aspartate and acetyl CoA bind competitively to PC, though they do not share the 
identical binding sites (Sirithanakorn et al. 2014, Osmani et al. 1984, Woronick and 
Johnson 1960). The nucleotidyl moiety of acetyl CoA was demonstrated to play an 
indispensable role on the activation of PC, while the rest of the molecule was shown to 
primarily enhance the binding affinity. Hence, previous studies have only focused on the 
binding site of the nucleotidyl moiety of acetyl CoA, while the rest of the molecule has 
been overlooked. In chapter IV section 3.2, it confirmed a partially overlapping binding 
site between L-aspartate and acetyl CoA at the pantothenic acid and acetyl group binding 
site. Interestingly, the structure of SaPC with bound CoA reveals that the pantothenic acid 
arm is located outside of the allosteric site, at the BC domain dimer interface (Yu et al. 
2009). This suggests that L-aspartate might also be binding near the BC domain dimer 
interface (See Figure IV-3).  
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Figure IV-3 The pantothenic acid arm binding site at the BC dimer interface in PC 
Overlay of BC dimer from SaPC (3HO8) structure and AnPC structure, centering at the BC domain from the 
top face. Blue is SaPC BC domain, grey is AnPC BC domain. CoA is shown in sticks and from SaPC (3HO8). 
In the absence of a crystal structure, alternative scenarios can also explain the 
competition data between L-aspartate and acetyl CoA. Most notably, the competition for 
binding may result from conformational changes in the enzyme that are stabilized by 
binding with either of the two effectors at completely separate binding sites. A fluorescent 
analogue of ATP, 2’,3’-O-(2,4,6-trinitrophenyl) adenosine 5’-triphosphate (TNP-ATP), 
acts as an activator of PC as well as a competitor to the binding with acetyl CoA.  It has 
CoA
BC domain dimer
Pantothenic acid arm
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been shown that TNP-ATP, acetyl CoA, and L-aspartate bind at three distinct sites and 
competively binding with each other (Sirithanakorn et al. 2014). The above study has 
suggested that the conformational change of PC induced by binding with allosteric 
effectors, could result in competitive binding among different effectors. 
In this chapter, the studies on the regulation of the carrier domain translocation by 
L-aspartate was described. The inhibition by L-aspartate is universal to all the translocation 
pathways, suggesting L-aspartate doesn’t alter the translocation pattern of the carrier 
domain. In chapter III, it was proposed that the promoted translocation pathway adopted 
by the BCCP domain in RePC in the presence of acetyl CoA could contribute to the 
enhanced coupling efficiency. L-aspartate has no effect on the coupling efficiency, even 
though it has the antagonistic effects towards the activation by acetyl CoA. Here, no 
alternation in the translocation of the BCCP domain, after L-aspartate binding, is consistent 
with the fact that L-aspartate has no effects on the coupling efficiency, indicating the 
inhibition by L-aspartate might be solely on the active site of the BC domain.  
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V. CONCLUSIONS  
1. Mechanisms of Allosteric Regulation of Pyruvate Carboxylase  
In this section, two models will be proposed to illustrate the mechanism of allosteric 
regulation of PC. The crossing guard model is primarily used to explain how altered BCCP 
translocation can offer a mechanism for the activation by acetyl CoA. The free-energy 
population shift model attempts to incorporate all of the insights gained from the current 
study, so as to generate a unified view of the fundamental mechanism applicable to the 
allosteric regulation of PC. 
The crossing guard model. The kinetic studies on the activation of PC by acetyl 
CoA have been focused on the enhanced turnover rate of HCO3--dependent MgATP 
cleavage at the BC domain. The effects of acetyl CoA on the pre-steady state kinetics of 
the BC domain reaction revealed that acetyl CoA enhances the rate of ATP cleavage, 
supposedly through promoting substrate binding at the optimal position for the catalysis at 
the BC domain active site (Legge, Branson, and Attwood 1996). However, the structure of 
PC with acetyl CoA bound revealed that acetyl CoA binds at the allosteric domain that is 
far away from the BC domain active sites and no significant conformational change was 
observed at the BC domain active site, likely indicating the activation by acetyl CoA is not 
solely on the BC domain active site. 
The two-step catalysis of PC is coupled by the translocation of the carrier domain. 
The coupling efficiency between the two-half reactions was shown to be enhanced in the 
presence of acetyl CoA, indicating that the movement of the carrier domain is likely to be 
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regulated by acetyl CoA (Zeczycki, Menefee, Jitrapakdee, et al. 2011). Binding with 
pyruvate at the CT domain was shown to promote the ATP cleavage from the BC domain 
from the subunit across the face, suggesting that there is communication between the two 
active sites (Westerhold et al. 2016), which could be through the translocation of the carrier 
domain. Furthermore, studies on acetyl CoA sensitive PC from Staphylococcus aureus 
(SaPC), have shown a thermodynamic linkage between pyruvate binding and ATP 
cleavage, only in the presence of acetyl CoA, suggesting that communication between the 
two catalytic domains is mediated by acetyl CoA.  
A single translocation pathway from the BC domain of its own subunit to the CT 
domain of the opposing subunit, adopted by the carrier domain during catalysis, has been 
demonstrated to be catalytically functional in acetyl CoA sensitive PC homologues through 
kinetic and structural studies (Lasso et al. 2014, St Maurice et al. 2007). However, no direct 
evidence has demonstrated that acetyl CoA alters the translocation of the carrier domain. 
The unique position of the carrier domain in the acetyl CoA insensitive PC homologue 
from Aspergillus nidulans (AnPC) runs contrary to the dogma of carrier domain 
translocation identified in acetyl CoA sensitive PC homologues. Three translocation 
pathways were tested in AnPC and the acetyl sensitive PC homologue from Rhizobium etli 
(RePC), from which new insights were revealed in the mechanism of activation of PC by 
acetyl CoA. 
The “crossing guard” model proposes that RePC, in the absence of acetyl CoA, the 
enzyme remains in an “LOW” activity form with the carrier domain translocating between 
multiple catalytic domains to transfer a carboxyl group between any compatible 
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combination of two active sites. The intermediate transfer is inefficient due to 
undirected/uncoordinated translocation of the carrier domain.  In the presence of acetyl 
CoA, the translocation pathway adopted by the carrier domain occurs between the BC 
domain from the same subunit to the CT domain on the opposing subunit and is promoted 
by acetyl CoA, which leads to an enhanced BC domain catalysis and a more ordered 
coupling between the two half reactions. In contrast, all three tested translocation pathways 
were not stimulated by binding with acetyl CoA in AnPC, which is consistent with its 
insensitivity to the activation by acetyl CoA. The role played by acetyl CoA is like a 
crossing guard, changing the undirected translocation of the carrier domain to a dominant 
pattern through regulating the movement of the carrier domain.  
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The crossing guard model illustrates the activation of PC by acetyl CoA in terms 
of the regulation of the carrier domain translocation, which was able to, for the first time, 
provide a mechanism to explain how acetyl CoA enhances the coupling efficiency between 
the two half reactions without directly affecting the active sites of PC (See Figure V-1).  
 
 
 
 
Figure V-1 Crossing guard model of allosteric activation of PC by acetyl CoA 
a, b, c and d represent the four translocation pathways of the BCCP domain; in the absence of acetyl CoA, 
the catalytically functional pathway ways are shown in black; in the presence of acetyl CoA, the catalytically 
functional pathways are shown in orange; the orange arrow represents the enhanced translocation pathway. 
However, the crossing guard model does not explain how acetyl CoA promotes one 
translocation pathway over the others. It may be related to subtle structural rearrangements 
+ acetyl CoA !.
b.
c.
d.
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in the individual domains, similar to the BC domains reported for Staphylococcus aureus 
PC in the presence of acetyl CoA (Yu et al. 2009). In addition, in my current studies, kinetic 
studies on the domain contributions to the activation by acetyl CoA have revealed that the 
sensitivity to the activation by acetyl CoA is determined by the BC domain, which is 
consistent with previous studies on PCs from other species. (Legge, Branson, and Attwood 
1996, Islam, Sueda, and Kondo 2005, Jitrapakdee et al. 2007). The BC-dependent 
sensitivity to the activation by acetyl CoA can not be easily explained by the crossing guard 
model. Moreover, the crossing guard model cannot provide the mechanism that gives rise 
to the divergent regulatory properties between the two PC homologues, AnPC and RePC. 
Specifically, why does AnPC not respond to activation by acetyl CoA? Even though none 
of the translocation patterns were stimulated by acetyl CoA in AnPC, AnPC displays an 
intrinsically high turnover rate compared to RePC, suggesting that AnPC might adopt a 
different mechanism to control carrier domain translocation during catalysis. The 
thermodynamic studies have revealed divergent properties between AnPC and RePC, 
which contribute to the following free-energy landscape population shift model.   
Free-energy landscape population shift model. Before I introduce the free-energy 
model, a critical assumption in this model must be noted: the rate-limiting step of pyruvate 
carboxylation is biotin-dependent ATP cleavage at the BC domain active site that results 
in the carboxylation of the biotin co-factor in both RePC and AnPC. The catalytic rate in 
the steady-state is determined by the rate-limiting step. ATP cleavage has been 
demonstrated to be the rate-limiting step in acetyl CoA sensitive PC homologues from 
chicken and sheep liver (Attwood and Wallace 1986, Goodall et al. 1981), which were also 
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demonstrated to be sensitive to acetyl CoA activation. In the current study, an similar 
degree of acetyl CoA activation was observed for both the ATP cleavage and the full 
pyruvate carboxylation reaction catalyzed by RePC; in AnPC, ATP cleavage was not 
activated by acetyl CoA, which is consistent with its insensitivity to acetyl CoA. Hence, it 
is valid to assume that, for both AnPC and RePC, the rate-limiting step for the overall 
pyruvate carboxylation reaction is ATP cleavage catalyzed at the BC domain. If we assume 
the rate limiting step is ATP cleavage at the BC domain, the thermodynamic properties of 
AnPC and RePC associated with their response to the activation by acetyl CoA can be 
illustrated as Figure V-2.  
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Figure V-2 A thermodynamic illustration of allosteric regulation in PC  
The peaks of each curve represent the transition state of the individual half-reactions. The higher the transition 
state, the larger the activation energy required to perform the catalysis. Blue lines represent RePC; yellow 
lines represent AnPC; dashed lines represent the reaction in the presence of acetyl CoA; solid lines represent 
the reaction in the absence of effectors. DG is the free energy difference between the substrates and products; 
DG⧧ is the activation energy. DGBC⧧ represents the activation energy for the BC domain half-reaction; DGCT⧧ 
represents the activation energy for the CT domain half-reaction; 
Figure V-2 illustrates the effects of acetyl CoA on the activation energy barrier 
associated with the individual half reactions in both AnPC and RePC. Since the rate-
limiting step is catalyzed at the BC domain, even though the CT domain catalysis is 
PC+ATP+HCO3-
PC+ oxaloacetate
PC-CO2
+ ADP + Pi 
+ pyruvate
BC domain catalysis 
CT domain catalysis
Free energy G
Reaction path
substrates
products
△G
RePC△△GBC⧧
AnPC△GBC ⧧
RePC△GBC⧧
AnPC△△GCT⧧
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demonstrated to be activated by acetyl CoA in AnPC in chapter II, the turnover rate for the 
overall pyruvate carboxylation reaction is not affected. 
It needs to be clarified that the rate-limiting ATP cleavage defined in this model 
does not include the biotin-independent ATP cleavage. From previous studies, as well as 
in chapter II, it was shown that abortive ATP cleavage was occurring at the BC domain 
without formation of oxaloacetate, which is not the rate-limiting ATP cleavage step 
assigned in this model as it does not contribute to the overall pyruvate carboxylation 
reaction. This means that the rate-limiting step, biotin-dependent ATP cleavage, requires 
participation from both the BC and BCCP domains during catalysis. 
The productive carboxylation of biotin at the BC domain active site requires the 
proper positioning of MgATP and biotin, as well as the residues within the active site at 
the BC domain, which was also proposed to be facilitated by binding with acetyl CoA 
(Attwood, Wallace, and Keech 1984, Zeczycki, Menefee, Adina-Zada, et al. 2011, 
Zeczycki, Menefee, Jitrapakdee, et al. 2011). Thus, the proper conformation of the BC 
domain that stabilizes the interaction with the BCCP domain is important to achieve an 
optimal reaction catalyzed by the BC domain (biotin-dependent ATP cleavage). Previous 
studies have revealed that in the absence of BCCP-biotin, acetyl CoA does not affect the 
rate of biotin-independent ATP cleavage (Islam, Sueda, and Kondo 2005), suggesting that 
activation by acetyl CoA occurs by manipulating the interaction between BCCP-biotin and 
the BC domain.  
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In the free-energy landscape population shift model (See Figure V-3), it is proposed 
that the free-energy landscape profile of the BC domain is fundamentally different between 
the two apo-PC enzymes, which gives rise to divergent regulatory properties.  
 
Figure V-3 Free-energy population shift model of allosteric regulation of PC 
Solid lines represent the simplified free-energy profile of the BC domain conformations. Each well represents 
a low-energy minimum of the BC domain conformation that is stabilized by BCCP-BC interaction; The BC 
domain conformation stabilized by the BC-BCCP intermolecular interaction that result in the biotin-
dependent ATP cleavage is indicated as the blue star; The BC domain conformation stabilized by the BC-
BCCP intramolecular interaction that result in the biotin-dependent ATP cleavage is indicated as the orange 
star. 
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A free-energy landscape profile of protein represents an ensemble of multiple 
conformations that are stabilized at relatively low-energy states. Each conformation is 
represented as a low-energy state well. AnPC has an intrinsically “stable” BC domain with 
fewer low-energy states, while RePC has a “dynamic” BC domain with more low-energy 
states. The “dynamic” BC domain of RePC is suggested as the dimerization is more 
sensitive to the mutations of residues at the BC dimer interface, while the “stable” AnPC 
BC domain is not (chapter II). 
The simplest free-energy landscape profile of the BC domain contains at least two 
conformations that are associated with a low-energy state: one is for the intermolecular 
interaction with the carrier domain from the opposing subunit, the other is for the 
intramolecular interaction with the carrier domain from its own subunit (See Figure V-3). 
Both conformations remain in equilibrium with one another and binding with ligands will 
shift the distribution of the population, resulting in a population equilibrium that is 
dominated by the conformation with the lowest-energy state. 
In a simplified profile of the BC domain, the model assumes that the BC domain in 
AnPC is dominated by a “HIGH” activity state, with the “stable” BC domain existing in 
only two low-energy states: one for the intramolecular interaction and the other for the 
intermolecular interaction. In RePC, the BC domain is dominated by the “LOW” activity 
state with the “dynamic” BC domain existing in multiple low-energy states, some of which 
result in catalytically incompetent conformations with the carrier domain that are unable 
to perform biotin-dependent ATP cleavage. This means that, in apo RePC, the BCCP 
domain has to sample multiple low-energy conformations of the BC domain in order to 
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achieve the optimal interaction for catalysis. In the presence of acetyl CoA, acetyl CoA 
alters the free-energy landscape profile of the BC domain, resulting in lowering the energy 
state of the conformation for intramolecular interaction with the BCCP domain. This leads 
to promotion of a single translocation pathway that is adopted by the BCCP domain during 
catalysis. In other word, I proposed that the translocation of the BCCP domain in controlled 
by the conformational ensemble of the BC domain through domain-domain interaction. 
Most importantly, this model does not exclude the existence of multiple pathways (pathway 
b, c, d from chapter III) even in the presence of acetyl CoA, which was also demonstrated 
to be true in the current study. Meanwhile, for AnPC, the “stable” BC domain only adopts 
two conformations that contribute to the catalytically functional inter and intramolecular 
interaction with the BCCP domain, resulting in a permanently activated state. Although 
acetyl CoA does bind with AnPC at the same site (See chapter II), the reaction rate is 
unaffected in the presence of acetyl CoA.  
Compared to acetyl CoA, L-aspartate acts to “destabilize” the BC domain, possibly 
by reducing the barriers between multiple low-energy state conformations, permitting 
many more conformations that are sampled by the BCCP domain, many of which are 
catalytically incompetent. In doing so, L-aspartate reduces the proportion of the population 
that is competent for catalysis, which results in a universal inhibition to all of the carrier 
domain translocation pathways. Consequently, a relatively low allosteric efficacy for 
inhibition by L-aspartate of RePC that has the “dynamic” BC domain; while a high 
allosteric efficacy for the inhibition by L-aspartate of AnPC has the “stable” BC domain.  
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The free-energy landscape population shift model provided a unified mechanism of 
allosteric regulation of PC, which will need further evidence to support the model. 
2. Divergent Regulatory Properties of Homologues Enzymes 
Allosteric regulation is the functional switch that is accomplished by 
communication between the allosteric effector binding site and the functional site. 
Allosteric pathway is a fundamental factor that contributes to allosteric efficacy and is 
composed of energetically linked amino acids serving the function of propagating the 
signal between the allosteric site and functional site. Based on the principle that the 
allosteric site and functional site co-evolved (Suel et al. 2003), studies have identified 
conserved networks of residues mediating allosteric communication in homologues 
proteins (Lockless and Ranganathan 1999). The conserved allosteric network governs the 
coupling between distant sites for the signal propagation carried by proteins. Hence, the 
divergent sensitivities to allosteric regulation amongst homologues enzymes could be due 
to modification of the network. Studies on allosteric regulation of pyruvate kinases (PYK) 
have revealed that different allosteric strategies (different allosteric networks) were 
adopted for PYK homologs from bacteria and human. However, the underlying principle 
is to maximize kcat/Km of the enzyme by stabilizing the conformation of protein tetramer 
(Morgan et al. 2014). It appears that the “active state” of PYK is conserved among 
homologs, but the route, i.e. the allosteric network, to achieve the “active state” could be 
different. For multidomain enzymes like PC, it is very difficult to track the allosteric 
network, which could potentially involve residues on the same polypeptide chain or a 
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separate polypeptide. So far, an allosteric network in PC that connects the allosteric site 
and functional site remains unknown. In the current study, instead of trying to identify the 
allosteric network that contributes to the allosteric efficacy, I compared two PC homologs 
that are regulated by the same effectors with different allosteric efficacy. My results fully 
support the modern concept of protein allostery that the allosteric efficacy is not governed 
by the binding of the allosteric effectors, but instead by the difference of free energy 
between the apo-protein and effector-bound state of the protein (Tsai and Nussinov 2014).  
The dynamics of apo enzymes in the unbound state have an intrinsic ability to 
sample conformations that meet the functional requirements (Bahar, Chennubhotla, and 
Tobi 2007). The distribution between the “unfunctional” and “functional” state of the apo-
enzyme determines the “basal” activity. The high “basal” activity of AnPC in the absence 
of acetyl CoA, indicating high percentage of the “functional” state of the apo enzyme. 
Although AnPC has higher turnover rate compared to RePC, under saturating concentration 
of the inhibitor L-aspartate, AnPC and RePC have very similar residual turnover rate. Hence, 
the high degree of inhibition of AnPC by L-aspartate is not due to a lower turnover rate 
upon binding of L-aspartate, instead, is due to the intrinsically high activity of the apo-
enzyme. “Degree of regulation” has often been used to describe the allosteric efficacy, or 
represent the sensitivity of allosteric regulation. However, without referring to the absolute 
values of the turnover rate of the apo and effector-bound enzyme, the “degree of regulation” 
sometimes could be misleading for us to fully understand the feature of the enzyme.  
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To summarize, the divergent regulatory properties of homologues enzymes could 
be derived from the different “basal” activities of the apo-enzyme which are likely 
determined by the distribution between the “functional” and “unfunctional” states.  
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VI.  APPENDIX A: REGULATION OF THE PI RELEASE AT PRE-STEADT STATE 
BY ACETYL COENZYME A 
 Previous studies have revealed that acetyl CoA activates the full pyruvate 
carboxylation reaction by stimulating the rate limiting step of ATP cleavage. Studies in 
chapter II have revealed that the sensitivity to acetyl CoA activation is determined by the 
BC domain. In this section, some preliminary data of the pre-steady state kinetics of the Pi 
release from ATP cleavage at the BC domain was presented, in order to further investigate 
the activation of the BC domain catalysis by acetyl CoA regarding the divergent regulatory 
properties between RePC and AnPC.  
Pi release pre-steady state kinetics assay protocol: The pre-steady state kinetics of 
Pi release from the ATP cleavage using PBP-MDCC were measured in the stopped-flow 
apparatus (refer to chapter II methods and materials).  
All the substrates, enzyme and PBP-MDCC solution were made in mopped 1× 
assay buffer with concentration of 0.1 mM This (pH 7.8), 7 mM MgCl2 and 0.1 mM KCl. 
Substrates and acetyl CoA were made in 4× stock solution depending on the final 
concentration applied in the assays. PBP-MDCC was made in mopped 1× assay buffer as 
4× stock solution with the concentration of 80 µM. Enzyme was diluted in 1× assay buffer 
as 2× stock solution. All the stock solutions were mopped with 0.1 U/ml PNPase and 300 
µM 7MEG for 2 hours before performing the assay. Two syringes on the stopped-flow 
apparatus are for injecting the samples, one was used for injecting enzyme solution, and 
the rest of the reactants were injected through the other syringe. The 4× stock solutions of 
PBP-MDCC and the substrates were premixed, in order to equilibrate the contaminating Pi 
  
 
 
185 
in the substrates stock solution. After premixing, inject 1ml of the mixture (2x substrates 
concentration and PBP concentration) into syringe A and the 2× enzyme solution into 
syringe B. For measuring the rate of Pi release, most of the data was collected in two phases, 
2000 reads in phase one from 0-0.5 s and 10000 reads in phase two from 0.5-5.5 s.  
In order to transform the changing of fluorescence to the changing of the Pi 
concentration, a standard curve of fluorescence vs Pi concentration was performed. For 
making the standard curve, syringe A was filled with 2× PBP-MDCC stock with 
concentration of 40µM in 2×assay buffer. Syringe B was filled with the known 
concentration of 2× Pi stock solution were made as 0 µM, 0.8 µM, 1.6 µM, 3.2 µM, 6.4 
µM in Milli Q water respectively. For standard curve, the fluorescence signal was collected 
1000 points for 5.5 s.  
For every set of experiments, there must be two controls: in control A, syringe A is 
filled with enzyme in 1x buffer mixing against all the components in 1x buffer from the 
syringe B except for ATP, so as to confirm that all the changes of the Pi level observed 
from the reaction is from ATP cleavage. In control B, syringe A is filled with 1x buffer in 
mixing against all the components mixed in 1x buffer from the syringe B including ATP, 
so as to confirm that all the changes of the Pi level observed from the reaction is from the 
ATP cleavage catalyzed by the enzyme. For both of the controls, a straight line with 0 slop 
is expected and the data need to be collected according to the set up for the enzyme 
reactions. If it is not zero slope in control A, it means there is contaminating chemicals that 
can also release Pi gradually and the experiment has to be aborted; if it is not a 0 slope in 
control B, it indicates that the assay buffer ATP carries on spontaneous hydrolysis. The Pi 
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release data collected from the enzyme reactions need to subtract the corresponding values 
from the control B, in order to acquire the net change of Pi level catalyzed by the enzyme. 
Results: 
1). Determination of the rate of Pi release from ATP cleavage at steady-state 
catalyzed by PC. Using the stopped-flow equipment, I was able to determine the rate of Pi 
release from ATP cleavage at both steady and pre-steady state. The rate of Pi release at 
steady state was determined in both AnPC and RePC (See Figure VI-1).  
 
 
 
 
Figure VI-1 Rate of Pi release at steady-state from ATP cleavage catalyzed by PC 
Pi release from 0.2 µM PC. Green is RePC, black is RePC in the presence of 0.25 mM acetyl CoA, purple is 
AnPC, red is AnPC in the presence of 0.25 mM acetyl CoA. A, data collected from stopped-flow apparatus 
showing the overall profile of Pi release from PC. The saturating signal represents running out of PBP-MDCC; 
B, curve fitting of the linear portion of the Pi release catalyzed by PC at steady-state from 0.15 s-0.2 s. Dashed 
lines are the results from curve fitting.  
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The rate of PC catalytic turnover is very fast (~1000-2000 min-1), due to the limited 
concentration of PBP-MDCC (20 µM), the signal starts getting saturated at 1 s when the 
enzyme concentration is 0.2 µM. The slope (µM/s) of the curve at the linear stage 
represents the rate of Pi release at steady state. The linear data between 0.15 s-0.2 s were 
extracted for linear-regression curve fitting to determine the rate of Pi release at steady-
state. (See Figure VI-1B and Table VI-1). 
 
Table VI- 1 Rate of Pi release at steady state using data collected from stopped-flow apparatus 
 kcat0, min-1 kcatAcoA, min-1 
AnPC 1860 1560 
RePC 114 1110 
The values were determined from one set of experiment. 
The values obtained from the curve fitting were close to the rate of oxaloacetate 
production (second-half reaction) at steady state, suggesting the data collected from the 
stopped-flow apparatus using PBP-MDCC to detect the rate of Pi release is valid.  
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2). Determination of the Pi release profile at pre-steady state catalyzed by PC. The 
Pi release from ATP cleavage catalyzed by PC at pre-steady state shows a unique double 
burst profile. One rapid Pi release burst followed by a lag phase and then another rapid 
burst was shown in the pre-steady state of Pi release of both AnPC and RePC in the presence 
of acetyl CoA. In the absence of acetyl CoA, Pi release from AnPC shows the same profile 
while RePC shows a two-phase pre-steady state profile (See Figure IV-2A). In order to 
acquire a higher resolution of the two-phase Pi release profile of RePC in the absence of 
acetyl CoA, higher concentration of enzyme was used in the assay (See Figure IV-2B).  
 
 
 
 
Figure VI-2 Pre-steady state of Pi release in AnPC and RePC 
A, Pi release catalyzed by 1 µM PC in the presence and absence of acetyl CoA. red line represents 1 µM 
AnPC in the absence of acetyl CoA; blue line represents 1 µM AnPC in the presence of acetyl CoA; black 
line represents 1µM RePC in the presence of acetyl CoA; green line represents 1 µM RePC in the absence of 
acetyl CoA. B, purple line represents 2 µM RePC in the absence of acetyl CoA; orange line represents 1 µM 
AnPC in the absence of acetyl CoA. All the reactions were performed in 0.1 mM HEPES buffer (pH 7.8), 
0.1 mM KCl, 10 mM MgCl2 under saturating concentration of substrates: 12 mM pyruvate, 2.5 mM ATP, 25 
mM HCO3-. Acetyl CoA concentration was 0.25 mM. 
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Using 2 µM RePC, I was able to acquire a higher resolution of the two-phase pre-
steady state Pi release profile, from which the first phase was also shown as a burst. 
Comparing to AnPC, as well as RePC in the presence of acetyl CoA, the first burst showed 
a much smaller amplitude and rate. 
In order to investigate the factors that contribute to the formation of the double-
burst of Pi release, I measured the Pi release at pre-steady state under various conditions.  
Based on the results, it seems like the cause of the double-burse of Pi release was the 
presence of pyruvate (See Figure VI-3). For RePC, in the absence of pyruvate, there was 
only a single burst phase of Pi release which ends around 0.03 s and is then followed by a 
slow steady state (Figure VI-3).  
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Figure VI- 3 Pre-steady state of Pi release in RePC  
Green represents RePCxCT in the presence of acetyl CoA; Blue represents wild-type RePC in the presence 
of acetyl CoA; Black represents RePCxCT in the absence of acetyl CoA; Red represents wild-type RePC in 
the absence of acetyl CoA. Assays performed with wild type RePC were done in the absence of pyruvate; 
assays performed with RePCxCT were done in the presence of pyruvate. All the reactions were performed 
in 0.1 mM HEPES buffer (pH 7.8), 0.1 mM KCl, 10 mM MgCl2 under saturating concentration of substrates: 
2.5 mM ATP, 25 mM HCO3-. Acetyl CoA concentration was 0.25 mM and pyruvate concentration was 12 
mM. 
The addition of acetyl CoA did not change the number of bursts, but increased the 
rate of the bursts (parameter B). Pi release from the mutant with the pyruvate binding site 
(R621 and T882) of RePC mutated, RePCxCT, had the very similar profiles as wild type 
  
 
 
191 
RePC in the absence of pyruvate, suggesting that the profile of Pi release changing from 
double burse to single burst was likely due to the absence of pyruvate. After fitting the 
single burst kinetics data to a single exponential decay followed by a linear phase (Equation 
VI-1), all the parameters were shown in table VI-2.  
Equation VI-1 𝑌 = 𝐶 ∗ 𝑥 + 	𝐴(1 − 𝑒q∗) 
A is the amplitude of the burst which equals to the number of functional active sites; B is the rate of the burst; 
C is the slope of the linear phase which equals to the steady state Pi release rate in s-1 
 
Table VI- 2 Curve fitting results for the Pi release from RePC in the absence of pyruvate 
 A B C 
2 µM RePC 0.630 ± 0.005 6.98 ± 0.06 0.24 ± 0.01 
2 µM RePC + acetyl CoA 0.846 ± 0.002 23.3 ± 0.2 0.420 ± 0.007 
2 µM RePC xCT 0.733 ± 0.005 8.57 ± 0.07 0.29 ± 0.01 
2 µM RePC xCT + acetyl CoA 0.894 ± 0.002 27.5 ± 0.2 0.273 ± 0.005 
 
Further investigation of the pre-steady state of Pi release in AnPC has shown that, 
consistent with RePC, the double burst of Pi release was also likely caused by binding with 
pyruvate. In the absence of pyruvate, a single burst of Pi release (ends at ~0.03 s) 
corresponds to the first burst phase of the Pi release in the presence of pyruvate. Most 
interestingly, unlike RePC, the Pi release in AnPC was not affected by binding with acetyl 
CoA and has a very similar profile to the wild type RePC in the presence of acetyl CoA.  
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In order to test if the pre-bound pyruvate at the CT domain active site of PC will 
have an effect on the Pi release, I pre-incubated RePC with pyruvate before initiating the 
reaction. The pre-bound pyruvate of PC attenuated the amplitude of the first burst of Pi 
release at the pre-steady state, but had no effect on the steady state rate.  
 
 
 
 
Figure VI- 4 Pi release from AnPC and RePC under various conditions 
A, time scale is 0 – 2 s; B, time scale is 0 – 0.2 s. All the reactions were performed in 0.1 mM HEPES buffer 
(pH 7.8), 0.1 mM KCl, 10 mM MgCl2 under saturating concentrations of substrates: 2.5 mM ATP, 25 mM 
HCO3-. Acetyl CoA concentration is 0.25 mM and pyruvate concentration is 12 mM. 
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VII. APPENDIX B: MIXING CONDITIONS THAT PROMOTE THE 
RECOMBINATION OF REPC TETRAMERS IN SOLUTION  
PC from chicken liver was examined at equilibrium between monomers, dimers 
and tetramers. Dilution of the protein will cause dissociation of the tetramers to form 
dimers and monomers. Previous studies have taken advantage of this feature to generate 
hybrids between the two PC species.  I originally applied the same approach  in my research 
to make hybrid tetramers between two PC individual mutants (St Maurice et al. 2007), 
which did not produce hybrid tetramers with a high degree of recombination (See Table 
III-3). Especially in AnPC, the tetramer structure appears to be more stable than RePC, 
while there was a very low degree of recombination between the two PC species after 
mixing. In order to obtain the hybrid tetramers with a high degree of recombination, I tested 
the mixing degree under various conditions. I used individual domain mutants RePC´CT 
and RePC´BC´BCCP, from which the hybrid tetramers generated have shown promising 
recovered activity for the pyruvate carboxylation reaction. The individual domain mutants 
are inactive for the catalysis of pyruvate carboxylation. Consequently, any recovered 
activity measured from the mixture is from the hybrid tetramers, which can be used to 
represent the degree of mixing under various conditions. 
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The tested conditions and the corresponding recovered activity from the hybrid 
tetramers are shown in Table VII-1. 
 
Table VII- 1 Recovered activity from the mixture of RePC´CT and RePC´BC´BCCP under 
different mixing conditions 
conditions Mixing conditions 
a Recovered 
activity 
kcat, min-1 
1 1mg/ml wild type RePC was incubated at RT for 30 mins prior to initiating the reaction 1330 ± 40 
2 Two 1mg/ml individual RePC mutants were incubated at RT for 30mins with no acetyl-CoA prior to initiating the reaction 100 ± 2 
3 Two 1mg/ml individual RePC mutants were mixed at RT for 30 mins with 0.25mM acetyl-CoA prior to initiating the reaction 53 ± 5 
4 Two 1mg/ml individual RePC mutants were mixed at RT for 40 mins with no acetyl-CoA prior to initiating the reaction 134 ± 3 
5 
Two 1mg/ml individual RePC mutants were mixed at RT for 40 mins in 
the presence of 0.25mM acetyl-CoA and diluted for 10-fold prior to 
initiating the reaction 
27.3 ± 0.1 
6 *Two 1mg/ml individual RePC mutants were mixed at RT for 60 mins with no acetyl CoA and diluted for 10-fold prior to initiating the reaction 140 ± 4 
7 
Two 1mg/ml individual RePC mutants were diluted for 10-fold and 
sitting at RT for 40min; mix the two PC mutants at RT for 30 mins prior 
to initiating the reaction 
112 ± 1 
8 
Two 1mg/ml individual RePC mutants were diluted for 10-fold and 
sitting at RT for 40mins with 0.25mM AcoA; mix the two PC mutants at 
RT for 30 mins prior to initiating the reaction 
80 ± 1 
9 Two 1mg/ml individual RePC mutants were mixed right away 18.8 ± 0.1 
10 
Two 1mg/ml individual RePC mutants were mixed and diluted for 10- 
fold; incubate it at RT for 20 mins; add acetyl-CoA to finial concn. Of 
0.25mM and incubate everything for another 10mins prior to initiating 
the reaction 
60 ± 1 
11 
Two 1mg/ml individual RePC mutants were mixed and diluted for 10-
fold; incubate the mixture at RT for 20 mins prior to initiating the 
reaction 
56 ± 1 
12 
Two 1mg/ml individual RePC mutants were mixed and diluted for 10-
fold; incubate the mixture at RT for 20 mins with 0.25mM acetyl-CoA 
prior to initiating the reaction 
24 ± 1 
a, All the assays were performed in the presence of 0.25mM acetyl CoA; mean value and standard deviation 
were calculated from two repeats; * protocol cited from previous publication (St Maurice et al. 2007) 
From the results, it can be concluded that: 1) incubation of the enzyme at room 
temperature for 30 mins does not inactivate the enzyme activity (condition 1); 2) the mixing 
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requires at least 30 mins of incubation (condition 2,4,9); 3) Dilution before (condition 4vs7) 
and after (condition 4vs6) the mixing step does not enhance the recombination degree; 4) 
incubating the protein with acetyl CoA during the mixing step reduces the recombination 
degree (condition 3vs4, 5vs6, 7vs8, 11vs12). 5) incubating the protein with acetyl CoA 
after the mixing step does not enhance the recombination degree (condition 10); 6) amongst 
all the conditions I have tested, the condition that generate the most hybrid tetramers was 
mixing the two PC homo tetramer species with 1mg/ml at room temperature for at least 30 
mins.  
From the previously published protocol, the mixture of two PC homo tetramer 
species were diluted 10-fold prior to initiating the reaction. The purpose of doing the 
dilution step was to promote the formation of dimers and monomers, so as to increase the 
degree of recombination between different species. In my experiment, I have found dilution 
did not improve the recombination degree between the two PC species. I argue that 
although dilution will shift the PC tetramers over to the dimer and monomer populations, 
it simultaneously prevents the formation of the hybrid tetramers.  At high concentrations 
(1mg/ml), although PC mostly stays as tetramers, it goes through the rapid dynamic 
equilibrium between monomer, dimer, and tetramer populations, which promotes the 
rehybridization.  
Since acetyl CoA stabilizes the tetramer of PC, I tried adding acetyl CoA after the 
mixing step and prior to initiating the reaction to promote the formation of recombined 
tetramers, which did not show significant enhancement on the recombination degree. 
Previous studies have used the procedure of adding acetyl CoA during the mixing step, in 
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order to facilitate the rehybridization of the PC monomers (Westerhold et al. 2016). 
However, in my experiment, I found that the addition of acetyl CoA during the mixing step 
actually prevented the formation of hybrid tetramers, resulting in a much lower recovered 
activity from the mixture. My results indicate that acetyl CoA can only stabilize the existing 
PC tetramers, but does not shift the equilibrium toward the tetramer population.  
In my study, I systematically tested several mixing conditions and identified the 
optimal condition for mixing. For my study in chapter III, I used co-expression as an 
alternative approach to generate hybrid tetramers with a higher recombination degree, 
using the mixing procedure would be simpler and more efficient if it could generate a fully 
recombined population of hybrid tetramers. Due to the absence of a direct measurement to 
quantify the oligomerization state of PC, it is difficult to modify the conditions without 
knowing the effects on the oligomerization state of PC. Future biophysical assays, such as 
FRET, need to be further developed for this system in order to directly monitor the 
dynamics of the PC oligomerization state.  
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VIII. KINETIC CHARACTERIZATION OF THE INHIBITION OF REPC M419V 
AND ANPC V452M BY L-ASPARTATE 
In chapter II, two a helix structures that were composed by 10 amino acids were 
identified to play an important role on dimerization of the BC domain. A conserved 
methionine residue was identified among the acetyl CoA sensitive PC homologues, 
including RePC but not the acetyl CoA insensitive PC homolog AnPC. RePC M419V was 
generated by mutating the conserved methionine to valine, the equivalent residue in AnPC. 
Similarly, the mutant AnPC V452M has the valine residue in AnPC mutated to the 
equivalent residue methionine from RePC. Kinetic characterization of the activation of the 
two mutants by acetyl CoA demonstrated the mutant RePC M419V had reduced the 
sensitivity to acetyl CoA activation, possibly by disrupted BC dimer interface. 
The allosteric inhibitor L-aspartate and acetyl CoA have the antagonistic effects on 
the catalysis at the BC domain. In order to investigate if disruption of the BC domain 
dimerization has effects on the inhibition of PC by L-aspartate, I characterized the kinetics 
of the inhibition to by L-aspartate of RePC M419V and AnPC V452M (See Table VIII-1). 
 
Table VIII- 1 Inhibition by L-aspartate for the full forward pyruvate carboxylation reaction 
 kcat0, min-1 kcatAsp, min-1 kcatAsp, min-1 / kcat0, min-1 Ki Asp, mM 
wild-type RePC  110± 3 79 ± 4 0.72 ± 0.04 4.6 ± 0.9 
RePC M419V 29.8 ± 1.3 16.9 ± 1.1 0.56 ± 0.04 4.3 ± 1.5 
wild-type AnPC 1990 ± 80 220 ± 60 0.11 ± 0.03 4.0 ± 0,4 
AnPC V452M 1240 ± 30 88 ± 26 0.07 ± 0.02 5.3 ± 0.3 
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The results showed the binding affinity of L-aspartate was not affected by the 
mutations, indicating the binding site of L-aspartate was not disrupted in the mutants. The 
size-exclusion chromatography profile of RePC M419V suggests most of the protein stays 
as monomers and dimers. Previous studies have shown that PC only functions as tetramer, 
which means the activity measured for the steady state turnover rate is only contributed by 
PC tetramers of RePC M419V. Consequently, the unchanged Ki value of L-aspartate 
indicates that the binding site of L-aspartate only exists in PC tetramers. In chapter V, 
studies on the competitive binding between L-aspartate and acetyl CoA analogues have 
suggested that L-aspartate and acetyl CoA partially share the binding site at the pantothenic 
acid arm, most likely at the BC dimer interface. My results on the mutant RePC M419V 
again suggest L-aspartate binding at the BC dimer interface that can only form from intact 
PC tetramers.  
However, the degree of inhibition by L-aspartate was not affected in any of the 
mutants, suggesting that while L-aspartate and acetyl CoA share binding site at the BC 
dimer interface, the inhibition by L-aspartate is not to counteract to the effects caused by 
the activation by acetyl CoA. 
